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Abstract
Transition metal-catalyzed reactions are rapidly being developed for the synthesis complex natural and non-
natural products. Among these, palladium-catalyzed reactions are both attractive and reliable. However, a
formidable challenge at the forefront of organic chemistry is the control of selectivity to enable the selective
formation of diverse structural motifs from readily available substrate classes. Herein, progress toward
broadening the scope of palladium-catalyzed C–C bond-forming reactions is demonstrated, with a particular
focus on controlling reactivity, regioselectivity, and chemoselectivity.
Chapters 1 and 2 describe detailed studies of chemoselectivity with palladium-based phosphine catalysts and
readily available 2-B(pin)-substituted allylic acetates, benzoates, and carbonates. Depending on the choice of
reagents, catalysts and reaction conditions, 2-B(pin)-substituted allylic acetates and derivatives can be steered
into one of three reaction manifolds: allylic substitution, Suzuki-Miyaura cross-coupling, or elimination to
form allenes, all with excellent chemoselectivity. Detailed study of this system indicates the relative order of
reactivity toward Pd(0) is Ar–I > Ar–Br > allylic carbonate > allylic benzoate > allylic acetate, with the
reactivity of allylic carbonates approaching that of aryl bromides. Additionally, we also probe the
regioselectivity with 1,2,3-trisubstituted allylic substrates in Tsuji-Trost allylic substitution reactions. Bulkier
C–2 substituents in 1,2,3-trisubstituted η3-allylpalladium intermediates provide stronger preference for
nucleophilic attack at anti-oriented benzylic termini.
Chapters 3 and 4 describe a direct C–H functionalization approach to produce skeletally diverse
aryl(pyridyl)methyl core structures. The novel arylation step is catalyzed by a Pd(OAc)2/NIXANTPHOS-
based system via a deprotonative cross-coupling process. Under conditions where the azaarylmethyl amines
or ethers’ benzylic C–H is reversibly deprotonated, a Pd(OAc)2/NIXANTPHOS-based catalyst couples the
resulting carbanions with various aryl halides to provide new C–C bonds. The efficient and operationally
simple protocols enable generation of either arylation products or tandem arylation/[1,2]-Wittig
rearrangement products with remarkable selectivity and good to excellent yields. Choice of base, solvent, and
reaction temperature play a pivotal role in tuning the reactivity of intermediates and controlling the relative
rates of competing processes. These practical methods will be applicable for the synthesis of a broad array of
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	 Transition	 metal-catalyzed	 reactions	 are	 rapidly	 being	 developed	 for	 the	 synthesis	 complex	
natural	 and	non-natural	 products.	 	Among	 these,	palladium-catalyzed	 reactions	 are	both	attractive	 and	
reliable.		However,	a	formidable	challenge	at	the	forefront	of	organic	chemistry	is	the	control	of	selectivity	
to	 enable	 the	 selective	 formation	 of	 diverse	 structural	 motifs	 from	 readily	 available	 substrate	 classes.		











reactions.	 	 Bulkier	 C–2	 substituents	 in	 1,2,3-trisubstituted	 η3-allylpalladium	 intermediates	 provide	
stronger	preference	for	nucleophilic	attack	at	anti-oriented	benzylic	termini.	
	 Chapters	3	and	4	describe	a	direct	C–H	functionalization	approach	to	produce	skeletally	diverse	
aryl(pyridyl)methyl	 core	 structures.	 	 The	 novel	 arylation	 step	 is	 catalyzed	 by	 a	 Pd(OAc)2/NIXANTPHOS-
based	 system	 via	 a	 deprotonative	 cross-coupling	 process.	 	 Under	 conditions	 where	 the	 azaarylmethyl	
amines	 or	 ethers’	 benzylic	 C–H	 is	 reversibly	 deprotonated,	 a	 Pd(OAc)2/NIXANTPHOS-based	 catalyst	
couples	 the	resulting	carbanions	with	various	aryl	halides	 to	provide	new	C–C	bonds.	 	The	efficient	and	
operationally	simple	protocols	enable	generation	of	either	arylation	products	or	tandem	arylation/[1,2]-
Wittig	rearrangement	products	with	remarkable	selectivity	and	good	to	excellent	yields.		Choice	of	base,	
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CHAPTER	 2	 PALLADIUM-CATALYZED	 CHEMOSELECTIVE	 ALLYLIC	 SUBSTITUTION,	 SUZUKI-




















































	 Transition	metal-catalyzed	 allylic	 substitution	 reactions	 are	 among	 the	most	 powerful	
synthetic	 methods	 in	 organic	 chemistry.1,2	 	 In	 particular,	 the	 palladium-catalyzed	 Tsuji-Trost	
reaction	has	become	an	efficient	method	to	construct	carbon–carbon	and	carbon–heteroatom	
bonds.1b,1c,2b,3		One	of	the	most	interesting	and	challenging	aspects	of	allylic	substitutions	is	the	
control	 of	 regioselectivity.1a,1b,4	 	 The	 regioselectivity	 of	 the	 palladium-catalyzed	 allylic	
substitution	 reaction	depends	on	 several	 parameters1a,4b,4c	 including:	 the	nature	of	 the	 ligand,	
solvent,	counter	anion,	leaving	group,	nucleophile,	base,	allyl	fragment,	and	additives.2f,3a,5	
	 The	 mechanism	 of	 the	 Pd-catalyzed	 allylic	 substitution	 has	 been	 well	 investigated.		
Initial	 coordination	 of	 the	 allylic	 substrate	 at	 the	 double	 bond	 is	 followed	 by	 attack	 of	













of	 chiral11	 or	 electronically	 differentiated12	 ligands,	 the	 reaction	 can	 show	 strong	 memory	
effects.		Under	conditions	of	slow	isomerization,	nucleophilic	attack	has	a	strong	preference	for	
reaction	 at	 anti-oriented	 termini.13	 	 In	 the	 absence	 of	memory	 effects,	 the	 regioselectivity	 is	
largely	dependent	on	the	steric	and	electronic	nature	of	the	terminal	η3-allyl	substituents.4b,4c		In	
general,	 nucleophilic	 attack	will	 occur	 at	 the	 allylic	 terminus	with	 the	 highest	 partial	 positive	
charge.14	 	 Conjugated	 products	 are	 frequently	 preferred,	 in	 particular	 with	 strongly	 electron	











































controlling	 the	 steric	 bulk	 of	 the	 ligands.13,16	 	 In	 these	 cases,	 the	 preferred	 regio-	 and	 stereo-
selectivity	can	be	understood	in	terms	of	distortion	of	the	(η3-allyl)Pd	intermediate.16-17			
	 Previous	 mechanistic	 investigations	 have	 mostly	 focused	 on	 substrates	 giving	 rise	 to	
mono-	or	1,3-disubstituted	 (η3-allyl)Pd	 intermediates.1b,18	 	 In	general,	1-aryl-3-alkyl-substituted	
(η3-allyl)Pd	complexes	have	a	strong	preference	for	nucleophilic	attack	at	the	alkyl-substituted	
terminus,	 yielding	 conjugated	 products.16-17,19	 	 This	 preference	 can	 be	 further	 increased	 by	
utilization	 of	 ligands	 to	 force	 the	 alkyl	 substituent	 into	 the	 more	 reactive	 anti-configuration	
(Scheme	1.1).	13,16-17	
	 Our	 interest	 in	 trisubstituted	 (η3-allyl)Pd	 intermediates	 grew	 out	 of	 methods	 we	
developed	for	the	synthesis	of	2-B(pin)-substituted	allylic	acetates	and	related	compounds.20,21		
At	 the	outset	 of	 our	 studies,	we	demonstrated	2-B(pin)-substituted	 allylic	 acetates	 undergoes	
the	Tsuji-Trost	allylic	substitution	reaction	successfully.21		In	the	meantime,	a	few	methods	with	
boron-substituted	 allyls	 have	 been	 reported	 in	 allylic	 substitution	 reactions	 (Scheme	 1.2).21,22		
Before	our	preliminary	 results	 (Scheme	1.2D),21	however,	no	prior	examples	of	allylic	acetates	
containing	 a	 boron	 at	 the	 2-position	 were	 employed	 in	 transition	 metal-catalyzed	 allylic	
substitution	 reactions,	 although	 some	 examples	 of	 3-boron	 substituted	 analogs	 had	 been	
generated	or	proposed	as	intermediates.22	
	 As	 inferred	 by	 Scheme	 1.2D,21	 2-B(pin)-substituted	 allylic	 acetates	 are	 expected	 to	
generate	 (η3-1-aryl-2-boryl-3-alkyl-allyl)palladium	 intermediates.	 	 Contrary	 to	 aliphatic	
substitutions,16	 however,	 nucleophilic	 attack	 occurred	 at	 the	 benzylic	 position	 with	 very	 high	
selectivity	(Scheme	1.2D).		In	general,	products	derived	from	benzylic	attack	of	(η3-1-aryl-3-alkyl-	
allyl)palladium	 intermediates	 are	 the	 minor	 isomer.16-17,19a-d	 	 Herein,	 we	 have	 undertaken	 an	
experimental	 and	 computational	 investigation	 of	 cationic	 (η3-1-phenyl-2-B(pin)-3-alkyl-	
4	
allyl)Pd(PPh3)2	and	related	intermediates.		We	present	a	systematic	substrate-selectivity	study	to	








1,2,3-trisubstituted	 allylic	 acetates	 is:	 What	 is	 the	 impact	 of	 the	 2-substituent	 on	 the	
regioselectivity	 of	 nucleophilic	 attack?	 	 This	 question	 emerged	 as	 we	 explored	 palladium-
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up to >20:1 of benzylic substitution productR
1, R2 = aryl or aliphatic













	 We	 recently	 communicated21	 the	 palladium-catalyzed	 allylic	 substitution	 reaction	
employing	 2-B(pin)-substituted	 allylic	 acetates	 (1.1,	 Table	 1.1).	 	 In	 our	 initial	 study,	 we	 were	
surprised	to	find	that	the	2-B(pin)	group	plays	a	decisive	role	in	determining	the	regioselectivity	
of	 nucleophilic	 attack.	 	 For	 example,	 2-B(pin)-substituted	 allylic	 acetate	 1.1a	 underwent	
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a See the experimental sextion for details. b Yield of purified and isolated products. c Ratios 
were determined by 1H NMR spectroscopy of unpurified reaction mixtures. d Reference 21.  




provided	 the	 benzylic	 substitution	 products	 (1.2b	 and	 1.2c)	 with	 excellent	 regioselectivity	
(>95:5)	 in	 92	 and	 80%	 yield,	 respectively	 (entries	 2	 and	 3).	 	 It	 is	 noteworthy	 that	 isomeric	 2-
B(pin)-substituted	 allylic	 acetates	 1.1a	 and	 1.1d	 underwent	 substitution	 to	 afford	 the	 same	
product,	 1.2a,	 with	 nearly	 identical	 regioselectivities	 (entries	 1	 vs.	 4).	 	 This	 result	 clearly	
demonstrates	 the	 absence	 of	 regiochemical	memory	 effects.10	 	 Allylic	 acetate	1.1d,	 however,	
afforded	 a	 diminished	 yield	 of	 the	 substitution	 product	 (51%,	 entry	 4)	 relative	 to	 1.1a	 (79%	
yield).		Primary	and	secondary	amines	also	participated	in	the	allylic	substitution	reaction	to	give	
similar	 regioselectivities	 (>90:10)	 by	 nucleophilic	 attack	 at	 the	 benzylic	 position.21	 	 We	 were	
concerned	 that	 the	 3-n-butyl	 substituent	 might	 adopt	 a	 conformation	 180°	 opposite	 the	
palladium	center	and	hinder	nucleophilic	attack	at	 the	3-position	 (Figure	1.1).	 	To	 remove	any	
potential	conformational	 issues	caused	by	the	3-n-butyl	substituent,	2-B(pin)-substituted	allylic	
acetate	 1.1e,	 with	 a	 smaller	 3-methyl	 substituent	 in	 place	 of	 the	 n-butyl	 group	 of	 1.1a,	 was	
prepared	 (see	 Supporting	 Information	 for	 details).	 	 Interestingly,	 1.1e	 also	 provided	 benzylic	
substitution,	 affording	 1.2e	 with	 excellent	 regioselectivity	 (>95:5)	 in	 70%	 yield	 (entry	 5).	 	 As	
outlined	 in	 Table	 1,	 the	 1-aryl-2-B(pin)-3-alkyl	 η3-allyls	 showed	 a	 strong	 preference	 for	
nucleophilic	attack	at	the	benzylic	site,	in	contrast	to	the	observed	regioselectivity	in	Tsuji-Trost	
allylic	 substitution	 reactions	 with	 1-aryl-substituted	 η3-allyl	 intermediates.19a-c,19e	 	 The	 unique	










(η3-allyl)Pd	complexes.23	 	 In	 these	calculations	 it	 is	 found	 that	 the	 transition	 state	 is	unusually	
sensitive	to	the	nature	of	the	solvent	employed.24		To	minimize	such	solvent	related	issues,	we	
employ	 a	 neutral	 model	 nucleophile	 (ammonia)	 reacting	 with	 a	 cationic	 (η3-allyl)Pd(PPh3)2	
complex	to	yield	a	cationic	allyl	ammonium	product	coordinated	to	a	neutral	Pd0(PPh3)2	moiety.		
This	 procedure	 maintains	 the	 overall	 charge,	 minimizing	 computational	 artifacts	 arising	 from	
imperfect	 solvation	of	 complexes	with	different	 charges.12	 	All	 calculations	were	performed	 in	
Jaguar25	 with	 B3LYP-D3,	 which	 uses	 the	 dispersion-correction	 of	 Grimme	 and	 co-workers26	
together	 with	 the	 classical	 B3LYP	 functional.27	 	 We	 utilized	 the	 LACVP*	 basis	 set28	 and	 PBF	
solvation29	with	default	parameters	for	THF.	
	 We	 located	 the	 approximate	 “transition	 states”	 by	 scanning	 the	 forming	 C–N	 bond	
distance	while	 relaxing	 all	 other	 coordinates	 in	 the	 presence	 of	 the	 continuum	 solvent.	 	 This	
technique	 has	 been	 successful	 for	 very	 similar	 systems,30	 and	 is	 expected	 to	 yield	 final	
transitions	 state	energies	within	 a	 few	kJ	mol-1	 of	 the	expected	 fully	 converged	 values.31	 	 The	



















depending	 on	 the	 starting	 point,	 by	 up	 to	 4	 kJ	 mol-1.	 	 Furthermore,	 the	 final	 frequency	
calculation	 always	 yielded	 2–3	 additional	 imaginary	 frequencies,	 with	wavenumbers	 up	 to	 31	
cm-1.		However,	the	reaction	coordinate	was	always	well	defined,	with	imaginary	frequencies	in	
the	 range	 106–207	 cm-1,	 and	 on	 visualization,	 this	 vector	 always	 corresponded	well	 with	 the	
expected	attack	of	the	nucleophile	on	an	allyl	terminus.		Qualitatively,	the	results	from	the	full	
TS	searches	and	the	scans	were	the	same,	and	numerically,	the	final	energies	were	within	a	few	
kJ	mol-1	 from	each	other.	 	Due	 to	 the	uncertainty	 in	 the	 former,	 the	energies	 reported	herein	
come	from	the	scan	approach.	
	 All	 transition	states	were	fully	validated	by	QRC	calculations.32	 	For	the	scans,	the	QRC	
was	 implemented	 by	 minimizing	 the	 end	 points	 on	 the	 scan	 and	 verifying	 that	 they	
corresponded	 to	pre-reactive	 complex	and	an	allyl	 ammonium	complex,	 respectively.	 	 For	 the	
results	 from	 the	 TS	 searches,	 the	 starting	 points	 for	 the	 minimizations	 were	 constructed	 by	
distortion	along	the	Cartesian	eigenvector	corresponding	to	the	reaction	coordinate,	scaled	by	
0.3.	
	 It	 has	 been	 previously	 demonstrated	 that	 the	 regioselectivity	 in	 Pd-catalyzed	 allylic	
substitution	 can	 be	 rationalized	 by	 considering	 the	 geometry	 of	 the	 intermediate	 η3-allyl	




intermediate.17	 	 Steric	 interactions	between	 the	 ligand	and	allyl	moieties	 caused	a	 rotation	of	
the	allyl	toward	a	product-like	conformation.		Such	a	rotation	could	selectively	elongate	one	Pd–
C	 bond,	 thereby	 increasing	 its	 reactivity.	 	 Both	 of	 these	 factors	 are	 known	 to	 influence	 the	
regioselectivity	of	the	nucleophilic	attack.17		We	are	unaware,	however,	of	previously	considered	
cases	 in	 which	 the	 regioselective	 benzylic	 attack	 dominates.	 	 We	 therefore	 calculated	 the	
structures	of	 intermediates	 for	a	 few	model	systems	to	rationalize	 the	observed	behavior.	 	To	
avoid	 extensive	 conformational	 searching,	 we	 performed	 the	 computational	 study	 on	 the	
smallest	relevant	system,	cationic	(η3-1-Ph-2-B(pin)-3-Me-allyl)Pd(PPh3)2.			
	 We	first	considered	three	possible	 intermediates	(Figures	1.2	and	1.3).	 	 In	the	absence	
of	 ligand-allyl	 interactions,	 the	 dominant	 structure-determining	 factor	 in	(η3-allyl)Pd	
complexes	is	 the	repulsion	 between	 the	 substituent	 and	Pd.		Due	 to	 the	 tilt	 of	the	 η3-allyl	
moiety,	 an	anti-substituent	is	 much	 closer	 to	 Pd	 than	 a	syn-substituent,	 as	 can	 be	 seen	 in	
representative	X-ray	structures	with	both	syn	and	anti	aryl	moieties.33		Measuring	the	distances	
from	Pd	to	the	aryl	substituent	ipso-carbons,	the	anti-aryls	are	closer	to	Pd	by	ca.	0.3	Å,	and	are	
clearly	 within	 the	 repulsive	 region.		 For	 this	 reason,	 unencumbered	 complexes	 almost	
exclusively	 prefer	 the	 less	 encumbered	syn	 configuration.	 	 However,	 the	 preference	 can	 be	
shifted	by	ligands	that	protrude	into	the	η3-allyl	coordination	plane.		For	example,	2,9-dicyano-
1,10-phenanthroline,	which	 selectively	 interferes	with	 syn-methyl	 groups	 in	 crotyl	 complexes,	
shifts	 the	 preference	 to	 anti.13	 	 The	 last	 important	 interaction	 is	 the	 repulsion	 between	 a	 2-
substituent	 and	 a	 syn-substituent.	 	 There	 are	 X-ray	 structures	 showing	 the	anti	 preference	 of	
alkyl	groups	in	such	complexes.13		For	aryl	groups,	the	preference	for	the	syn	isomer	is	stronger;	





anti.	 	 It	 is	 from	 such	 structures	 we	 can	 see	 the	 interactions	 in	 the	 X-ray	 (mostly	 1,1,3-
triphenyl).34	 	 Togni	 has	 suggested	 that	 a	 phenyl	 that	 can	 adopt	 the	 syn	 or	 anti	 position,	 but	
prefers	 anti	 when	 a	 very	 hindered	 ligand	 is	 employed.34	 	 Moreover,	 Faller	 and	 co-workers	
generalized	that	steric	factors	of	substitutions	on	allyl	moieties	can	change	the	ratio	of	syn	and	
anti	 isomers	 in	 cationic	 (η3-1,2-disubstituted	 allyl)Pd	 and	 (η3-1,2,3-trisubstituted	 allyl)Pd	
intermediates.35		Their	studies	demonstrate	that	bulky	substitution	on	C-2	can	force	generation	








TS-1.3	 reaction.	 	 It	 is	 known	 that	 (η3-allyl)Pd	 intermediates	 can	 rapidly	 equilibrate	 before	 the	





































































































































































































































































































reactions.5,37	 	 If	the	rate	of	isomerization	among	INT-1.1,	INT-1.2,	and	INT-1.3	 is	fast,	the	more	











	 In	 transition	 states	 TS-1.1	 and	 TS-1.3	 (Figures	 2	 and	 3),	 the	 distances	 between	 the	
ammonia	nucleophile	and	Carbon-1	 is	2.72	Å	 in	TS-1.1	vs.	2.87	Å	 in	TS-1.3.	 	For	 the	small	NH3	
nucleophile,	 there	 is	 little	 repulsive	 interaction,	 however,	 larger	 nucleophiles	 will	 encounter	
more	severe	steric	interactions	in	the	TS.		A	more	important	effect	arises	upon	elongation	of	the	
Pd–C	 bond	 in	 the	 TS.	 	 This	 elongation	 alleviates	 the	 repulsion	 between	 Pd	 and	 an	 anti-
substituent.	 	 In	contrast,	 the	rehybridization	on	nucleophilic	attack	pushes	 the	syn	 substituent	
down	 into	 the	 ligand,	 resulting	 in	 destabilization.	 	 Furthermore,	 the	 conjugation	 penalty	 that	
was	 found	 for	1-anti-3-syn	 INT-1.2	 is	much	 less	 severe	 in	TS-1.3,	because	most	of	 the	penalty	




positions	 (TS-1.1	 and	 1.2),	 such	 that	 the	 energy	 for	 the	 anti-addition	 TS	 is	 lower	 despite	 the	










	 It	 is	also	 important	that	allylic	substitution	products	with	the	 	 (Z)-olefin	geometry	have	
not	been	detected	 in	any	of	experiments	outlined	here.	 	 This	 clearly	 shows	 that	 any	anti,syn-
complexes	 are	 attacked	exclusively	 at	 the	anti-	position,	 and	 also	 that	anti,anti-complexes	do	
not	play	a	role	in	this	chemistry,	in	good	agreement	with	earlier	studies.10d,13,16-17			
	






















10 mol % Pd(OAc)2
20 mol % PPh3
THF (0.1 M), 40 °C
15	
carbonates	synthesized	for	this	study	include	the	parent	derivatives,	bearing	a	2-hydrogen	(1.1f	
and	 1.1g),	 and	 the	 2-methyl	 (1.1h	 and	 1.1m),	 2-n-butyl	 (1.1i),	 and	 2-cyclohexyl	 (1.1j–l)	














































1.1f 1.1g 1.1h 1.1i
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13 [Pd(allyl)Cl]2 1570 24

















































8 [Pd(allyl)Cl]2 366570 24 641.1h























































a See the Supporting Information for experimental details. b Yield of purified and isolated products. c Ratios determined 




















the	 identical	 condition	 using	 Pd(OAc)2	 as	 a	 catalyst	 precursor,	 highlighting	 the	 impact	 on	
reactivity	of	 an	 alkyl	 group	at	 the	2-position	 (Table	1.2,	 entry	5).	 	 In	 the	presence	of	 catalytic		
[Pd(allyl)Cl]2/4PPh3	 and	 3	 equiv	 of	 NaCH(CO2Me)2	 in	 THF	 at	 40	 °C,	 however,	 the	 2-methyl	
substrate	1.1h	 provided	 the	 allylic	 substitution	 product	with	 regioselectivity	 of	 63:37	 favoring	
benzylic	attack	and	forming	predominantly	regioisomer	1.2h		(entry	6).		While	the	Pd-catalyzed	
allylic	 substitution	with	 stabilized	 carbon	nucleophiles	 is	 usually	 irreversible	 and	under	 kinetic	
control,	dialkyl	malonates	can	act	as	 leaving	groups	at	higher	temperature	and	longer	reaction	
times,	 and	 product	 formation	 can	 be	 under	 thermodynamic	 control.38	 	 To	 investigate	 this	
possibility,	 reaction	 of	 1.1h	 at	 40	 and	 70	 °C	 with	 longer	 reaction	 times	 did	 not	 result	 in	
significant	changes	in	the	regioselectivities	(entries	7	and	8).		Furthermore,	control	experiments	
showed	 that	 the	 reaction	of	 the	mixture	of	1.2h	 and	1.3h	 (63:37)	 in	 the	presence	of	 catalytic	
[Pd(allyl)Cl]2/4PPh3	and	3	equiv	of	NaCH(CO2Bn)2	in	THF	at	40	°C	or	70	°C	led	to	the	same	ratio	of	
1.2h	 and	 1.3h	 without	 any	 detectable	 amount	 of	 corresponding	 substitution	 products	 from	
NaCH(CO2Bn)2.39	 	 The	 larger	 2-n-butyl	 substituted	 allylic	 acetate	 1.1i	 resulted	 in	 increased	
benzylic	attack	with	a	regioselectivity	of	81:19	of	1.2i:1.3i	(entries	9	and	10).		After	observing	a	
switch	 in	 regioselectivity	 upon	 changing	 the	 size	 of	 the	 substituent	 at	 the	 2-position,	 we	
employed	 the	 larger	 2-cyclohexyl	 group	 to	 further	 explore	 this	 trend	 further.	 	 Substrate	 1.1j	
underwent	 reaction	with	NaCH(CO2Me)2	and	catalyst	generated	 from	[Pd(allyl)Cl]2	or	Pd(OAc)2	
to	 afford	 predominantly	 product	 1.2j	 via	 benzylic	 attack	 with	 regioselectivities	 of	 84:16	 and	
86:14,	respectively	(entries	11–13).		It	is	noteworthy	that	benzylic	acetate	1.1j	 is	more	reactive	
with	 the	 Pd(OAc)2-based	 catalyst	 than	 aliphatic	 acetate	 1.1h,	 which	 did	 not	 react	 with	 this	





the	 formation	 of	 allylpalladium	 intermediate.	 	 It	 is	 known	 that	 allylic	 carbonates	 are	 more	
reactive	than	their	acetate	counterparts	by	about	2	orders	of	magnitude.40		Using	more	reactive	
allylic	 carbonate	1.1l	 led	 to	 only	 5%	 isolated	 yield	 of	 the	 allylic	 substitution	product	1.2j	with	
83:17	 regioselectivity	 (entry	 15).	 	 Thus,	 regardless	 of	 (E)-	 or	 (Z)-geometry	 of	 the	 starting	
materials,	 the	 benzylic	 substitution	products	with	 (E)-configuration	were	observed	 (entries	 12	
and	 15).	 	 The	 close	 regiochemical	 agreement	 from	 both	 (E)-	 and	 (Z)-substrates	 strongly	
supported	 a	 rapid	 isomerization	 of	 sterically	 hindered	 1,2,3-trisubstitued	 allylpalladium	





A-values	of	substituents	 to	explicit	modeling.	 	For	 the	Tsuji-Trost	 reaction,	steric	 influences	on	
the	activation	barrier	have	been	modeled	using	explicit	probes.17	More	recently,	Sigman	and	co-
workers41	demonstrated	that	selectivities	in	the	Tsuji-Trost	reaction	can	be	reproduced	using	a		
linear	 correlation	 with	 Charton	 steric	 parameters.42	 	 We	 therefore	 attempted	 a	 correlation	
between	 the	 Charton	 value	 of	 the	 2-substituents	 and	 the	 logarithm	 of	 the	 observed	
regioselectivity,	 as	 shown	 in	 Table	 1.3.	 	 Consideration	 of	 this	 steric	 parameter	 quantitatively	



























10 mol % [Pd(allyl)Cl]2























a logarithm of ([1.2]/[1.3]). b 1.1h  was used, instead of the regioisomer shown here.
20	
1.2.4. Palladium-Catalyzed	 1,4-Elimination	 Reaction	 of	 1,2,3-Trisubstituted	 Allylic	
Acetates.	
	 The	 palladium-catalyzed	 elimination	 reaction	 of	 allylic	 acetates	 is	 a	 useful	method	 to	
form	 1,3-dienes.43	 	 Palladium(0)	 mediated	 ionization	 of	 allylic	 acetates	 1.1	 forms	 η3-
allylpalladium(II)	intermediates	1.5	(Scheme	1.3).		Allylpalladium(II)	regenerates	palladium(0)	via	
anti-	 or	 syn-	 elimination	 to	 furnish	 1,3-dienes	 1.4.44	 	 Consistent	 with	 this	 proposed	 reaction	




	 Inspired	 by	 these	 observations,	 allylic	 acetates	 1.1i	 and	 1.1j	 were	 reexamined	 in	 the	
allylic	 substitution	 reaction	 and	 1,3-dienes	 were	 isolated	 at	 40	 °C	 in	 17	 and	 22%	 yield,	
respectively	 (Table	 1.4,	 entries	 1	 and	 3).	 	 The	 ratios	 of	 dienes	 were	 determined	 by	 1H	 NMR	
spectroscopy	 of	 unpurified	 reaction	 mixtures,	 and	 the	 stereochemistry	 of	 the	 dienes	 was	
confirmed	by	 comparison	 to	 similar	 known	 compounds.	 	 In	 the	 reactions	 above,	 the	 ratios	 of	




regioselectivity	 (81:19).	 	 The	 1,4-elimination	 product	 was	 isolated	 in	 67%	 yield	with	 a	 similar	
diene	ratio	 to	the	reaction	at	40	°C	[(Z,E)-1.4i	 :	 (E,E)-1.4i	=	27	 :	73,	Table	1.4,	entry	2].	 	The	2-






a	 1-anti-η3-allyl	 complex	 as	 a	 reactive	 intermediate.44h	 	 Irrespective	 of	 the	 mechanism	 of	
elimination	(E2	or	β-hydride	elimination),	the	(Z,E)-product	can	arise	from	an	intermediate	with	
the	 phenyl	 substituent	 in	 the	 anti-position	 of	 the	 (η3-allyl)Pd	 intermediate.	 	 This	 observation	
lends	further	support	to	our	interpretation	that	anti-configured	intermediates	are	important	in	
the	nucleophilic	attack.		The	newly	formed	double	bond	in	the	3,4-position	can	be	formed	from	






































substituted	 2-B(pin)-allylic	 acetates,	 the	 boryl	 group	 plays	 a	 pivotal	 role	 in	 determining	 the	
regioselectivity	 of	 the	 allylic	 substitution	 reaction.	 	 The	 unsymmetrical	 2-B(pin)-substituted	
allylic	acetates	show	preference	for	nucleophilic	attack	at	the	benzylic	site,	which	is	opposite	to	
the	 expected	 regioselectivity	 in	 Tsuji-Trost	 allylic	 substitution	 reactions	with	 (η3-1-aryl-3-alkyl-
allyl)Pd	intermediates.		A	computational	study	of	the	mechanism	responsible	for	regioselectivity	
with	cationic	(η3-1-Ph-2-B(pin)-3-Me-allyl)Pd(PPh3)2	indicates	that	the	unusual	regioselectivity	is	









[Pd(allyl)Cl]2 (5 mol %)




2 70 20 67
1 40 83 17
4 70 15 70
































 R = n-Bu
 R = Cy
1.2i,
1.2j,
 R = n-Bu











a Yield of purified and isolated products. b Ratios determined by 1H NMR spectroscopy of 
unpurified reaction mixtures.
23	
the	 bulkier	 the	 group	 at	 the	 2-position	 of	 1-aryl-2,3-disubstituted	 η3-allyl	 intermediates,	 the	
greater	 propensity	 for	 nucleophilic	 attack	 at	 the	 benzylic	 position.	 	 The	 use	 of	 Charton	 steric	
parameters	 led	 to	 a	 strong	 correlation	 between	 the	 size	 of	 the	 C-2	 substituent	 and	 the	
regioselectivity	 of	 nucleophilic	 attack	 at	 the	 corresponding	 η3-allyls.	 	 Based	 on	 the	 working	
models	garnered	from	computational	and	experimental	studies,	we	attribute	this	selectivity	to	
the	 repulsion	between	 the	1-	and	2-substituents,	 forcing	 the	1-aryl	group	 into	a	 reactive	anti-
position	through	rapid	syn-anti	isomerization.	
	 Finally,	palladium-catalyzed	1,4-elimination	reactions	of	allylic	acetates	also	support	the	






glassware.	 	 All	manipulations	 involving	 dicyclohexylborane,	 dimethylzinc	 and	 diethylzinc	were	
carried	out	under	an	inert	atmosphere	in	a	Vacuum	Atmospheres	drybox	with	an	attached	MO-
40	Dritrain	or	by	using	standard	Schlenk	or	vacuum	line	techniques.	 	Chemicals	were	obtained	
from	 Aldrich,	 Acros,	 or	 GFS	 Chemicals	 unless	 otherwise	 specified.	 	 Solvents	 were	 purchased	
from	 Fischer	 Scientific.	 	 Toluene	 was	 dried	 through	 an	 activated	 alumina	 column,	 and	 then	
thoroughly	 degassed	 prior	 to	 use.	 	 Tetrahydrofuran	 was	 distilled	 from	 sodium	 and	












of	 regioisomeric	 ratios	 was	 performed	 by	 analysis	 of	 1H	 NMR	 spectra	 of	 unpurified	 reaction	
products.	 	The	vinyl	boronate	ester	 is	susceptible	to	oxidation	of	the	B–C	bond	on	silica	under	




















mL).	 The	 combined	 organic	 solution	 was	 dried	 over	 MgSO4,	 filtered,	 and	 the	 solvent	 was	
removed	under	reduced	pressure	to	yield	a	colorless	oil.	The	crude	product	was	purified	by	flash	


































mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	




boron	 group	 is	 not	 observed);	 11B	NMR	 (CDCl3,	 128	MHz)	 δ	 29.8;	 IR	 (neat)	 2979,	 2933,	 1740,	






	(E)-2-Butyl-1-phenylhept-2-en-1-yl	 acetate	 (1.1i).	 To	 a	 suspension	 of	 HBCy2	
(107	mg,	0.6	mmol)	in	toluene	(1.0	mL)	equipped	with	a	stir	bar	under	N2	was	

















































until	 TLC	 showed	 complete	 consumption	 of	 the	 intermediate	 allylic	 alkoxide.	 The	 reaction	
mixture	was	then	diluted	with	EtOAc	(5	mL)	and	quenched	with	saturated	NH4Cl	(5	mL)	at	0	°C.	






















1) t-BuLi (2 equiv), THF




1.1j, 87% yield1.1j-ol,  78% yield
28	
		(E)-2-Cyclohexyl-1-phenylhept-2-en-1-ol	 (1.1j-ol).	 To	 an	 oven-dried	 Schlenk	
flask	 equipped	with	 a	 stir	 bar	 under	 N2	 was	 added	 (E)-(1-Bromohex-1-en-1-
yl)cyclohexane47	(245	mg,	1.0	mmol)	and	THF	(2	mL).	The	reaction	vessel	was	cooled	to	–78	°C	in	





benzaldehyde	 (102	 uL,	 1.0	 mmol)	 was	 added	 slowly	 and	 the	 reaction	 mixture	 was	 slowly	
warmed	to	rt	over	2	h.	The	reaction	mixture	was	diluted	with	EtOAc	(5	mL)	and	quenched	with	
saturated	 NH4Cl	 (10	 mL).	 The	 organic	 layer	 was	 separated	 and	 the	 aqueous	 solution	 was	
extracted	with	EtOAc	(3	x	10	mL).	The	combined	organic	 layer	was	washed	with	brine	 (10mL),	
dried	 over	MgSO4,	 filtered,	 and	 the	 solvent	 was	 removed	 under	 reduced	 pressure	 to	 yield	 a	















	(E)-2-Cyclohexyl-1-phenylhept-2-en-1-yl	 acetate	 (1.1j).	 To	 a	 20	mL	 glass	 vial	
equipped	 with	 a	 stir	 bar	 was	 added	 (E)-2-cyclohexyl-1-phenylhept-2-en-1-ol	
(136	mg,	0.5	mmol)	and	CH2Cl2	(1	mL).	DMAP	(12.2	mg,	0.1	mmol)	was	added	
to	the	solution	and	the	reaction	mixture	was	stirred	at	rt	for	5	min.	To	the	reaction	mixture	was	
added	 acetic	 anhydride	 (142	 uL,	 1.5	 mmol)	 and	 the	 vial	 was	 sealed	 with	 a	 screw	 cap.	 The	
reaction	mixture	was	stirred	at	rt	 for	2	h.	The	reaction	mixture	was	diluted	with	CH2Cl2	 (5	mL)	
and	quenched	with	DI	water	(10	mL).	The	organic	layer	was	separated	and	the	aqueous	solution	
was	 extracted	 with	 CH2Cl2	 (2	 x	 10	 mL).	 The	 combined	 organic	 layer	 was	 dried	 over	 MgSO4,	
filtered,	and	the	solvent	was	removed	under	reduced	pressure	to	yield	a	colorless	oil.	The	crude	




Hz,	 1H),	 1.38	 –	 1.04	 (m,	 9H),	 0.90	 (t,	 J	 =	 7.0	Hz,	 3H);	 13C{1H}	NMR	 (125	MHz,	 CDCl3)	 δ	 170.1,	
141.8,	140.0,	129.7,	128.3,	127.8,	127.7,		76.8,	40.0,	32.3,	32.0,	31.7,	27.6,	27.2	(two	overlapping	





















	(Z)-2-Cyclohexyl-1-phenylhept-2-en-1-yl	 acetate	 (1.1k).	 To	 a	 20	 mL	 glass	 vial	
equipped	 with	 a	 stir	 bar	 was	 added	 (Z)-2-cyclohexyl-1-phenylhept-2-en-1-ol48	
(120	mg,	0.38	mmol)	and	CH2Cl2	(1	mL).	DMAP	(9.8	mg,	0.08	mmol)	was	added	to	
the	solution	and	the	reaction	mixture	was	stirred	at	 rt	 for	5	min.	To	the	reaction	mixture	was	
added	 acetic	 anhydride	 (108	 uL,	 1.14	 mmol)	 and	 the	 vial	 was	 sealed	 with	 a	 screw	 cap.	 The	
reaction	mixture	was	stirred	at	rt	 for	2	h.	The	reaction	mixture	was	diluted	with	CH2Cl2	 (5	mL)	
and	quenched	with	DI	water	(10	mL).	The	organic	layer	was	separated	and	the	aqueous	solution	
was	 extracted	 with	 CH2Cl2	 (2	 x	 10	 mL).	 The	 combined	 organic	 layer	 was	 dried	 over	 MgSO4,	
filtered,	and	the	solvent	was	removed	under	reduced	pressure	to	yield	a	colorless	oil.	The	crude	















i) n-BuLi (1.1 equiv), –78 °C to 0 °C, THF











































OAcAc2O (3 equiv)DMAP(0.1 equiv)
Et3N (3 equiv)
CH2Cl2, rt, 30 min
1.1m,  87% yield
32	
	(E)-2-Methyl-1-phenylpent-2-en-1-yl	 acetate	 (1.1m).	 To	 a	 20	 mL	 glass	 vial	
equipped	with	 a	 stir	 bar	was	 added	 (E)-2-methyl-1-phenylpent-2-en-1-ol49	 (550	
mg,	3.12	mmol)	and	CH2Cl2	(6	mL).	DMAP	(38	mg,	0.31	mmol)	and	Et3N	(1.3	mL,	
9.36	mmol)	were	added	to	the	solution	and	the	vial	was	sealed	with	a	screw	cap.	The	reaction	
mixture	was	stirred	at	 rt	 for	5	min.	To	 the	 reaction	mixture	was	added	acetic	anhydride	 (0.88	
mL,	9.36	mmol)	and	the	resulting	solution	was	stirred	at	rt	for	30	min.	The	reaction	mixture	was	
then	 diluted	with	 CH2Cl2	 (5	mL)	 and	 quenched	with	 DI	 water	 (10	mL).	 The	 organic	 layer	 was	
separated	 and	 the	 aqueous	 solution	 was	 extracted	 with	 CH2Cl2	 (2	 x	 20	 mL).	 The	 combined	
organic	 layer	 was	 dried	 over	 MgSO4,	 filtered,	 and	 the	 solvent	 was	 removed	 under	 reduced	






















hydride	 (7.9	mg,	 0.33	mmol)	 in	 2.0	mL	 of	 dry	 and	 degassed	 THF	 under	 N2,	 and	 the	 reaction	
mixture	cooled	 to	0	 °C	 in	an	 ice	bath.	To	 this	white	 suspension	was	added	dropwise	dimethyl	
malonate	(35	µL,	39.6	mg,	0.3	mmol)	at	0	°C,	which	was	accompanied	by	rapid	evolution	of	H2.	
The	reaction	soon	became	clear,	after	which	 it	was	heated	to	 reflux	under	N2	 for	15	min.	The	
dimethyl	malonate	 sodium	 solution	 (3	 equiv)	was	 cooled	 to	 rt,	 and	 then	 cannulated	 into	 the	

















catalyst	 solution	 was	 added	 2-B(pin)-substituted	 allylic	 acetate	 (0.10	mmol)	 and	 the	 reaction	
mixture	stirred	for	an	additional	15	min,	after	which	N,O-bis(trimethylsilyl)acetamide	(BSA)	(73	
µL,	 61.0	mg,	 0.30	mmol,	 3	 equiv)	 and	dimethylmalonate	 (34	µL,	 39.6	mg,	 0.3	mmol,	 3	 equiv)	
were	 added	at	 rt	 followed	by	 catalytic	 KOAc.	 The	 reaction	mixture	was	warmed	 to	40	 °C	 and	
stirred	 until	 TLC	 showed	 complete	 consumption	 of	 the	 2-B(pin)	 substituted	 allylic	 acetate,	
typically	10	–	12	h.	The	reaction	mixture	was	then	cooled	to	rt,	diluted	with	EtOAc	(4	mL)	and	
filtered	through	a	plug	of	silica	and	the	solvent	was	removed	under	reduced	pressure.	The	crude	











To	 an	 oven-dried	microwave	 vial	 equipped	with	 a	 stir	 bar	was	 charged	with	NaH	 (48	mg,	 2.0	
mmol)	and	the	vial	was	capped,	and	then	the	vial	was	purged	with	N2.	To	the	vial	was	added	dry	
and	degassed	THF	(1.77	mL)	at	rt	and	the	reaction	mixture	cooled	to	0	°C	in	an	ice	bath.	To	this	






General	 Procedure	 D:	Palladium	 Catalyzed	 Allylic	 Substitution	 of	 2-B(pin)-Substituted	 Allylic	
Acetates	 or	 2-Substituted	 Allylic	 Acetates	 with	 NaCH(CO2Me)2.	 To	 an	 oven-dried	microwave	
vial	equipped	with	a	stir	bar	was	charged	with	the	allylic	acetate	1.1e	(63.2	mg,	0.20	mmol)	and	
the	 vial	 was	 capped	 and	 purged	 with	 N2.	 	 To	 the	 vial	 was	 added	 a	 stock	 solution	 of	
[Pd(allyl)Cl]2/2	equiv	PPh3	in	0.143	M	THF	(1.4	mL,	10	mol%	Pd	and	20	mol	%	PPh3)	by	a	syringe	
and	 the	 reaction	 mixture	 was	 stirred	 at	 rt	 for	 30	 min,	 after	 which	 a	 stock	 solution	 of	
NaCH(CO2Me)2	 in	0.1	M	THF	(0.6	mL,	0.6	mmol)	was	added	by	a	syringe	at	rt.	 	The	sealed	vial	
was	warmed	 to	40	 °C	 and	 stirred	until	 TLC	 taken	under	positive	pressure	of	 nitrogen	 showed	
complete	consumption	of	allylic	acetate,	 typically	0.5	–	24	h.	 	Note	 that	aliquots	 for	TLC	were	
taken	under	positive	pressure	of	nitrogen.		The	reaction	mixture	was	cooled	to	rt,	diluted	with	
EtOAc	(2	mL)	and	then	quenched	with	three	drops	of	water.		The	solution	was	filtered	through	a	
plug	 of	MgSO4	 and	 celite.	 	 The	 pad	 was	 rinsed	 with	 additional	 ethyl	 acetate	 (5	 mL)	 and	 the	
solvent	 was	 removed	 under	 reduced	 pressure	 to	 yield	 a	 pale	 red	 or	 yellow	 oil.	 The	 crude	
product	was	 dissolved	 in	 CDCl3	 and	 the	 ratio	 of	 regioisomers	 and	 the	 ratio	 of	 1,4-elimination	
products	were	determined	by	1H	NMR	spectroscopy	of	unpurified	reaction	mixtures.	CDCl3	was	
removed	 under	 reduced	 pressure	 and	 the	 crude	 product	 was	 purified	 by	 flash	 column	
chromatography	on	silica	gel	(hexanes:EtOAc	=	95:5)	to	afford	the	mixture	of	dimethyl	malonate	
substituted	 products	 and	 the	mixture	 of	 1,4-elimination	 products.	 The	 vinyl	 boronate	 ester	 is	






















yl)but-2-en-1-yl)malonate	 (1.2e).	 	 The	 product	 was	 prepared	 by	 General	
Procedure	D	using	(E)-1-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-




























53.0,	 52.4	 (two	 overlapping	 resonances),	 25.0,	 24.9,	 17.5	 (the	 quaternary	 vinyl	 C	 bearing	 the	





minor)	 and	 Dimethyl	 (E)-2-(1-phenylhept-1-en-3-
yl)malonate	 (1.3f,	major).	 The	 reaction	was	performed	
following	General	 Procedure	D	with	1.1g	 (23.2	mg,	 0.1	mmol)	 in	 the	 presence	 of	 5	mol	%	 of	















The	 title	 compound	 can	 also	 be	made	 by	 General	 Procedure	 D	with	1.1g	 at	 rt	 for	 30	min	 to	
afford	the	mixture	of	products	1.2f	and	1.3f	(16:84,	25.3	mg,	83%	yield).	








1-phenylhept-1-en-3-yl)malonate	 (1.3h,	 minor).	 The	
reaction	was	 performed	 following	General	 Procedure	D	with	1.1h	 (24.6	mg,	 0.1	mmol)	 in	 the	
presence	of	5	mol	%	of	[Pd(allyl)Cl]2	and	20	mol	%	of	PPh3	of	the	stock	solution		and	3	equiv	of	
NaCH(CO2Me)2	from	a	stock	solution.	The	reaction	mixture	was	stirred	at	40	°C	for	3	h.	The	ratio	
of	 regioisomers	was	1.2h:1.3h	 =	 63:37	 determined	 by	 1H	NMR	 spectra	 of	 unpurified	 reaction	
products.	 The	 crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	
(hexanes:EtOAc	 =	 95:5)	 to	 afford	 the	mixture	of	 dimethyl	malonate	 substituted	products	 as	 a	
colorless	oil	(28.0	mg,	88%	yield)	and	characterized	as	the	mixture	of	regioisomers.	The	reaction	
of	1.1h	provided	the	mixture	of	1.2h	and	1.3h	(79%,	63:37)	at	40	°C	for	24	h,	and	1.2h	and	1.3h	













168.5,	 140.1,	 134.8,	 128.5,	 128.1,	 127.1,	 126.6,	 55.8,	 53.9,	 52.7,	 52.6,	 32.0,	 27.8,	 22.5,	 15.1,	









Dimethyl	 (E)-2-(2-butyl-1-phenylhept-2-en-1-yl)malonate	 (1.2i,	 major	 of	 1.2i+1.3i),	 dimethyl	





NaCH(CO2Me)2	stock	 solution.	 The	 reaction	mixture	was	 stirred	 at	 40	 °C	 for	 8	 h.	 The	 ratio	 of	
isomers	 was	 1.2i:1.3i	 =	 81:19	 and	 (1Z,3E)-1.4i:(1E,3E)-1.4i	 =	 24:76	 determined	 by	 1H	 NMR	





























2H),	 1.67	–	 1.58	 (m,	 1H)	 1.55	–	 1.10	 (m,	 8H),	 0.90	 (t,	 J	 =	 7.0	Hz,	 3H),	 0.83	 (t,	 J	 =	 7.0	Hz,	 3H);	
13C{1H}	NMR	(125	MHz,	CDCl3)	δ	168.7,	168.5	140.2,	139.6,	128.6,	128.4,	127.2,	125.2,	57.0,	52.6,	
52.5,	51.2,	32.2,	30.7,	30.6,	27.7,	23.0,	22.5,	14.2,	14.1;	Dimethyl	 (E)-2-(6-benzylidenedecan-5-
yl)malonate	 (1.3i).	 1H	NMR	 (500	MHz,	CDCl3)	δ	7.35	–	7.15	 (m,	5H),	6.31	 (s,	1H),	3.76	 (s,	3H),	
3.66	(s,	3H),	3.63	(d,	J	=	10.5	Hz,	1H),	2.98	(ddd,	J	=	10.5	Hz,	9.0	Hz,	4.5	Hz,	1H),	2.24	–	2.12	(m,	
2H),	1.57	–	1.10	 (m,	10H),	0.94	–	0.80	 (m,	6H);	 13C{1H}	NMR	 (125	MHz,	CDCl3)	δ	169.3,	168.9,	
142.3,	138.2,	128.7,	128.3,	128.2,	126.5,	57.0,	52.7,	52.6,	49.9,	31.7,	31.0,	30.7,	29.3,	23.4,	22.9,	



























7.0	Hz,	 2H),	 1.58	–	 1.34	 (m,	 6H),	 0.96	–	 0.87	 (m,	 6H);	 13C{1H}	NMR	 (125	MHz,	 CDCl3)	 δ	 139.4,	
138.4,	132.4,	128.9,	128.2,	127.8,	126.9,	126.3,	35.6,	34.7,	31.5,	23.0,	22.9,	14.3,	14.0;	((1E,3E)-




130.2,	 129.6,	 128.9,	 128.4,	 126.5,	 35.4,	 31.7,	 27.6,	 23.3,	 23.0,	 14.2,	 14.0;	 (1Z,3E)-1.4i	 and	




Dimethyl	 (E)-2-(2-cyclohexyl-1-phenylhept-2-en-1-yl)malonate	 (1.2j,	 major	 of	 1.2j+1.3j),	
dimethyl	 (E)-2-(2-cyclohexyl-1-phenylhept-1-en-3-yl)malonate	 (1.3j,	 minor),	 (1Z,3E)-2-




NaCH(CO2Me)2	stock	 solution.	 The	 reaction	mixture	was	 stirred	at	40	 °C	 for	24	h.	 The	 ratio	of	
regioisomers	was	1.2j:1.3j	=	84:16	and	(1Z,3E)-1.4j:(1E,3E)-1.4j	=	85:15	determined	by	1H	NMR	




































7.06	 (m	5H),	5.36	 (t,	 J	=	6.0	Hz,	1H),	4.18	 (d,	 J	=	12.5	
Hz,	1H),	3.92	(d,	J	=	12.5	Hz,	1H),	3.69	(s,	3H),	3.41	(s,	3H),	2.36	(tt,	J	=	12.0	Hz,	3.5	Hz,	1H),	2.15	–	
2.05	(m,	2H),	1.80	–	1.10	(m,	14H),	0.92	(t,	J	=	7.0	Hz,	1H);	13C{1H}	NMR	(125	MHz,	CDCl3)	δ	168.9,	
168.4,	 143.3,	 141.0,	 128.9,	 128.3,	 127.0,	 125.7,	 58.8,	 52.6,	 52.5,	 48.0,	 41.7,	 32.5,	 31.8,	 31.6,	























































mixture	 was	 stirred	 at	 40	 °C	 for	 4	 h.	 The	 ratio	 of	 regioisomers	 was	 1.2m:1.3m	 =	 53:47	
determined	by	1H	NMR	spectra	of	unpurified	reaction	products.	The	crude	product	was	purified	
by	 flash	column	chromatography	on	silica	gel	 (hexanes:EtOAc	=	95:5)	 to	afford	 the	mixture	of	
dimethyl	 malonate	 substituted	 products	 (1.2m+1.3m)	 as	 a	 colorless	 oil	 (26.1	mg,	 90%	 yield).	
Dimethyl	(E)-2-(2-methyl-1-phenylpent-2-en-1-yl)malonate	(1.2m).	1H	NMR	(500	MHz,	CDCl3)	δ	
7.33	–	7.17	(m,	5H),	5.43	(t,	J	=	7.0	Hz,	1H),	4.11	(d,	JAB	=	12.5	Hz,	1H),	4.00	(d,	JAB	=	12.5	Hz,	1H),	
3.71	 (s,	3H),	3.47	 (s,	3H),	2.00	 (dt,	J	=	7.5	Hz,	7.0	Hz,	2H),	1.48	 (s,	3H),	0.94	 (t,	J	=	7.5	Hz,	3H);	
13C{1H}	 NMR	 (125	MHz,	 CDCl3)	 δ	 168.7,	 168.5,	 140.1,	 134.4,	 128.5,	 128.2,	 128.1,	 127.1,	 55.8,	














	 All	 structures	 have	 been	 optimized	 in	 solvent	 using	 Jaguar	 v.	 7.950	 at	 the	 B3LYP-
D3/lacvp*	 level.	 	 B3LYP-D3	 uses	 the	 hybrid	 B3LYP	 functional51	 augmented	 with	 dispersion	
corrections	 developed	 by	 Grimme	 and	 coworkers,26	 as	 implemented	 in	 Jaguar.50	 	 The	 lacvp*	
basis	 set	 combines	 6-31G*	 for	 light	 elements	 with	 the	 Hay-Wadt	 ECP	 and	 basis	 set	 for	 Pd.28	
Continuum	solvation	used	the	PBF	model29	with	parameters	for	THF.		








more	than	0.2	Å	 in	the	forming	C–N	bond.	 	The	 low	curvature	makes	transition	state	searches	
unreliable,	 especially	 with	 continuum	 solvent,	 but	 on	 the	 other	 hand,	 relaxed	 scans	
(constraining	 forming	C–N	bond,	 2.0-2.5	Å	 in	 steps	of	 0.1	Å,	 full	 optimization	of	 all	 remaining	
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	 One	of	 the	most	 significant	 impediments	 to	 the	efficient	 synthesis	of	 complex	natural	
and	non-natural	products	 is	 the	 low	 level	of	chemoselectivity	exhibited	by	many	reagents	and	
catalysts.1	 	 To	 compensate	 for	 poor	 chemoselectivity,	 synthetic	 organic	 chemists	 have	 been	
forced	 to	design	and	 implement	elaborate	protecting	group	 strategies	 in	 their	 construction	of	
complex	natural	products.2	
	 Although	considerable	effort	has	been	devoted	to	understanding	chemoselectivity	with	
classical	 reagents,	 fewer	 studies	 have	 focused	 on	 chemoselectivity	 with	 transition	 metal	
catalysts.	 	 Given	 the	 increasing	 importance	 of	 transition	metal-catalyzed	 reactions	 in	 organic	
synthesis,3	we	 set	 out	 to	 optimize	 and	 control	 catalyst	 chemoselectivity	 in	 some	 of	 the	most	
synthetically	 valuable	 transition	 metal-catalyzed	 reactions,	 the	 Tsuji-Trost	 allylic	 substitution4	
and	 the	 Suzuki-Miyaura	 cross-coupling	 reactions.5	 	 Palladium	 phosphine	 complexes	 catalyze	
both	 reactions	 even	 though	 the	 mechanistic	 pathways	 are	 distinct	 (Figure	 2.1).	 	 Allylic	
substitutions	 begin	 with	 coordination	 of	 the	 substrate	 to	 palladium(0)	 to	 form	 a	 π-complex	
(Figure	 2.1,	 right-hand	 cycle).	 	 Backside	 attack	 by	 the	 palladium	 on	 the	 carbon	 bearing	 the	
leaving	 group	 in	 an	 oxidative	 ionization	 generates	 a	 π-allylpalladium	 complex.	 	 External	
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nucleophilic	 addition	 to	 the	 π-allylpalladium	 complex	 followed	 by	 liberation	 of	 the	 product	
regenerates	 the	 palladium(0).	 	 In	 contrast,	 in	 the	 Suzuki-Miyaura	 cross-coupling	 palladium(0)	
undergoes	 oxidative	 addition	 with	 an	 aryl	 halide	 to	 form	 the	 palladium(II)	 aryl	 halide	
intermediate	 (Figure	2.1,	 left-hand	cycle).6	 	Transmetallation	with	boronic	acid	derivatives	and	
bases	 provides	 the	 second	 Pd–C	 bond.7	 	 Reductive	 elimination	 forms	 the	 C–C	 bond	 of	 the	
product	 and	 regenerates	 palladium(0).	 	More	broadly	 speaking,	 the	palladium	does	not	 come	
into	 contact	with	 the	 leaving	 group	 or	 nucleophile	 in	 the	 allylic	 substitution,8	whereas	 in	 the	




palladium-phosphine-based	 catalyst	 toward	 an	 allylic	 acetate,	 an	 aryl	 halide,	 and	 a	 vinyl	
boronate	ester	be	controlled	by	careful	choice	of	reagents	and	conditions?		This	report	answers	
this	question	and	introduces	a	third	orthogonal	reaction	pathway	of	2-B(pin)-substituted	allylic	
acetates	 that	 generates	 allenes	 with	 excellent	 chemoselectivity.	 	 Based	 on	 the	 highly	
chemoselective	 reactions	 developed	herein,	 2-B(pin)-substituted	 allylic	 acetate	 derivatives	 are	
useful	 “linchpins”	 that	 can	 be	 utilized	 for	 the	 preparation	 of	 an	 array	 of	 small	 molecules,	
including	 functionalized	 allylic	 amines	 and	 malonates,	 α-amino	 ketones,	 trisubstituted	 allylic	
esters	 and	 carbonates,	 and	 1,3-disubstituted	 allenes.	 	 A	 portion	 of	 this	work	 related	 to	 allylic	












	 The	 application	 of	 multifunctional	 substrates	 in	 tandem	 reactions	 enables	 the	 rapid	
construction	of	diverse	chemical	arrays.	 	Key	 to	 the	 success	of	 such	 strategies	 is	 the	ability	 to	
control	 chemoselectivity	 by	 controlling	 the	 relative	 rates	 of	 processes	 that	 lead	 into	 different	
reaction	manifolds.	In	this	study,	we	have	embedded	a	vinyl	boronate	ester	in	an	allylic	acetate	
with	 the	 goal	 of	 controlling	 chemoselectivity	 between	 palladium-catalyzed	 Tsuji-Trost	 allylic	
substitution,	 Suzuki-Miyaura	 cross-coupling	 and	 allene-forming	 reactions	 (Figure	 2.2).	 	 Given	
that	 the	 same	 palladium	 catalysts	 promote	 allylic	 substitution,	 cross-coupling,	 and	 allene	





























	 A	 crucial	 step	 toward	 the	 development	 of	 new	 synthetic	 methods	 is	 introduction	 of	
reliable	and	scalable	procedures	to	prepare	the	substrates.	 	Using	our	stereodefined	1-alkenyl-
1,1-heterobimetallic	 reagents,	 the	 2-B(pin)-substituted	 allylic	 acetates	were	 easily	 prepared	 in	
one-pot	 from	readily	available	alkynyldioxaborolanes	 (Scheme	2.1).9-10	 	Thus,	hydroboration	of	
air-stable	 alkynyldioxaborolanes	 with	 dicyclohexylborane	 generates	 1-alkenyl-1,1-dibora	
intermediates	 as	 the	 only	 observable	 regioisomer	 (1H	 NMR).11	 	 Although	 neither	 B–C	 bond	 is	
very	nucleophilic,	the	boron	centers	are	electronically	quite	different	due	to	resonance	donation	
from	 the	 pinacolato	 group	 of	 the	 B(pin).	 	 The	 partially	 occupied	p-orbital	 of	 the	 B(pin)	 boron	
dramatically	raises	the	barrier	to	transmetallation,	and	the	vinyl–BCy2	undergoes	selective	B	to	
Zn	 transmetallation	 at	 –78	 °C	 to	 generate	 the	heterobimetallic	 intermediate.	 	 Addition	of	 the	
Zn–C	bond	to	aldehydes	and	quenching	the	resulting	alkoxides	with	acetic	anhydride	provided	2-
B(pin)-substituted	 (E)-allylic	 acetates	2.1	 in	 52–85%	 yield	 (Scheme	 2.1).	 	 The	 reaction	worked	
well	with	linear	and	branched	aliphatic	aldehydes	(67–85%	yield).	 	Likewise,	benzaldehyde	and	
its	derivatives	with	electron	withdrawing	or	donating	substituents	proved	 to	be	good	reaction	
partners	 (52–78%	 yield).	 	 Cinnamaldehyde	 gave	 60%	 yield	 of	 the	 rearranged	 dienyl	 product	
formed	 on	 isomerization	 of	 the	 acetate	 (see	 Supporting	 Information).	 	 The	
alkynyldioxaborolanes	can	be	derived	from	either	aliphatic,	aromatic,	or	functionalized	alkynes	
[R2	=	n-Bu,	(CH2)4Cl,	Ph].		The	scalability	of	this	method	was	demonstrated	in	the	synthesis	of	2-

















































iv. Ac2OR2 ii. Me2Zn
52-85% yield
R1,  R2 = aliphatic, aryl, styryl
2.1
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acetate	 derivatives	 containing	 a	 boron	 at	 the	 2-position13	 had	 been	 used	 in	 transition	metal-
catalyzed	 allylic	 substitution	 reactions,13b	 although	 some	 examples	 of	 3-boron	 substituted	
analogs	had	been	generated	or	proposed	as	intermediates.14	Despite	the	lack	of	clear	precedent,	
the	 conjugate	 base	 of	 dimethyl	 malonate	 and	 several	 primary	 and	 secondary	 amines	





single	 allylic	 substitution	 to	 produce	 2e	 in	 65%	 yield	 (entry	 5).	 The	 unsymmetrical	 dialkyl	
substrate	2.1c	underwent	substitution	with	morpholine	catalyzed	by	[Pd(allyl)Cl]2	and	PPh3	(1:4)	
with	nucleophilic	attack	at	the	less	hindered	position	of	the	π-allyl	with	excellent	regioselectivity	
(>20:1,	 entry	 6).	 	 Isomeric	 2-B(pin)-substituted	 allylic	 acetates	 2.1d	 and	 2.1f	 each	 underwent	
reaction	with	morpholine	and	NaCH(CO2Me)2	using	catalyst	generated	from	Pd(OAc)2	(10	mol	%)	
and	PPh3	(20	mol	%)	to	afford	the	same	regioisomer	of	allylic	substitution	products	2.2h	and	2.2i	
with	 ≥10:1	 regioselectivity	 (entries	 7–10).	 	 The	 styryl	 derivative	 2.1d	 was	 found	 to	 be	 less	
reactive	 than	 2.1f	 toward	 the	 same	 palladium	 catalyst,	 resulting	 in	 lower	 yields	 of	 the	
substitution	products	2.2g	and	2.2h	 (entries	7–10,	45	vs.	80%	and	51	vs.	79%).	 	 In	contrast	 to	
most	 π-allylpalladium	 complexes	 with	 a	 single	 aryl	 group	 at	 the	 terminus,	 allylic	 substitution	
took	 place	 at	 the	 benzylic	 position	 in	 each	 case.	 	 The	 reversal	 in	 regioselectivity	 is	 due	 to	
formation	 of	 the	 anti-aryl-π-allyl	 isomer,	 which	 exhibits	 enhanced	 reactivity	 at	 the	 benzylic	
position,	as	outlined	in	our	related	study.10d		Analogous	reactions	with	electron	withdrawing	or	
donating	 substituents	 on	 the	 aryl	 groups	 (2.1g–j)	 provided	 the	 benzylic	 substitution	 products	
57	
(2.2i–l)	 in	 75–92%	 isolated	 yield	 with	 >10:1	 regioselectivity	 (entries	 11–14).	 	 The	 unique	











[Pd(allyl)Cl]2 (5 mol %)a
or Pd(OAc)2 (10 mol %)b
PPh3 (20 mol %)
nucleophile
(3 equiv)









































































































































a [Pd(allyl)Cl]2. b Pd(OAc)2. c Yield of purified and isolated products. 
d Regioselectivities ≥10:1 (except entry 7) and were determined by 1H NMR spectroscopy of unpurified reaction 













	 Tandem	 reactions	 are	 important	 in	 streamlining	 organic	 synthesis,	 enabling	 a	 rapid	







lead	 to	 α-functionalized	 ketones.	 	 For	 the	 tandem	 allylic	 substitution/oxidation	 process,	 the	
allylic	substitution	was	performed	as	outlined	in	Table	2.1.	
After	 the	 allylic	 substitution,	 the	 crude	 reaction	 mixture	 was	 treated	 with	 alkaline	 hydrogen	
peroxide	to	oxidize	the	B–C	bond.		When	NaCH(CO2Me)2	was	employed	as	the	nucleophile	in	the	
substitution,	subsequent	oxidation	generated	substituted	ketone	2.3a	 in	85%	yield	 in	this	one-
pot	 procedure	 (Table	 2.2,	 entry	 1).	 	 Secondary	 amines	 performed	 well	 in	 the	 tandem	 allylic	
substitution/oxidation	sequence	to	form	α-amino	ketones	2.3b–2.3e	in	65–82%	yield	(entries	2–


















Nu[Pd(allyl)Cl]2 (5 mol %)
PPh3 (20 mol %)
Nu–/NuH


























































a Yield of purified and isolated products. b Allylic substitution carried out with Pd(OAc)2 (5 mol 
%) and PPh3 (10 mol %) at rt, and oxidation carried out with 3 equiv of NaBO3H2O in 
THF/H2O (1:1) at rt.
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such	 compounds	 is	 via	 allylic	 substitutions	 of	 enantioenriched	 2-B(pin)-substituted	 allylic	
acetates.	 	With	 this	 in	mind,	2-B(pin)-substituted	allylic	acetate	1f	of	80%	ee	was	prepared	by	
OPh
OPh














































with	 acetic	 anhydride	 (Scheme	 2.4).9	 	 We	 then	 conducted	 the	 allylic	 substitution	 of	 1f	 and	
morpholine	 to	 form	 the	 2-B(pin)-substituted	 benzyl	 amine	 2.2b	 in	 82%	 yield	 without	 loss	 of	
enantiomeric	 excess	 (Scheme	 2.5).	 	 A	 tandem	 allylic	 substitution/B–C	 bond	 oxidation	 with	
NaBO3·H2O	generated	the	α-amino	ketone	with	77%	ee	in	80%	yield	(Scheme	5).		Unfortunately,	
employing	 alkaline	 H2O2	 in	 place	 of	 NaBO3·H2O	 for	 the	 oxidation	 led	 to	 racemization	 of	 the	
amino	ketone	product.	
	









OH Ti(Oi-Pr)4 (1.0 equiv)
(+)-DIPT (1.2 equiv)
4 Å MS, CH2Cl2 
–20 °C
Me2Zn (1.2 equiv) 



























OAc Pd(OAc)2 (5 mol %)
PPh3 (10 mol %)











2.1f (80% ee) 2.2b, 80% ee, 82% yield 2.4e, 77% ee, 80% yield
(one-pot from 2.1f)




Acrivastine	 (Semprex),15,22	 Flunarizine	 (Sibelium,	 Ca	 channel	 blocker),23	 and	 several	 BA	 uptake	
inhibitors.24	 	 In	 the	synthesis	of	allylic	amines,	 it	 is	usually	 important	 that	 the	geometry	about	
the	C=C	bond	be	controlled	to	provide	a	single	product.		With	that	in	mind,	we	sought	to	achieve	
a	 one-pot	 allylic	 substitution/Suzuki-Miyaura	 cross-coupling	 reaction	 of	 2-B(pin)-substituted	
allylic	 acetates.	 	 As	 alluded	 to	 in	 Figure	 1,	 it	 is	 conceivable	 that	 the	 allylic	 substitution	 and	
Suzuki-Miyaura	cross-coupling	could	be	catalyzed	using	the	same	palladium	source.		One	of	the	
key	factors	to	turn	on	the	Suzuki-Miyaura	cross-coupling	will	be	the	activation	of	the	B–C	bond,	
initiated	 by	 hydrolysis	 to	 the	 boronic	 acid.	 	 It	 is	 noteworthy	 that	 a	 successful	 allylic	
substitution/cross-coupling	 sequence	 enables	 the	 synthesis	 of	 a	 variety	 of	 2-arylated	 allylic	
amines	 and	malonates	 from	easily	 accessible	 2-B(pin)-substituted	 allylic	 acetates,	 aryl	 halides,	
amines,	and	malonates.	 	The	allylic	substitution	of	2-B(pin)	allylic	acetate	2.1a	and	morpholine	




3),	 including	 the	 3-pyridyl	 derivative.	 	 Likewise,	 unsymmetrical	 2-B(pin)-substituted	 allylic	
acetate	2.1f	underwent	the	tandem	allylic	substitution	with	morpholine/cross-coupling	to	yield	
trisubstituted	 benzylic	 amines	 2.5d–f	 in	 50–70%	 yield	 (entries	 4–7).	 	 Aryl	 bromide	 coupling	
partners	with	electron	donating	or	withdrawing	substituents	were	well	tolerated.		Iodobenzene	
gave	 a	 lower	 yield	 than	 the	 aryl	 bromides	 (entries	 4	 and	 5).	 	 Tandem	 Suzuki-Miyaura	 cross-
coupling	 of	 allylic	 substitution	 product	 2.2h	 with	 sodium	 malonate	 failed	 with	 iodobenzene,	
64	
recovering	 allylic	 substitution	 product	 2.2h	 (43%	 yield,	 entry	 8).	 	 In	 contrast,	 2.1f	 and	 2.1h	
underwent	tandem	allylic	substitution	with	NaCH(CO2Me)2/cross-couplings	with	bromobenzene	
in	51	and	61%	yield	 (entries	9	and	10).	 	 Importantly,	 in	 all	 cases,	 the	geometry	of	 the	double	
bond	was	maintained.	
	 Related	 palladium-catalyzed	 tandem	 reactions	 have	 been	 reported	 by	 the	 groups	 of	
Kazmaier	and	Pucheault.	 	Kazmaier	and	co-workers	established	one-pot	allylic	amination/Stille	
couplings	 of	 β-stannylated	 allylic	 carbonates	 to	 provide	 allylic	 amine	 derivatives	 (Scheme	
2.6A).25	 	 This	 approach	 provides	 disubstituted	 allylic	 amines	 and	 is	 complementary	 to	 the	






those	 in	 Scheme	 2.6.	 	 To	 expand	 the	 synthetic	 utility	 of	 2-B(pin)-substituted	 allylic	 ester	
derivatives	 further,	we	next	set	out	 to	 reverse	 the	chemoselectivity	by	performing	the	Suzuki-
Miyaura	cross-coupling	in	the	presence	of	the	allylic	ester	derivatives.	
	











THF or toluene / H2O
100 °C, 24 h
B(pin)
n-BuR
OAc Pd(OAc)2 (10 mol %)
PPh3 (20 mol %)


























































































a Yield of purified and isolated products. b No cross-coupling product was observed.
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of	allylic	acetates,6,8	 very	 few	studies	compare	 the	 relative	 rates	of	 these	 two	processes.26	 	As	
pointed	out	by	Organ,19e,27	 	 in	 cases	where	a	 comparison	was	made,	 the	 substrates	employed	
were	 frequently	 biased	 by	 either	 steric	 effects	 or	 conformational	 restrictions	 that	 disfavor	
proper	orbital	alignment	needed	for	the	allylic	ionization	to	proceed.		
2.2.3.1. Precedents	 for	 Oxidative	 Addition	 of	 Aryl	 Halides	 in	 the	 Presence	 of	 Allylic	
Acetates	
	 The	 chemoselectivity	 of	 palladium-based	 catalysts	 has	 been	 investigated	 by	 several	











Pd(OAc)2 (1 mol %)











[Pd(allyl)Cl]2 (1 mol %)






75 – 78% yields
34 – 96% yields
67	
involves	 β-OAc	 elimination	 (Scheme	 2.7A).29	 	 Jiao	 and	 co-workers	 demonstrated	 a	
complementary	Heck	reaction	of	allylic	acetates	that	undergo	traditional	β-hydride	elimination	
rather	 than	 β-acetate	 elimination	 (Scheme	 2.7B).30	 	 Genet	 and	 co-workers	 conducted	 a	
chemoselective	 Suzuki-Miyaura	 cross-coupling	 of	 γ-borylated	 allylic	 acetates	 with	 activated	
alkenyl	 iodides	 (Scheme	2.7C).31	 	 Kočovský	 and	 co-workers	 investigated	 Suzuki-Miyaura	 cross-




is	 faster	than	 ionization	of	allylic	acetates,	but	the	 increased	reactivity	of	carbonates	results	 in	
low	cross-coupling	yields	(Scheme	2.7D).	
	 In	 the	 case	 of	 aryl	 bromides,	 Trost,	 Malhotra,	 and	 Chan	 recently	 found	 that	 Boc	
activated	allylic	alcohols	undergo	allylic	substitution	in	the	presence	of	an	aryl	bromide	(Scheme	
2.7E).32	 	 Interestingly,	 Organ	 demonstrated	 that	 the	 same	 palladium	 catalyst	 can	 be	 used	 to	
afford	 either	 the	 allylic	 substitution	 or	 vinylic	 cross-coupling	 products	 selectively	 from	
polyfunctionalized	 olefin	 building	 blocks	 (Scheme	 2.7F).19e,27	 	 Due	 to	 the	 diverse	 substrates,	
catalysts,	 and	 conditions	 employed	 in	 Scheme	 7,	 only	 a	 fragmented	 picture	 of	 the	 reactivity	











































Pd(PPh3)4 (5 mol %)
(1.0 equiv)
Pd(PPh3)4 (5 mol %)






CN Pd2dba3•CHCl3 (2.5 mol %)
L* (Trost ligand)
(7.5 mol %)










88% yield, 87% ee
18:1 (branched vs. linear)
NaCMe(CO2Me)2










Pd(OAc)2 (2.5 mol %)










Ar-I Pd(PPh3)4 (6 mol %)
K2CO3 (3 equiv)
















2.2.3.2. Development	 of	 Orthogonal	 Reaction	 Conditions	 for	 the	 Palladium-
Catalyzed	Allylic	Substitution	and	Suzuki-Miyaura	Cross-Coupling	





(Figure	 2.1).	 	 To	 explore	 the	 possibility	 of	 conducting	 the	 Suzuki-Miyaura	 cross-coupling	 of	 2-
B(pin)-substituted	 allylic	 acetates,	 the	 di-n-butyl	 substrate	 2.1a	 was	 combined	 with	
iodobenzene,	Pd(OAc)2	 (15	mol	%),	PPh3	(30	mol	%),	and	Cs2CO3	 (3	equiv)	 in	a	10:1	THF/water	
reaction	 mixture	 (Scheme	 2.8).	 	 At	 70	 ˚C	 a	 clean	 reaction	 occurred	 to	 generate	 the	 2-aryl-







Pd(OAc)2 (15 mol %)
Cs2CO3 (3 equiv)
THF/H2O (10:1)
70 °C, 10 h











mol	%	Pd	resulted	 in	decreased	yield	of	 the	cross-coupled	product	2.6a	 (Table	4,	entry	2).	 	To	
optimize	the	coupling,	different	phosphine	ligands	were	employed.		The	bulky	P(o-Tol)3	formed	
the	product	 in	 only	 20%	 yield	 (entry	 3).	 	 Bidentate	 phosphine	 ligands	 gave	poor	 yields	 of	 the	
arylated	allylic	acetates	(27–62%	yield,	entries	4–6).		Subjecting	the	di-n-butyl	allylic	acetate	2.1a	




THF	or	dioxane,	 the	catalyst	 loading	could	be	 lowered	 to	5	mol	%	with	 shorter	 reaction	 times	




2.2.3.3. Substrate	 Scope	 of	 Suzuki-Miyaura	 Cross-Coupling	 of	 2-B(pin)-
Substituted	Allylic	Acetates	with	Aryl	Iodides	
	 To	 determine	 the	 substrate	 scope	 for	 Suzuki-Miyaura	 cross-coupling	 of	 2-B(pin)-
substituted	 allylic	 acetates,	 we	 decided	 to	 vary	 the	 allylic	 acetate	 (R1	 and	 R2)	 as	 well	 as	 the	
coupling	partner	 (Ar–I).	 	Aliphatic	2-B(pin)-substituted	allylic	acetate	2.1a	 cleanly	provided	 the	
































(10 mol %, 1:2) Cs2CO3 THF 0.022 48 62
Cs2CO3 THF 0.022 48 80
Pd(OAc)2/P(o-tol)3 
(10 mol %, 1:2) Cs2CO3 THF 0.022 48 20
Pd(PPh3)4 
(10 mol %) Cs2CO3 THF 0.022 36 87
Pd(OAc)2/DPPP   
(10 mol %, 1:1) Cs2CO3 THF 0.022 48 32
Pd(OAc)2/DPPE   
(10 mol %, 1:1) Cs2CO3 THF 0.022 48 27
Pd(OAc)2/DPPF   
(10 mol %, 1:1) Cs2CO3 THF 0.022 48 62
PdCl2(PPh3)2/PPh3 
(10 mol %, 1:1) Cs2CO3 THF 0.08 24 71
10 PdCl2(PPh3)2/PPh3 (10 mol %, 1:1) Cs2CO3 Dioxane 0.08 18 61
11 PdCl2(PPh3)2/PPh3 (10 mol %, 1:1) CsF Dioxane 0.08 18 25
12 PdCl2(PPh3)2/PPh3 (10 mol %, 1:1)
K3PO4 toluene 0.08 24 52
13 Pd(OAc)2/PPh3 (10 mol %, 1:3) Cs2CO3 toluene 0.17 4 96
f
14 Pd(OAc)2/PPh3 (5 mol %, 1:3) Cs2CO3 toluene 0.17 18 95
f,g




(10 mol %) Cs2CO3 toluene 0.17 18 96
f,g
Pd(OAc)2/P(t-Bu)3 
(10 mol %, 1:1)
2.6a
a mol % of Pd and molar ratio of Pd to phosphine provided in parenthesis. b 3 equiv of base and 
iodobenzene used unless otherwise noted. c 10:1 ratio of solvent to H2O. d Ratio of 1a (mmol) / 
solvent (mL). e Yield determined by 1H NMR integration of the crude reaction mixture using 1,4-
dimethoxybenzene as the internal standard. f Yield of isolated and purified products.  g 2 equiv of 
Cs2CO3 and iodobenzene used.
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the	oxidative	 ionization	of	 acetate	 is	 not	 reversible	 or	 does	not	 disrupt	 a	 tight	 ion	pair	 under	
these	 conditions.8	 	 To	 demonstrate	 scalability	 of	 the	 Suzuki-Miyaura	 cross-coupling	 2-B(pin)-
substituted	allylic	acetates	2.1e	was	subjected	to	cross-coupling	conditions	on	a	5	mmol	scale	to	
give	1.3	g	of	the	2-arylated	allylic	acetate	2.6i	in	80%	isolated	yield	(Scheme	2.9).			
	 Given	 that	 aryl	 iodides	 react	 faster	 with	 palladium(0)	 than	 allylic	 acetates,	 we	 next	
examined	 less	 reactive	 aryl	 bromides.	 	 We	 are	 aware	 of	 one	 study	 involving	 comparison	 of	
relative	 reactivity	 of	 sp2	 C–Br	 bonds	 vs.	 allylic	 acetates	 with	 palladium	 catalysts.	 	 Organ	
demonstrated	that	the	preference	of	palladium	was	dependent	on	the	nucleophile	(see	Scheme	
2.7F).27		
	 Subjecting	 the	2-B(pin)-substituted	allylic	 acetates	 to	 the	Suzuki-Miyaura	 conditions	 in	
entry	 13	 of	 Table	 2.4	 with	 various	 aryl	 and	 heteroaryl	 bromides	 resulted	 in	 chemoselective	
activation	of	the	aryl	bromides	over	the	allylic	acetates.		The	substituents	on	the	allylic	acetate	
(R1	and	R2)	and	the	aryl	bromide	coupling	partners	(Ar–Br)	were	varied	to	determine	the	scope	
of	 the	 chemoselective	 cross-coupling	 (Table	 2.6).	 	 2-B(pin)-substituted	 aliphatic	 allylic	 acetate	
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Pd(OAc)2 (5 mol %)
Cs2CO3 (3 equiv)
toluene/H2O (10:1)
4–18 h, 90 °C

















































entry acetate product yielda (%)Ar-I






OAcPd(OAc)2 (10 mol %)
PPh3 (30 mol %)
PhI (3 equiv), Cs2CO3 (3 equiv)
2.1e
5 mmol scale 1.3 g, 80% isolated yield
2.6i
toluene/H2O (5:1), 90 °C, 6 h
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OAc Pd(OAc)2 (5 mol %)
Cs2CO3 (3 equiv)
toluenel/H2O (10:1)
4–18 h, 90 °C



















3 1a 4-O2N-C6H4-Br 91
6 1b 87n-Bui-Pr
OAc













4 1a 4-F3C-C6H4-Br 85

























entry acetate product yielda (%)Ar-Br
a Yield of isolated and purified products. b The reaction was conducted at 75 °C in THF/H2O (10:1).
1 6
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	 2.1a	 underwent	 cross-coupling	 with	 aryl	 bromides	 bearing	 electron	 withdrawing	 or	
electron	 donating	 groups	 with	 para-	 and	 ortho-substitution	 to	 provide	 the	 arylated	 allylic	
acetates	2.6a–c,	2.6j	and	2.6k	in	moderate	to	excellent	yields	(54–91%,	Table	2.6,	entries	1–5).		
α–Branching	is	tolerated	as	shown	in	the	reaction	of	the	allylic	acetate	2.1b	with	bromobenzene	
(87%	 yield,	 entry	 6).	 	 The	 styryl	 derived	 allylic	 acetate	2.1d	 gave	 excellent	 yield	 of	 the	 cross-
coupled	product	2.6f	with	1-bromo-4-nitrobenzene	(90%	yield,	entry	7).			
	 With	 the	 isomeric	 allylic	 acetate	 2.1f,	 the	 Suzuki-Miyaura	 cross-coupled	 product	 2.6h	
was	obtained	 in	 80%	yield	 (entry	 8)	with	no	observed	 scrambling	of	 the	 acetate	position.	 	 As	
shown	 in	 entries	 9	 and	 10,	 heteroaryl	 bromides	 such	 as	 2-	 or	 3-bromothiophene	 underwent	
cross-coupling	with	2.1a	in	74–82%	yield.		Having	demonstrated	that	aryl	iodides	and	bromides	




2.2.3.5. Substrate	 Scope	 of	 Suzuki-Miyaura	 Cross-Coupling	 of	 2-B(pin)-
Substituted	Allylic	Benzoates	and	Carbonates		




therefore,	 prepared	 several	 2-B(pin)-substituted	 allylic	 benzoates	 and	 carbonates	 from	 the	
parent	 di-n-butyl-2-B(pin)-substituted	 allylic	 alcohol	 (see	 the	 Supporting	 Information).	 	 The	 2-
B(pin)-substituted	 allylic	 benzoates	 and	 carbonates	 were	 subjected	 to	 the	 optimal	 cross-
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coupling	 reaction	 conditions	 in	 entry	 13	 of	 Table	 2.4	with	 aryl	 iodides	 and	 bromides.	 	 The	 2-
B(pin)-substituted	allylic	benzoate	2.7a	underwent	cross-coupling	with	 iodobenzene	 to	 furnish	
the	2-aryl	substituted	allylic	benzoate	2.9a	in	96%	yield	(Table	2.7,	entry	1).		Bromobenzene,	on	
the	 other	 hand,	 resulted	 in	 low	 yield	 of	 the	 cross-coupled	 product	 2.9a	 (38%),	 with	multiple	
byproducts	(entry	2).		The	palladium	catalyst	likely	activates	the	allylic	benzoate	in	the	presence	
of	less	reactive	bromobenzene.		Electron	deficient	aryl	halides	are	known	to	undergo	oxidative	
addition	 more	 rapidly	 than	 analogous	 electron	 rich	 aryl	 halides.33	 	 With	 4-trifluoromethyl	
bromobenzene	 and	 allylic	 benzoate	2.7a	 the	 cross-coupled	 product	2.9b	 was	 isolated	 in	 76%	








2.2.4. Chemoselective	 Allene	 Formation	 from	 2-B(pin)-Substituted	 Allylic	 Acetates,	
Benzoates,	and	Carbonates	
	 As	 demonstrated	 in	 Table	 2.7,	 the	 efficiency	 of	 Suzuki-Miyaura	 cross-coupling	 of	 2-
B(pin)-substituted	allylic	substrates	is	related	to	the	ability	of	the	allylic	 leaving	group	to	ionize	
under	 palladium	 catalysis.	 	 Reactive	 substrates	 toward	 allylic	 ionization,	 such	 as	 benzoate,	
carbonates,	or	substrates	with	benzylic	acetates	(entries	9	and	10	in	Table	2.7)	tended	to	yield	
less	 cross-coupling	 products	 and	 more	 decomposition	 products.	 	 Analysis	 of	 1H	 NMR	
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spectroscopy	 of	 unpurified	 reaction	 mixtures	 suggested	 that	 decomposed	 products	 included	
	









LG Pd(OAc)2 (10 mol %)
Cs2CO3 (3 equiv)
toluene/H2O (10:1)
90–110 °C, 12–24 h
































































a Yield of isolated and purified products. b Starting materials were decomposed.
entry 2 productAr-X yield (%)a
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allenes	 with	 a	 catalytic	 amount	 of	 palladium	 and	 2	 equiv	 of	 diethylzinc	 as	 reducing	 agent	
(Scheme	2.10A).36	 	More	 recently,	 Kazmaier	 and	 co-workers	 demonstrated	 that	β-stannylated	





Scheme	 2.10.	 A.	 Tanaka’s	 palladium-catalyzed	 elimination	 reaction	 with	 diethylzinc.	 B.	



















R1 = Ph, i-Pr, H
R2 = Ac, Ph









that	 would	 favor	 allene	 formation	 from	 1-phenyl-2-B(pin)-substituted	 allylic	 acetate	 2.1f.		
Subjecting	2.1f	to	catalytic	Pd(PPh3)4	in	THF/H2O	(5:1)	at	60	°C	resulted	in	20%	consumption	of	
2.1f	 with	 no	 allene	 formation	 (1H	 NMR,	 Table	 2.8,	 entry	 1).	 	 Using	 stoichiometric	 Pd(PPh3)4	
resulted	 in	 only	 4%	 allene	 2.10a	 with	 mostly	 decomposition	 products	 (entry	 2).	 	 We	 next	
examined	bases,	which	dramatically	changed	the	outcome	of	the	reaction.		Addition	of	1	equiv	
Cs2CO3	and	1	mol	%	Pd(PPh3)4	led	to	allene	formation	in	87%	yield,	while	Cs2CO3	alone	exhibited	
no	 reactivity	 (entries	 3	 and	 4).	 	With	 the	 conditions	 in	 entry	 3,	 other	 palladium	 sources	 and	
phosphines	were	examined	(entries	5–9).		Both	Pd(OAc)2/2PPh3	and		[Pd(allyl)Cl]2//4PPh3	formed	
suitable	catalysts	 for	allene	formation	(73	and	80%	yield,	 respectively,	entries	5	and	6).	 	Some	
diene	products	(<5%)	were	also	produced.		With	[Pd(allyl)Cl]2	and	4	equiv	DPPE,	the	reaction	did	
not	reach	completion	in	1.5	h	(72%	yield	of	2.10a	and	12%	remaining	2.1f,	entry	7).	Precatalyst	
[Pd(allyl)Cl]2/3	 equiv	 PCy3	 resulted	 in	 93%	 yield	 (entry	 8).	 	 Finally,	 [Pd(allyl)Cl]2/3	 equiv	
CyJohnPhos	and	1	equiv	of	Cs2CO3		at	60	°C	resulted	in	99%	assay	yield	of	allene	product	2.10a	
(entry	9).		Screening	Buchwald’s	phosphine	ligands	SPhos,	XPhos,	DavePhos	and	JohnPhos	with	
[Pd(allyl)Cl]2	 resulted	 in	 slower	 conversion	 to	 allenes.38	 	 In	 the	 absence	 of	 Cs2CO3	 at	 60	 °C	
[Pd(allyl)Cl]2/3	equiv	CyJohnPhos	resulted	 in	formation	of	only	7%	of	allene	product	2.10a	and	
90%	 unreacted	 2.1f	 (entry	 10).	 	 Lowering	 the	 Cs2CO3	 loading	 to	 0.5	 equiv	 did	 not	 affect	 the	
reactivity	significantly	(94%	yield,	entry	11),	and	3	equiv	of	Cs2CO3	rendered	the	reaction	slower	
(85%	yield	of	2.10a	and	15%	recovered	2.1f,	entry	12).	 	Bases	such	as	NaOAc⋅3H2O,	K2CO3	and	











di-n-butyl-2-B(pin)	 allylic	 acetate	 2.1a	 was	 not	 suitable	 for	 this	 transformation	 (entry	 6),	
benzoate	 substrates	2.7a	 and	2.7c	were	 converted	 to	allene	products	2.10f	 and	2.10g	 in	53%	
and	79%	isolated	yields	(entries	7	and	8).		With	the	dialkyl	2-B(pin)-substituted	derivatives,	the	
greater	leaving	group	ability	of	the	carbonates	2.8a	and	2.8d	resulted	in	higher	yields	of	allene	























THF/H2O (5:1)a, 60 °C




13 NaOAc•3H2O (3) 1.0
15 NaHCO3 (3) 1.0
16 NaHCO3 (1) 1.0






8 Cs2CO3 (1) 1.0PCy3 (1.5)
2
– 1.5–
5 Cs2CO3 (1) 1.5
6 Cs2CO3 (1) 1.5
PPh3 (2)
7 Cs2CO3 (1) 1.5DPPE (2)
PPh3 (2)




























3 Cs2CO3 (1) 1.5– 87Pd(PPh3)4
1
– 1.5Pd(PPh3)4c 4–
10 – 1.0CyJohnPhos (1.5) 7[Pd(allyl)Cl]2
11 Cs2CO3 (0.5) 1.0CyJohnPhos (1.5) 94[Pd(allyl)Cl]2




















a Reactions conducted at 0.17 M concentration on 0.04 mmol scale.  ‚Ä®b Yield determined by 1H 
NMR integration of the crude reaction mixture using 1,4-dimethoxybenzene as the internal standard. 
c 1 equiv of Pd(PPh3)4.
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THF/H2O = 5:1, 60 °C, 40–180 min
[Pd(allyl)Cl]2 (0.5 mol %)
CyJohnPhos (1.5 mol %)

































































































	 To	 rationalize	 the	 formation	 of	 allylic	 substitution	 vs.	 allene	 products,	 a	 plausible	
catalytic	cycle	for	allene	formation	is	illustrated	in	Figure	2.3.		Electron	donating	ligands,	such	as	
PCy3	 and	 CyJohnPhos,	 easily	 lead	 to	π-allylpalladium	 intermediates.	 	 In	 the	 presence	 of	 good	
nucleophiles,	 such	 as	 malonates	 or	 amines,	 allylic	 substitution	 occurs	 by	 addition	 of	 the	
nucleophile	 to	 the	π-allylpalladium.	 	 In	 contrast,	 in	 the	 absence	of	 a	 suitable	nucleophile,	 the	
base	 is	 proposed	 to	 attack	 the	 empty	 coordination	 site	 on	 boron	 or	 hydrolyze	 the	 boronate	
ester.	 	 Several	 possible	 explanations	 for	 the	 observed	 dependency	 on	 base	 strength	 can	 be	
considered.		The	stronger	bases	are	more	likely	to	promote	hydrolysis	of	the	B(pin)	group	to	the	



















	 Optically	 active	 allenes	 are	 ubiquitous	 intermediates	 and	 targets	 for	 the	 synthesis	 of	
natural	products	and	biologically	active	compounds.39	 	To	investigate	the	possibility	of	chirality	
transfer	 in	 the	catalytic	 cycle	of	Figure	2.3,	we	performed	 the	allene	 formation	 reaction	using	
enantioenriched	2-B(pin)-allylic	acetate	2.1f	 to	generate	allene	product	2.10a.	 	The	reaction	of	
2.1f	 (60%	 ee)	 in	 the	 presence	 of	 the	 Pd/CyJohnPhos	 catalyst	 afforded	 enantioenriched	 allene	
2.10a	 with	 36%	 ee	 in	 18%	 yield	 in	 10	min	 (Table	 2.10,	 entry	 2).	 	When	 the	 reaction	 reached	
completion	in	35	min,	however,	a	significant	loss	of	ee	was	observed	(Table	2.10,	entries	3	and	
4).	 Finally,	 allene	 product	 2.10a	 was	 racemized	 completely	 in	 1	 h	 (Table	 2.10,	 entry	 6).	 	 It	 is	
noteworthy	 that	 B(pin)-substituted	 1f	 (60%	 ee)	 was	 not	 racemized	 during	 the	 course	 of	 the	
reaction.	 	 These	 results	 suggest	 that	 2-B(pin)-allylic	 acetate	 undergoes	 stereoselective	 allene	


















diversity.	 	 Key	 to	 development	 of	 such	 a	methodology	 is	 to	 tailor	 the	 catalyst,	 reagents	 and	
conditions	 to	 afford	 chemoselective	 activation	 of	 the	 substrate.	 	 Toward	 this	 goal,	 we	
introduced	 a	 new	 class	 of	 bifunctional	 reagents	 that	 contain	 vinyl	 boronate	 esters	 embedded	
within	 allylic	 acetates.	 	 The	 requisite	 2-B(pin)-substituted	 allylic	 acetates	 are	 synthesized	 on	
gram	 scale	 in	 one-pot	 procedures	 from	 readily	 available	materials	 using	 the	 heterobimetallic	
chemistry	developed	in	our	laboratory.9-10		
	 To	 facilitate	 applications	 of	 our	 bifunctional	 substrates,	 methods	 to	 control	 the	





THF/H2O = 5:1, 60 °C
[Pd(allyl)Cl]2 (0.5 mol %)
CyJohnPhos (1.5 mol %)
Cs2CO3 (1 equiv) Ph • n-Bu
2.10a2.1f (60% ee)
































a Conversion yield determined by 1H NMR of aliquots of unpurified reaction mixture. 





reactions	 were	 conducted	 under	 conditions	 where	 the	 B(pin)	 group	 was	 stable	 to	 hydrolysis	
(and	 palladium	 hydroxide	 intermediates	 are	 not	 likely	 formed),[13,102]	 inhibiting	 B	 to	 Pd	
transmetallation.	 	 Under	 such	 conditions,	 oxidative	 ionization	 of	 the	 acetate	 and	 nucleophilic	
addition	 to	 the	π-allylpalladium	 intermediate	were	much	 faster	 than	 transmetallation.	 	 In	 the	
Suzuki-Miyaura	 cross-coupling	 of	 2-B(pin)-substituted	 allylic	 acetates,	 we	 found	 that	 the	
chemoselectivity	of	 the	Pd(0)	 is	Ar–I	>	Ar–Br	>	allylic	acetate.	 	Once	 the	Pd(0)	 is	 converted	 to	
Pd(II)	by	the	aryl	halide,	 ionization	of	the	allylic	acetate	does	not	interfere	with	cross-coupling.		
Under	 conditions	 where	 the	 B(pin)	 group	 hydrolyzes	 to	 the	 boronic	 acid	 (or	 palladium	
hydroxides	can	form),	transmetallation	is	also	fast.	 	Detailed	study	of	this	system	indicates	the	
relative	order	of	 reactivity	 toward	Pd(0)	 is	Ar–I	>	Ar–Br	>	allylic	carbonate	>	allylic	benzoate	>	
allylic	acetate,	with	 the	 reactivity	of	allylic	 carbonates	approaching	 that	of	aryl	bromides.	 	 For	
allylic	acetates	with	the	acetate	in	benzylic	position,	the	allylic	acetate	is	more	reactive	then	aryl	
bromides	 in	 the	 presence	 of	 L2Pd.	 	 The	 observations	 outlined	 herein	 enabled	 a	 complete	
reversal	of	chemoselectivity	from	allylic	substitution	reactions	to	Suzuki-Miyaura	cross-coupling	
of	allylic	acetates,	benzoates,	and	carbonates.						







high	 yields	 of	 1,3-disubstituted	 allenes	 under	 mild	 conditions.	 	 While	 the	 allene	 formation	
reaction	 of	 enantioenriched	 2-B(pin)	 allylic	 acetate	 provided	 the	 enantioenriched	 allene,	
palladium-catalyzed	racemization	of	the	allene	resulted	in	the	racemic	product	over	time.	
With	 the	ability	 to	control	 chemoselectivity,	various	 tandem	reactions	were	 investigated.	 	The	
allylic	substitution	of	2-B(pin)-substituted	allylic	acetates	can	be	followed	with	a	Suzuki-Miyaura	
cross-coupling	 to	 afford	 (E)-trisubstituted	 allylic	 amines	 and	 malonates	 with	 four	 points	 of	
diversity.		Enantioenriched	2-B(pin)-substituted	allylic	acetates	undergo	allylic	substitution	with	
net	stereochemical	retention,	allowing	isolation	of	B(pin)-containing	substitution	products	or	α-
amino	 ketones	 with	 little	 or	 no	 loss	 of	 ee.	 	 Alternatively,	 the	 allylic	 substitution	 of	 2-B(pin)-
substituted	allylic	acetates	can	be	paired	with	oxidation	of	vinyl	boronates	to	provide	valuable	
α-amino	ketones	and	1,4-dicarbonyl	compounds.	
	 Given	 the	 high	 levels	 of	 control	 over	 chemoselectivity	 in	 our	 optimized	 palladium-





All	 reactions	 were	 performed	 under	 a	 nitrogen	 atmosphere	 with	 oven-dried	 glassware.	 	 All	
manipulations	 involving	 dicyclohexylborane,	 dimethylzinc	 and	 diethylzinc	 were	 carried	 out	
under	an	inert	atmosphere	in	a	Vacuum	Atmospheres	drybox	with	an	attached	MO-40	Dritrain	
or	by	using	standard	Schlenk	or	vacuum	line	techniques.		Chemicals	were	obtained	from	Aldrich,	
Acros,	 or	 GFS	 Chemicals	 unless	 otherwise	 specified.	 	 Solvents	 were	 purchased	 from	 Fischer	
Scientific.	 	 Toluene	 was	 dried	 through	 an	 activated	 alumina	 column,	 and	 then	 thoroughly	
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degassed	prior	to	use.		Tetrahydrofuran	was	distilled	from	sodium	and	benzophenone	under	N2.		
B(pin)-substituted	 alkynes	 were	 prepared	 by	 literature	 methods.11a,11b	 	 Dimethylzinc	 and	
diethylzinc	 solutions	 (2.0	M	 in	 toluene)	were	 prepared	 and	 stored	 in	 a	 Vacuum	Atmospheres	
drybox.	 	 NMR	 spectra	were	 obtained	 on	 Brüker	 300,	 360,	 400	 or	 500	MHz	 Fourier	 transform	
spectrometers	at	the	University	of	Pennsylvania	NMR	facility.		1H	and	13C{1H}	NMR	spectra	were	
referenced	 to	 residual	 solvent.	 11B{1H}	 NMR	 spectra	 were	 referenced	 to	 BF3·OEt2.	 Analysis	 of	
enantiomeric	 excess	 was	 performed	 using	 a	 Hewlett-Packard	 1100	 Series	 HPLC	 and	 a	 chiral	
column.	 The	 infrared	 spectra	 were	 obtained	 using	 a	 Perkin-Elmer	 1600	 series	 spectrometer.		
HRMS	data	was	obtained	on	a	Waters	LC-TOF	mass	spectrometer	(model	LCT-XE	Premier)	using	
electrospray	 ionization	 in	 positive	 or	 negative	 mode,	 depending	 on	 analyte.	 Thin-layer	
chromatography	was	performed	on	Whatman	precoated	silica	gel	60	F-254	plates	and	visualized	










General	 Procedure	 A:	 Synthesis	 of	 2-B(pin)-substituted	 Allylic	 Acetates.	 To	 a	 suspension	 of	
HBCy2	 (770	mg,	4.32	mmol)	 in	 toluene	 (4.0	mL)	equipped	with	a	 stir	bar	under	N2	was	added	
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EtOAc	 (3	 x	 25	 mL).	 The	 combined	 organic	 solution	 was	 dried	 over	 MgSO4,	 filtered,	 and	 the	
solvent	was	 removed	 under	 reduced	 pressure	 to	 yield	 a	 colorless	 oil.	 The	 crude	 product	was	
purified	by	flash	column	chromatography	on	silica	gel	(hexanes:EtOAc	=	97:3)	to	afford	the	allylic	
acetate	 as	 a	 colorless	 oil.	 Importantly,	 the	 2-B(pin)	 allylic	 acetate	 product	 is	 susceptible	 to	
oxidation	 of	 the	 B–C	 bond	 on	 silica	 under	 air,	 and	 hence	 a	 rapid	 purification	 is	 necessary	 to	












isobutyraldehyde	 (130	 mg,	 0.16	 mL,	 1.80	 mmol),	 2-hex-1-ynyl-4,4,5,5-tetramethyl-1,3,2-











using	 n-pentanal	 (431	 mg,	 0.53	 mL,	 5.0	 mmol),	 2-(6-chlorohex-1-yn-1-yl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane	 (1.46	 g,	 6.0	 mmol)	 and	 acetic	 anhydride	 (1.42	mL,	 15	mmol).	 The	 crude	





26.8,	 25.0,	 24.7,	 22.6,	 21.5,	 14.1	 (the	 quaternary	 vinyl	 C	 bearing	 the	 boron	 group	 is	 not	
observed);	 11B	 NMR	 (CDCl3,	 128	MHz)	 δ	 30.2;	 IR	 (neat)	 2978,	 2958,	 2933,	 2862,	 1738,	 1636,	
























A	 using	p-tolualdehyde	 (433	mg,	 0.42	mL,	 3.60	mmol),	 2-hex-1-ynyl-4,4,5,5-tetramethyl-1,3,2-




















1,3-dien-5-yl	 acetate	 (2.1l).	 The	 product	 was	 prepared	 by	 General	
Procedure	 A	 using	 cinnamaldehyde	 (476	 mg,	 0.45	 mL,	 3.60	 mmol),	 2-hex-1-ynyl-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane	 (899	mg,	 1.0	mL,	 4.32	mmol)	 and	 acetic	 anhydride	 (1.02	mL,	
10.8	 mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	











General	 Procedure	 B:	 Palladium-Catalyzed	 Allylic	 Substitution	 of	 2-B(pin)-substituted	 Allylic	






dry	 and	 degassed	 THF	 at	 rt	 under	 N2,	 and	 the	 solution	 was	 stirred	 at	 rt	 for	 30	 min.	 To	 this	
catalyst	 solution	was	 added	 2-B(pin)-substituted	 allylic	 acetate	 (0.10	mmol),	 and	 the	 reaction	
mixture	was	 stirred	 for	 an	 additional	 30	 –	 45	min.	 In	 a	 separate	 5	mL	 round	 bottomed	 flask	
equipped	with	a	stir	bar	and	condenser	was	added	sodium	hydride	(7.9	mg,	0.33	mmol)	 in	2.0	
mL	of	dry	 and	degassed	THF	under	N2,	 and	 the	 reaction	mixture	was	 cooled	 to	0	 °C	 in	 an	 ice	
bath.	 To	 this	 white	 suspension	 was	 added	 dropwise	 dimethyl	 malonate	 (35	 µL,	 39.6	mg,	 0.3	
mmol)	 at	 0	 °C,	 which	 was	 accompanied	 by	 rapid	 evolution	 of	 H2.	 The	 reaction	 soon	 became	
clear,	after	which	 it	was	heated	to	reflux	under	N2	 for	15	min.	The	dimethyl	malonate	sodium	
solution	 (3	 equiv)	 was	 cooled	 to	 rt,	 and	 then	 transferred	 via	 cannula	 into	 the	 Schlenk	 flask	
containing	 the	 catalyst	 and	 2-B(pin)-substituted	 allylic	 acetate	 solution	 at	 rt.	 The	 reaction	
mixture	was	warmed	 to	 40	 °C	 and	 stirred	 until	 TLC	 showed	 complete	 consumption	 of	 the	 2-
B(pin)	substituted	allylic	acetate.	The	reaction	mixture	was	then	cooled	to	rt,	diluted	with	EtOAc	
(4	mL),	 and	quenched	with	 saturated	NH4Cl	 (4	mL).	 The	organic	 layer	was	 separated,	 and	 the	
aqueous	solution	was	extracted	with	EtOAc	(3	x	5	mL).	The	combined	organic	solution	was	dried	












this	 catalyst	 solution	 was	 added	 2-B(pin)-substituted	 allylic	 acetate	 (0.10	 mmol),	 and	 the	
reaction	mixture	was	stirred	for	an	additional	30	–	45	min,	after	which	the	amine	(3	–	5	equiv,	
dried,	distilled	and	degassed)	was	added	at	rt.	The	reaction	mixture	was	warmed	to	40	°C	and	
stirred	 until	 TLC	 showed	 complete	 consumption	 of	 the	 2-B(pin)	 substituted	 allylic	 acetate,	
typically	10	–	24	h.	In	the	case	of	Pd(OAc)2,	the	reaction	mixture	was	stirred	at	rt	for	24	h	or	until	







The	 allylic	 amine	 product	 is	 susceptible	 to	 oxidation	 of	 the	 B–C	 bond	 on	 silica	 under	 air,	 and	
hence	a	rapid	purification	is	necessary	to	minimize	oxidation	to	the	amino	ketone.	
	





catalyst	 solution	 was	 added	 2-B(pin)-substituted	 allylic	 acetate	 (0.10	mmol)	 and	 the	 reaction	
mixture	was	stirred	for	an	additional	15	min,	after	which	N,O-bis(trimethylsilyl)acetamide	(BSA)	
(73	µL,	61.0	mg,	0.30	mmol,	3	equiv)	and	dimethyl	malonate	(34	µL,	39.6	mg,	0.3	mmol,	3	equiv)	
were	added	at	 rt	 followed	by	catalytic	KOAc.	The	 reaction	mixture	was	warmed	 to	40	 °C,	and	
stirred	 until	 TLC	 showed	 complete	 consumption	 of	 the	 2-B(pin)	 substituted	 allylic	 acetate	
(typically	10	–	12	h).	The	reaction	mixture	was	then	cooled	to	rt,	diluted	with	EtOAc	(4	mL)	and	


















































































dioxaborolan-2-yl)hept-2-en-1-yl)malonate	 (2.2j).	 The	 compound	 was	














General	 Procedure	 E:	 Tandem	 Palladium-Catalyzed	 Allylic	 Substitution	 and	 Oxidation	 with	
H2O2/NaOH	
	To	a	 Schlenk	 flask	with	a	 stir	bar	was	added	 [Pd(allyl)Cl]2	(1.8	mg,	0.005	mmol,	 5	mol	%)	 and	
PPh3	(5.3	mg,	0.02	mmol,	20	mol	%)	in	1.0	mL	of	dry	and	degassed	THF	at	rt	under	N2,	and	the	















after	which	 the	 nucleophile	 (3	 –	 5	 equiv),	 either	 amines	 or	 dimethyl	malonate	 sodium	anion,	




of	 the	 oxidation	 reaction.	 The	 reaction	 was	 diluted	 with	 EtOAc	 (4	 mL),	 followed	 by	 distilled	






Dimethyl	 2-(6-oxoundecan-5-yl)malonate	 (2.3a).	 The	 compound	 was	
prepared	 by	 General	 Procedure	 E	 and	 the	 result	 was	 reported	 in	 our	
preliminary	communication.9		
	
	5-Morpholinoundecan-6-one	 (2.3b).	 The	 compound	 was	 prepared	 by	






















	Dimethyl	 2-(6-oxoundecan-5-yl)malonate	 (2.3d).	 The	 compound	 was	




General	 Procedure	 F:	 Tandem	 Palladium-Catalyzed	 Allylic	 Substitution	 and	 Oxidation	 with	
NaBO3·H2O.	To	a	Schlenk	flask	equipped	with	a	stir	bar	was	added	Pd(OAc)2	(2.2	mg,	0.01	mmol,	
10	mol	%)	and	PPh3	(5.3	mg,	0.02	mmol,	20	mol	%)	in	1.0	mL	of	dry	and	degassed	THF	at	rt	under	
N2,	and	 the	solution	was	stirred	 for	30	–	45	min.	To	 this	catalyst	 solution	was	added	2-B(pin)-
substituted	allylic	acetate	1f	(0.10	mmol),	and	the	reaction	mixture	was	stirred	for	an	additional	
30	 –	 45	min,	 after	 which	 the	 amine	 nucleophile	 (3	 equiv)	 was	 added	 at	 rt,	 and	 the	 reaction	




was	 diluted	 with	 diethyl	 ether	 (4	 mL).	 The	 organic	 layer	 was	 separated,	 and	 the	 aqueous	
solution	was	extracted	with	diethyl	ether	(3	x	5	mL).	The	combined	organic	solution	was	dried	
over	MgSO4,	filtered	through	Celite,	and	the	solvent	was	removed	under	reduced	pressure.	The	








1-Morpholino-1-phenylheptan-2-one	 (2.3e).	 The	 compound	was	 prepared	 by	








stirred	 for	 30	 –	 45	 min	 at	 rt,	 and	 the	 solution	 was	 stirred	 for	 30	 –	 45	 min.	 To	 this	 catalyst	
solution	was	 added	 2-B(pin)-substituted	 allylic	 acetate	 (0.10	mmol),	 and	 the	 reaction	mixture	
was	stirred	for	an	additional	30	–	45	min,	after	which	the	amine	(3	equiv)	was	added	at	rt.	The	
reaction	mixture	was	warmed	to	40	°C	and	stirred	until	TLC	showed	complete	consumption	of	




h.	 The	 reaction	 was	 cooled	 to	 rt,	 diluted	 with	 EtOAc	 (5	 mL),	 and	 saturated	 aqueous	 NH4Cl	
solution	 (5	 mL)	 was	 added.	 The	 organic	 layer	 was	 separated,	 and	 the	 aqueous	 solution	 was	
extracted	with	EtOAc	(3	x	5	mL).	The	combined	organic	solution	was	washed	with	brine,	dried	
over	MgSO4,	filtered	through	Celite	and	the	solvent	was	removed	under	reduced	pressure.	The	










	(E)-4-(1,2-Diphenylhept-2-enyl)morpholine	 (2.5d).	 The	 product	 was	
prepared	by	General	Procedure	G	using	(E)-1-phenyl-2-(4,4,5,5-tetramethyl-









3H);	 13C{1H}	 NMR	 (125	MHz,	 CDCl3)	 δ	 140.7,	 140.4,	 139.9,	 130.7,	 129.5,	 129.1,	 128.0,	 127.7,	







20	 mol	 %),	 morpholine	 (61	 µL,	 61.0	 mg,	 0.70	 mmol),	 Cs2CO3	 (137	 mg,	 0.42	 mmol),	 and	 4-














129.1,	 128.0,	 127.0,	 113.2,	 79.8,	 67.5,	 55.3,	 53.1,	 32.3,	 28.7,	 22.6,	 14.2;	 IR	 (neat)	 3027,	 2957,	




product	 was	 prepared	 by	 General	 Procedure	 G	 using	 2.1f	 (50.0	 mg,	 0.14	
mmol),	Pd(OAc)2	(3.1	mg,	0.014	mmol,	10	mol	%),	PPh3	(7.3	mg,	0.028	mmol,	
20	mol	%),	morpholine	(61	µL,	 61.0	mg,	 0.70	mmol),	 Cs2CO3	(137	mg,	 0.42	
mmol),	and	1-bromo-4-nitrobenzene	(84.8	mg,	0.42	mmol).	The	crude	product	was	purified	by	
flash	 column	 chromatography	 on	 deactivated	 silica	 gel	 (hexanes:EtOAc	 =	 90:10)	 to	 afford	 the	

































PPh3)	by	a	 syringe,	 and	 the	 reaction	mixture	was	 stirred	at	 rt	 for	30	min.	 	A	 stock	 solution	of	
NaCH(CO2Me)2	(0.1	M	in	THF,	0.6	mL,	0.6	mmol)	was	added	into	the	vial	via	a	syringe	at	rt.		The	
sealed	 vial	 was	 then	 warmed	 in	 an	 oil	 bath	 to	 40	 °C	 and	 stirred	 until	 TLC	 showed	 complete	
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consumption	 of	 allylic	 acetate.	 	 Aliquots	 for	 TLC	 were	 taken	 under	 a	 positive	 pressure	 of	
nitrogen.		After	completion	of	the	reaction,	the	reaction	mixture	was	then	diluted	with	degassed	
toluene	 (1.8	 mL)	 and	 H2O	 (0.2	 mL)	 followed	 by	 addition	 of	 Cs2CO3	 (3	 equiv,	 195.5	 mg,	 0.60	
mmol)	and	an	aryl	halide	(3	equiv,	0.60	mmol).		The	reaction	mixture	was	heated	in	an	oil	bath	
at	 90	 °C	 until	 the	 allylic	 substitution	 product	 had	 been	 consumed	 by	 TLC,	 typically	 24	 h.	 The	
reaction	was	cooled	to	rt,	diluted	with	EtOAc	 (5	mL)	and	saturated	aqueous	NH4Cl	 (5	mL)	was	
added.	The	organic	layer	was	separated,	and	the	aqueous	solution	was	extracted	with	EtOAc	(3	
x	 5	 mL).	 The	 combined	 organic	 solution	 was	 washed	 with	 brine,	 dried	 over	 MgSO4,	 filtered	
through	Celite	and	the	solvent	was	removed	under	reduced	pressure	to	yield	a	colorless	oil.	The	
crude	 product	 was	 purified	 by	 flash	 column	 chromatography	 on	 silica	 gel	 to	 afford	 tandem	
product.	
	
	(Z)-Dimethyl	 2-(1,2-diphenylhept-2-en-1-yl)malonate	 (2.5g).	 The	 product	
was	 prepared	 by	 General	 Procedure	 H	 using	 2.1f	 (71.7	 mg,	 0.2	 mmol),	 a	
stock	solution	of	Pd(OAc)2/2PPh3	(0.014	M	in	THF,	1.4	mL,	10	mol%	Pd	and	
20	mol	%	PPh3),	sodium	malonate	(0.1	M	THF,	0.6	mL,	0.6	mmol),	toluene	(1.8	mL),	H2O	(0.2	mL),	
Cs2CO3	 (195.5	 mg,	 0.6	 mmol),	 and	 bromobenzene	 (63.2	 µL,	 94.2	 mg,	 0.6	 mmol).	 The	 crude	









(neat)	 3029,	 2954,	 2929,	 2856,	 1761,	 1740,	 1600,	 1493,	 1454,	 1434,	 1318,	 1244,	 1193,	 1142,	
1030	cm-1;	HRMS	m/z	403.1882	[(M+Na)+;	calcd	for	C24H28O4Na:	403.1885].	





using	 2.1h	 (85.3	 mg,	 0.2	 mmol),	 a	 stock	 solution	 of	 Pd(OAc)2/2PPh3	
(0.014	M	in	THF,	1.4	mL,	10	mol%	Pd	and	20	mol	%	PPh3),	sodium	malonate	(0.1	M	THF,	0.6	mL,	







129.2,	128.9,	128.1,	127.1,	125.3	 (q,	 J	=	3.8	Hz),	124.3	 (q,	 J	=	270.6	Hz),	56.3,	53.5,	53.0,	52.8,	
32.1,	 28.8,	 22.3,	 14.1;	 IR	 (neat)	 3053,	 3021,	 2956,	 2930,	 2857,	 1762,	 1741,	 1618,	 1435,	 1325,	











a	 stir	 bar	was	 added	 Pd(OAc)2	(4	mg,	 0.018	mmol)	 and	 PPh3	(9.4	mg,	 0.036	
mmol)	in	5	mL	of	dry	and	degassed	THF	at	rt	under	N2,	and	the	solution	was	
stirred	 for	30	–	45	min.	To	 this	catalyst	 solution	was	added	2-B(pin)	 substituted	allylic	acetate	
2.1a	(39	mg,	0.12	mmol),	immediately	followed	by	Cs2CO3	(117	mg,	0.36	mmol),	1	mL	of	distilled	




washed	 with	 brine,	 dried	 over	MgSO4,	 filtered	 through	 Celite,	 and	 the	 solvent	 was	 removed	
under	 reduced	pressure.	 The	 crude	product	was	purified	by	 flash	 column	 chromatography	on	




138.4,	 131.0,	 129.5,	 128.2,	 127.1,	 78.6,	 33.2,	 32.0,	 28.4,	 27.9,	 22.6,	 22.4,	 21.6,	 14.2,	 14.1;	 IR	









Into	 a	 oven-dried	microwave	 vial	 equipped	with	 a	 stir	 bar	 were	 charged	 2-B(pin)-substituted	
allylic	 acetate	 2.1a	 (25.0	mg,	 0.074	mmol),	 Pd(OAc)2	 (1.7	mg,	 7.4	 x	 10-3	mmol),	 PPh3	 (5.8	mg,	
22.2	x	10-3	mmol)	and	Cs2CO3	(72.3	mg,	0.22	mmol).	The	vial	was	capped	and	purged	with	N2.	To	
the	 vial	 was	 added	 degassed	 toluene	 (0.4	 mL),	 H2O	 (40	 µL)	 and	 iodobenzene	 (24.8	 µL,	 0.22	
mmol),	and	the	reaction	mixture	was	stirred	at	90	 °C	 in	an	oil	bath	until	TLC	showed	complete	
consumption	 of	 the	 2-B(pin)-substituted	 allylic	 acetate	 2.1a.	 The	 reaction	 mixture	 was	 then	
cooled	to	rt	and	diluted	with	EtOAc	(2	mL).	The	solution	was	filtered	through	MgSO4	and	a	short	
silica	 pad,	 and	 the	 filtrate	was	 concentrated	 under	 reduced	 pressure.	 The	 crude	 product	was	





aryl	halide	coupling	partner.	Concentration	of	 the	 reactions	are	 typically	 in	 the	 range	of	0.17–
0.20	M.	
	
	(E)-6-(4-Methoxyphenyl)undec-6-en-5-yl	 acetate	 (2.6b).	 The	 product	 was	
prepared	by	General	Procedure	J	in	a	0.1	mmol	scale.	With	2.1a	(33.8	mg,	0.1	
mmol)	 and	 4-iodoanisole	 (70.2	mg,	 0.3	mmol)	 as	 the	 coupling	 partner,	 the	













	(E)-6-(4-Nitrophenyl)undec-6-en-5-yl	 acetate	 (2.6c).	 The	 product	 was	
prepared	by	General	Procedure	J	in	a	0.1	mmol	scale.	With	2.1a	(33.8	mg,	0.1	
mmol)	 and	 1-iodo-4-nitrobenzene	 (74.7	 mg,	 0.3	 mmol)	 as	 the	 coupling	
partner,	the	title	compound	was	isolated	in	92%	yield	(30.7	mg).	With	2.1a	(33.8	mg,	0.1	mmol)	







	(E)-2-Methyl-4-phenylnon-4-en-3-yl	 acetate	 (2.6d).	 The	 product	 was	
prepared	by	General	Procedure	J	in	a	0.1	mmol	scale.	With	2.1b	(32.4	mg,	0.1	
mmol)	and	iodobenzene	(33.6	µL,	61.2	mg,	0.3	mmol)	as	the	coupling	partner,	













22.4,	 21.5,	 19.5,	 17.8,	 14.1;	 IR	 (neat)	 2961,	 2923,	 2873,	 1743,	 1600,	 1575,	 1494,	 1467,	 1369,	
1238,	1021	cm-1;	HRMS	m/z	297.1835	[(M+Na)+;	calcd	for	C18H26O2Na:	297.1831].	
	
	(E)-1,2-Diphenylhept-1-en-3-yl	 acetate	 (2.6e).	 The	 product	 was	 prepared	 by	
General	Procedure	 J	 in	a	0.1	mmol	 scale.	With	2.1d	 (35.8	mg,	0.1	mmol)	and	














Hz,	1H),	2.13	 (s,	3H),	1.74	–	1.51	 (m,	2H),	1.46	–	1.20	 (m,	4H),	0.87	 (t,	 J	=	7.0	Hz,	3H);	 13C	 {1H}	










	(E)-1,2-Diphenylhept-2-en-1-yl	 acetate	 (2.6g).	 The	 product	was	 prepared	 by	
General	Procedure	J	in	a	0.1	mmol	scale	and	the	reaction	was	conducted	at	75	








	(E)-2-(4-Nitrophenyl)-1-phenylhept-2-enyl	 acetate	 (2.6h).	 The	 product	 was	
prepared	 by	 General	 Procedure	 J	 in	 a	 0.1	mmol	 scale,	 and	 the	 reaction	was	
conducted	at	 75	 °C	 in	 THF	 (0.4	mL)	 and	H2O	 (40	µL).	With	2.1f	 (35.8	mg,	 0.1	
mmol)	 and	 1-iodo-4-nitrobenzene	 (74.7	 mg,	 0.3	 mmol)	 as	 the	 coupling	 partner,	 the	 title	















	(E)-11-Chloro-6-phenylundec-6-en-5-yl	 acetate	 (2.6i).	 Into	 a	 oven-dried	
microwave	vial	equipped	with	a	stir	bar	were	charged	with	2.1e	 (1.86	g,	
5.0	mmol),	 Pd(OAc)2	 (112	mg,	 0.5	mmol),	 PPh3	 (262	mg,	 1.5	mmol)	 and	
Cs2CO3	 (3.26	mg,	 10	mmol).	 The	 vial	was	 capped	 and	 purged	with	N2.	 To	 the	 vial	was	 added	
degassed	toluene	(12	mL),	H2O	(2.4	mL)	and	iodobenzene	(1.11	mL,	10	mmol),	and	the	reaction	
mixture	was	stirred	 in	an	oil	bath	at	90	 °C	 for	6	h.	The	 reaction	was	cooled	 to	 rt,	diluted	with	
EtOAc	 (10	mL),	 followed	by	 saturated	 aqueous	NH4Cl	 solution	 (20	mL).	 The	 organic	 layer	was	
separated	 and	 the	 aqueous	 solution	 was	 extracted	 with	 EtOAc	 (3	 x	 15	 mL).	 The	 combined	
organic	 solution	 was	 washed	 with	 brine,	 dried	 over	 MgSO4,	 filtered	 and	 the	 solvent	 was	










































	(E)-6-(Thiophen-3-yl)undec-6-en-5-yl	 acetate	 (2.6l).	 The	 product	 was	
prepared	by	General	Procedure	 J	 in	a	0.15	mmol	 scale.	With	2.1a	 (50.7	mg,	




0.84	 (t,	 J	=	7.0	Hz,	3H),	0.83	 (t,	 J	=	7.2	Hz,	3H);	 13C	 {1H}	NMR	(125	MHz,	CDCl3)	δ	170.5,	137.9,	
134.6,	 132.7,	 129.1,	 124.8,	 123.2,	 78.8,	 33.2,	 32.1,	 28.7,	 27.9,	 22.6,	 22.5,	 21.7,	 14.2,	 14.1;	 IR	
(neat)	 2958,	 2930,	 2872,	 2860,	 1739,	 1466,	 1370,	 1235,	 1081,	 1235,	 1018	 cm-1;	 HRMS	m/z	
317.1552	[(M+Na)+;	calcd	for	C17H26O2SNa:	317.1551].	
	
	(Z)-6-(Thiophen-2-yl)undec-6-en-5-yl	 acetate	 (2.6m).	 The	 product	 was	
prepared	by	General	Procedure	 J	 in	a	0.15	mmol	 scale.	With	2.1a	 (50.7	mg,	

























NH4Cl	 (15	mL).	 The	organic	 layer	was	 separated	and	 the	aqueous	 solution	was	extracted	with	
CH2Cl2	(2	x	15	mL).	The	combined	organic	layers	were	washed	with	saturated	aqueous	NaHCO3	
(15	mL)	and	brine	(10	mL),	and	dried	over	MgSO4,	filtered,	and	the	solvent	was	removed	under	




benzoate	 (2.7a).	 The	product	was	 prepared	by	General	 Procedure	 K	 using	
















2.7a R = n-Bu
2.7b R = Ph













(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)non-4-en-3-ol10a	 (632	 mg,	 2	 mmol).	 The	 crude	





132.9,	 131.1,	 123.0,	 128.4,	 128.3,	 127.8,	 127.7,	 83.4,	 78.9,	 32.1,	 30.9,	 24.8,	 22.5,	 14.1	 (the	
quaternary	vinyl	C	bearing	the	boron	group	is	not	observed);	11B	NMR	(CDCl3,128	MHz)	δ	30.3;	IR	





(4.0	mL)	 equipped	with	 a	 stir	 bar	 under	N2	was	 added	 2-hex-1-ynyl-4,4,5,5-tetramethyl-1,3,2-













saturated	 NH4Cl	 (15	 mL).	 The	 organic	 layer	 was	 separated	 and	 the	 aqueous	 solution	 was	
extracted	with	EtOAc	(3	x	5	mL).	The	combined	organic	solution	was	dried	over	MgSO4,	filtered	







6H),	1.27	 (s,	6H),	0.90	 (t,	 J	=	7.0	Hz,	3H);	 13C{1H}	NMR	(125	MHz,	CDCl3)	δ	148.1,	142.6,	128.6,	
128.4,	 125.7,	 83.4,	 77.9,	 40.0,	 32.6,	 32.0,	 30.6,	 25.1,	 24.8,	 22.4,	 14.1	 (the	 quaternary	 vinyl	 C	
bearing	 the	 boron	 group	 is	 not	 observed);	 11B	 NMR	 (CDCl3,128	MHz)	 δ	 29.4;	 IR	 (neat)	 3451,	




en-3-yl	 benzoate	 (2.7c).	 The	 product	 was	 prepared	 by	 General	










3H);	 13C{1H}	 NMR	 (125	MHz,	 CDCl3)	 δ	 165.9,	 148.1,	 142.1,	 132.7,	 131.2,	 129.8,	 128.6,	 128.5,	
128.3,	 125.9,	 83.2,	 78.7,	 36.7,	 32.2,	 32.0,	 30.8,	 25.1,	 24.8,	 22.4,	 14.1	 (the	 quaternary	 vinyl	 C	
bearing	 the	 boron	 group	 is	 not	 observed);	 11B	NMR	 (CDCl3,	 128	MHz)	 δ	 30.1;	 IR	 (neat)	 3063,	







ice	 bath,	 and	 Et2Zn	 2.0	 M	 in	 toluene	 (1.2	 mL,	 2.4	 mmol)	 was	 added	 dropwise.	 The	 reaction	
mixture	was	stirred	at	this	temperature	for	10	min.	 tert-Butyl	1H-imidazole-1-carboxylate	(673	
mg,	 4	mmol)	 in	 toluene	 (3	mL)	was	 transferred	 to	 the	 reaction	mixture	 by	 a	 syringe	with	 an	
additional	2	mL	of	 toluene.	The	 reaction	mixture	was	 then	 stirred	at	 rt	 for	18	h.	 The	 reaction	
mixture	was	diluted	with	hexanes	(10	mL)	and	quenched	with	saturated	aqueous	NH4Cl	(15	mL).	
The	organic	 layer	was	 separated,	 and	 the	 aqueous	 solution	was	 extracted	with	 EtOAc	 (2	 x	 20	
mL).	 The	 combined	organic	 layers	were	washed	with	 saturated	 aqueous	NaHCO3	 (20	mL)	 and	
brine	(20	mL),	and	then	dried	over	MgSO4.	The	combined	organic	solution	was	filtered,	and	the	
118	
solvent	was	 removed	 under	 reduced	 pressure	 to	 yield	 a	 colorless	 oil.	 The	 crude	 product	was	

















carbonate	 (2.8b).	 The	 product	was	 prepared	 by	General	 Procedure	 K	 using	













0.88	 (t,	 J	=	6.9	Hz,	3H),	0.87	 (t,	 J	=	6.9	Hz,	3H);	 13C	 {1H}	NMR	(125	MHz,	CDCl3)	δ	154.9,	147.4,	
83.3,	81.9,	63.6,	34.9,	32.0,	30.8,	27.9,	25.1,	24.9,	22.6,	22.4,	14.5,	14.1,	14.0	 (the	quaternary	






using	 (E)-1-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)non-4-en-3-ol10a	 (632	 mg,	 2	




6H),	1.13	 (s,	6H),	0.87	 (t,	 J	=	7.0	Hz,	3H);	 13C{1H}	NMR	(125	MHz,	CDCl3)	δ	153.0,	146.0,	140.0,	
128.2,	128.0,	127.8,	83.3,	81.8,	80.7,	32.0,	30.8,	28.0,	24.9,	24.7,	22.4,	14.1	(the	quaternary	vinyl	













General	 Procedure	 L	 using	 (E)-1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)non-4-






32.0,	 30.7,	 28.0,	 25.1,	 24.8,	 22.2,	 14.1	 (the	quaternary	 vinyl	 C	bearing	 the	boron	group	 is	 not	









and	 iodobenzene	 (24.8	 µL,	 0.22	 mmol)	 as	 the	 coupling	 partner,	 the	 title	
compound	 was	 isolated	 in	 96%	 yield	 (24.9	 mg).	 With	 2.7a	 (29.6	 mg,	 0.074	 mmol)	 and	







3H);	 13C	 {1H}	 NMR	 (125	MHz,	 CDCl3)	 δ	 165.8,	 139.5,	 138.1,	 132.7,	 131.0,	 130.8,	 129.5,	 129.4,	




	(E)-6-(4-(Trifluoromethyl)phenyl)undec-6-en-5-yl	 benzoate	 (2.9b).	 The	





























				(E)-tert-Butyl	 (6-(4-nitrophenyl)undec-6-en-5-yl)	 carbonate	 (2.9d).	 The	
product	was	 prepared	 by	General	 Procedure	 J	 in	 a	 0.074	mmol	 scale.	With	
2.8a	(29.3	mg,	0.074	mmol)	and	1-iodo-4-nitrobenzene	(54.8	mg,	0.22	mmol)	
as	the	coupling	partner,	the	title	compound	was	isolated	in	78%	yield	(22.6	mg).	With	2.7a	(29.3	










(2.9e).	 The	 product	was	 prepared	 by	 General	 Procedure	 J	 in	 a	 0.074	mmol	














2861,	 1741,	 1617,	 1457,	 1369,	 1325,	 1276,	 1256,	 1166,	 1128,	 1067,	 1020,	 cm-1;	 HRMS	m/z	
437.2260	[(M+Na)+;	calcd	for	C23H33F3O3Na:	437.2279].		
	
	(E)-Ethyl	 (6-phenylundec-6-en-5-yl)	 carbonate	 (2.9f).	 The	 product	 was	
prepared	by	General	Procedure	 J	 in	a	0.10	mmol	scale.	With	2.8b	 (36.8	mg,	















The	 synthesis	of	hepta-1,2-dien-1-ylbenzene	 (2.10a)	 is	 representative	of	General	Procedure	M	
and	is	outlined	below.	Reactions	are	typically	conducted	in	0.08–0.2	mmol	scale	with	0.5	mol	%	









Hepta-1,2-dien-1-ylbenzene	 (2.10a).	 To	 an	 oven-dried	 microwave	 vial	
equipped	with	a	stir	bar	was	charged	the	allylic	acetate	2.1f	(38.8	mg,	0.10	




allylic	 acetate	2.1f.	 The	 reaction	mixture	was	 cooled	 to	 rt	 and	 diluted	with	 EtOAc	 (2	mL)	 and	
saturated	aqueous	NH4Cl	(2	mL).	The	organic	layer	was	separated	and	the	aqueous	solution	was	
extracted	with	EtOAc	(3	x	5	mL).	The	combined	organic	solution	was	washed	with	brine	(10	mL),	
dried	 over	MgSO4,	 and	 the	 solvent	was	 removed	 under	 reduced	 pressure.	 The	 crude	 product	





1-Chloro-4-(hepta-1,2-dien-1-yl)benzene	 (2.10b).	 The	 product	 was	
prepared	by	General	Procedure	M	using	2.1i	(39.3	mg,	0.01	mmol),	and	






























22.5,	 21.4,	 14.1;	 IR	 (neat)	 3021,	 2958,	 2926,	 2859,	 1947,	 1512,	 1465,	 1458	 cm-1;	 HRMS	m/z	
186.1409	[M+;	calcd	for	C14H18:	186.1409].	
	
	(E)-Nona-1,3,4-trien-1-ylbenzene	 (2.10e).	 The	 product	 was	 prepared	




	Undeca-5,6-diene	 (2.10f).	 The	 product	 was	 prepared	 by	 General	
Procedure	M	using	2.7a	(40.0	mg,	0.10	mmol).	The	title	compound	was	isolated	as	a	colorless	oil	
in	53%	yield	 (8.1	mg).	With	2.8a	 (39.6	mg,	0.10	mmol),	 the	product	was	 isolated	 in	85%	yield	
(12.9	mg).	The	NMR	spectral	data	match	the	previously	published	data.44	
		
Nona-3,4-dien-1-ylbenzene	 (2.10g).	 The	 product	 was	 prepared	 by	
General	 Procedure	 M	 using	 2.7c	 (44.8	 mg,	 0.10	 mmol).	 The	 title	
compound	 was	 isolated	 as	 a	 colorless	 oil	 in	 79%	 yield	 (15.8	 mg).	 With	 2.8d	 (44.4	 mg,	 0.10	
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	 Pyridine	 and	 quinoline	 derivatives	 are	 important	 heterocycles	 that	 are	 present	 in	 a	
broad	range	of	biologically	active	natural	products	and	pharmaceutically	relevant	compounds.1		
Aryl(azaaryl)methylamines	are	prominent	in	biologically	active	small	molecules,	exhibiting	anti-





































(X = N or CH)
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substitution	 reactions	 with	 amine	 nucleophiles,	 addition	 of	 aryl	 or	 azaaryl	 organometallic	
reagents	 to	 imines,	 and	 reduction	 of	 imines.8	 	 Despite	 the	 popularity	 of	 these	methods,	 they	
involve	 prefunctionalized	 electrophiles	 or	 nucleophiles.	 	 Transition	 metal-catalyzed	 cross-
coupling	reactions	also	represent	an	attractive	approach.7d	 	The	direct	C–H	functionalization	of	
amino	alkyl	moieties	(R’CH2NR2),	however,	is	challenging.9		Therefore,	activated	substrates,	such	
as	 Boc	 protected	 amines,	 ketimines	 and	 (η6-benzylamine)Cr(CO)3	 complexes	 have	 been	
employed	 to	 facilitate	 deprotonation	 of	 C–H	 bonds	 adjacent	 to	 nitrogen	 (Figure	 3.2).10	 	 The	
activating	 groups	 necessary	 in	 Figure	 3.2	 to	 increase	 reactivity	 are	 often	 subsequently	
transformed	into	the	desired	functional	groups	or	excised	from	the	product	entirely,	decreasing	
the	synthetic	efficiency.	
	 Considering	 the	 importance	 of	 aryl(azaaryl)methylamines,	 the	 development	 of	 in	 situ	
deprotonation/arylation	 strategies	 for	 their	 synthesis	 that	 do	 not	 employ	 activating	 groups	
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with	 weakly	 acidic	 substrates,	 we	 hypothesized	 that	 the	 reversible	 deprotonation	 of	
(aminomethyl)-pyridines	in	the	presence	of	a	palladium	catalyst	should	be	possible.	
	 Herein,	 we	 report	 a	 practical	 method	 to	 prepare	 aryl(azaaryl)methylamines	 from	
(aminomethyl)-pyridines	and	aryl	halides	using	a	Pd-NIXANTPHOS-based	catalyst	(Scheme	3.1).		
This	 approach	 affords	 single-step	 access	 to	 aryl(azaaryl)methylamines	 from	 simple	 starting	







	 We	anticipated	 two	challenges	 to	advancing	a	 successful	deprotonative	cross-coupling	
process	(DCCP)	with	(aminomethyl)-pyridine	derivatives:	(1)	introduction	of	conditions	for	the	in	
situ	deprotonation	of	the	weakly	acidic	C–H’s	of	the	substrate	and	(2)	identification	of	a	catalyst	
capable	 of	 promoting	 coupling	 of	 the	 resulting	 organolithium,	 -sodium,	 or	 -potassium	
derivatives	with	aryl	halides.		In	the	latter	case,	we	have	found	that	palladium	complexes	of	van	
Leeuwen’s	 NIXANTPHOS	 ligand16	 outperform	 other	 Pd-phosphine	 complexes	 in	 this	 class	 of	
reactions.		As	such,	it	has	become	our	“go	to”	ligand	for	new	substrate	classes.	Concerning	the	







Azaaryl = 2-Py, 3-Py, 4-Py, Quinoline
NR1R2  = acyclic, cyclic amines












pKa	 value	 of	 these	 substrates	 suggests	 that	 alkoxide	 and	 silylamide	 bases	 are	 good	 starting	






bases	 [LiOtBu,	NaOtBu,	KOtBu,	 LiN(SiMe3)2,	NaN(SiMe3)2	 and	KN(SiMe3)2]	were	employed,	and	
the	results	are	displayed	in	entries	1–6	of	Table	3.1.		
	 Although	MOtBu	bases	[M	=	Li,	Na,	K]	did	not	generate	the	desired	product	3.3a	(entries	
1–3),	MN(SiMe3)2	 bases	 [M	=	 Li,	Na,	 K]	were	 all	 very	 promising,	 affording	 80–87%	assay	 yield	
(AY)	of	the	cross-coupling	product	3.3a	 (entries	4–6).	 	The	most	promising	result	was	obtained	
with	LiN(SiMe3)2	(87%	AY	as	determined	by	1H	NMR,	entry	4).		We	next	screened	other	ethereal	
solvents	 [DME,	CPME,	1,4-dioxane]	 (entries	7–9).	 	Of	 these,	 1,4-dioxane	 led	 to	90%	AY	of	 the	
desired	product	(entry	9).		Examination	of	the	stoichiometry	indicated	use	of	a	1	:	1.2	:	2	ratio	of	
pyridylmethylamine	(3.1a)	:	1-bromo-4-tert-butylbenzene	(3.2a)	:	LiN(SiMe3)2		rendered	98%	AY	
of	3a,	 leading	to	92%	 isolated	yield	 (entry	11).	 	Use	of	a	stoichiometric	amount	of	1-bromo-4-
tert-butylbenzene	 (3.2a)	 or	 lower	 catalyst	 loading	 [2.5	 mol	 %	 Pd(OAc)2	 and	 3.75	 mol	 %	 of	








entry	 base	 3.1a:	3.2a:base	 solvent[a]	 yield	[%]	
1	 LiOtBu	 1:1.5:3	 THF	 –	
2	 NaOtBu	 1:1.5:3	 THF	 –	
3	 KOtBu	 1:1.5:3	 THF	 –	
4	 LiN(SiMe3)2	 1:1.5:3	 THF	 87	
5	 NaN(SiMe3)2	 1:1.5:3	 THF	 80	
6	 KN(SiMe3)2	 1:1.5:3	 THF	 83	
7	 LiN(SiMe3)2	 1:1.5:3	 DME	 82	
8	 LiN(SiMe3)2	 1:1.5:3	 CPME	 85	
9	 LiN(SiMe3)2	 1:1.5:3	 1,4-dioxane	 90	
10	 LiN(SiMe3)2	 1:1.5:2	 1,4-dioxane	 92	
11	 LiN(SiMe3)2	 1:1.2:2	 1,4-dioxane	 98	(92)[c]	
12	 LiN(SiMe3)2	 1:1:1.5	 1,4-dioxane	 73[d]	
13	 LiN(SiMe3)2	 1:1.2:2	 1,4-dioxane	 64[e]	











Pd(OAc)2 (5 mol %)
NIXANTPHOS (7.5 mol %)
base
solvent







	 The	 scope	 of	 the	 arylation	was	 initially	 explored	with	 2-(cyclic	 amino)methylpyridines	
(3.1)	using	aryl	bromides	(Scheme	3.2).		Morpholine,	pyrrolidine,	and	N-methyl	piperazine	were	
coupled	 with	 aryl	 bromides	 bearing	 various	 substituents,	 generating	 aryl(2-
pyridyl)methylamines	 in	 good	 to	 excellent	 isolated	 yields	 (65–98%).	 	 The	 arylated	 products	
3.3b–d	were	obtained	 in	 78–83%	yield	with	bromobenzene	and	1-bromonaphthalene.	 	Under	
the	 same	 reaction	 conditions,	 chlorobenzene	 was	 also	 a	 suitable	 coupling	 partner,	 providing	
3.3b	 in	 78%	 yield.	 	 Aryl	 bromides	 bearing	 electron-donating	 4-NMe2	 and	 4-OMe	 resulted	 in	
coupling	products	3.3e–h	in	71–94%	yield.		Aryl	bromides	with	electron-withdrawing	4-F	and	3-
CF3	 groups	 were	 well	 tolerated	 and	 provided	 aryl(2-pyridyl)methylamines	 3.3i–k	 in	 71–84%	
yield.	 	 Heterocyclic	 3-bromopyridine	 was	 also	 a	 suitable	 coupling	 partner	 to	 generate	
dipyridylmethyl	morpholine	 3.3l	 in	 65%	 yield.	 	 The	 reactions	 with	 1	mol	 %	 catalyst	 generally	
occurred	 in	good	yields	 (71–75%	yield,	3.3d,	3.3g	and	3.3i).	 	To	 illustrate	 the	scalability	of	our	





	 Next,	 we	 turned	 our	 attention	 to	 acyclic	 amines.	 	 The	 optimized	 arylation	 conditions	
employed	 with	 cyclic	 amines	 were	 easily	 transferable	 to	 N,N-dimethyl-	 or	 -diethylamine	























3.3b, 81% (X = Br)





















































aIsolated yields. bX = Br was used unless noted. c5 mol % of Pd(OAc)2 and 7.5 mol % of 
NIXANTPHOS and the yields in parentheses with 1 mol % Pd(OAc)2 and 1.5 mol % 
NIXANTPHOS. d4 mol % Pd(OAc)2 and 6 mol % NIXANTPHOS.
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substituents	 coupled	with	2-(N,N-dimethylaminomethyl)-pyridine,	providing	 the	 cross-coupling	
products	3.4a–3.4o	in	60–98%	yield	(Scheme	3).		The	yields	with	N,N-dimethylamine	derivatives	
are	 slightly	 higher	 than	 those	with	 cyclic	 amines.	 	 Several	 relatively	 challenging	 substrates	 (1-
bromo-4-trifluoromethylbenzene	 and	 5-bromobenzofuran)	 were	 also	 competent	 coupling	
partners,	 albeit	 in	 reduced	 yields	 (3.4i–3.4j,	 60–66%	 yield).	 	 While	 1-bromonaphthalene	
furnished	 coupling	 product	 3.4k	 in	 69%	 yield,	 the	 sterically	 more	 hindered	 2-bromotoluene	






Pd(OAc)2 (5 mol %)
NIXANTPHOS (7.5 mol %)
LiN(SiMe3)2 (2 equiv)
1,4-dioxane (0.2 M), 65 °C, 12 h
+ Ar-Br(1.2 equiv)
3.1 3.2 3.4
3.4a,R = p-tBu, 95%
3.4b,R = m-Me, 98%
3.4c,R = m-OMe, 85%
3.4d,R = p-OMe, 93%
3.4e,R = p-NMe2,  92%











3.4f, R = p-F,92%
3.4g,R = p-Cl, 96%
3.4h,R = m-CF3,  87%













	 The	 results	 above	 led	 us	 to	 wonder	 if	 this	 method	 would	 be	 limited	 to	 2-pyridyl	
derivatives,	 because	 it	 requires	 a	 directed	metallation	 for	 the	 deprotonation.	 	 To	 answer	 this	













3.5a, R = p-Me, 91%
3.5b, R = H,  92% (X = Cl, 85%)




N 3.5d, R = p-tBu, 81%
3.5e, R = p-OMe, 74% (88%)
3.5f, R = p-F, 55% (88%)
NMe2
N R
3.5g, R = H,  63%
3.5h, R = p-tBu, 68%
aIsolated yields. bX = Br unless noted. c1 mol % of Pd(OAc)2 and 1.5 mol % of NIXANTPHOS and 
the yields in parentheses with 5 mol % of Pd(OAc)2 and 7.5 mol % of NIXANTPHOS. d 5 mol % of 
Pd(OAc)2 and 10 mol % of NIXANTPHOS. eThe reaction was conducted in THF at 110 °C with 














Scheme	 3.4,	 4-pyridylmethylamine	 derivatives	 were	 excellent	 substrates,	 providing	 coupling	
products	in	52–92%	yield	(3.5a–3.5h)	with	1	mol	%	catalyst	loading.		These	results	indicate	that	











cyclic	 and	 acyclic	 aminomethyl	 substituted	 azaarenes	 with	 aryl	 bromides.	 	 A	 variety	 of	
aryl(azaaryl)methylamines	 were	 prepared	 in	 good	 to	 excellent	 yields	 from	 readily	 accessible	
tertiary	aminomethyl	azaarenes.		It	is	noteworthy	that	addition	and	removal	of	directing	groups	






General	Methods.	 	All	 reactions	were	 conducted	 under	 an	 inert	 atmosphere	 of	 dry	 nitrogen.		
Anhydrous	 1,4-dioxane	 and	 cyclopentyl	 methyl	 ether	 (CPME)	 were	 purchased	 from	 Sigma-
Aldrich	 and	 used	 without	 further	 purification.	 	 Dimethoxyethane	 (DME)	 and	 tetrahydrofuran	
(THF)	 were	 dried	 through	 activated	 alumina	 columns	 under	 nitrogen.	 	 Other	 solvents	 were	
commercially	 available	 and	 used	 as	 received	without	 further	 purification.	 	 Bases	 [LiN(SiMe3)2,	
NaN(SiMe3)2,	KN(SiMe3)2,		LiOtBu,	NaOtBu,	KOtBu]	were	purchased	from	Sigma-Aldrich	and	used	
without	 further	 purification.	 	 Chemicals	 were	 purchased	 from	 Sigma-Aldrich,	 Acros,	 Fisher	
Scientific	 or	 Matrix	 Scientific,	 and	 solvents	 were	 obtained	 from	 Fisher	 Scientific.	 	 Thin-layer	
chromatography	was	performed	on	Whatman	precoated	silica	gel	60	F-254	plates	and	visualized	
by	ultraviolet	light.		Flash	chromatography	was	performed	with	silica	gel	(Silicaflash,	P60,	40-63	
μm,	 Silicycle).	 	 NMR	 spectra	 were	 obtained	 using	 a	 Brüker	 500	MHz	 Fourier-transform	 NMR	
spectrometer	at	the	University	of	Pennsylvania	NMR	facility.		1H	and	13C	chemical	shifts	in	parts	
per	million	(δ)	were	referenced	to	internal	tetramethylsilane	(TMS).		The	infrared	spectra	were	
obtained	 with	 KBr	 plates	 using	 a	 Perkin-Elmer	 Spectrum	 1600	 Series	 spectrometer.	 	 High-
resolution	 mass	 spectrometry	 (HRMS)	 data	 were	 obtained	 on	 a	 Waters	 LC-TOF	 mass	
spectrometer	 (model	 LCT-XE	Premier)	 using	 chemical	 ionization	 (CI)	 or	 electrospray	 ionization	
(ESI)	in	positive	or	negative	mode,	depending	on	the	analyte.		Melting	points	were	determined	
on	 a	 Unimelt	 Thomas-Hoover	 melting	 point	 apparatus	 and	 are	 uncorrected.	 	 2-














	4-(Pyridin-2-ylmethyl)morpholine	 (3.1a).	 The	 product	 was	 prepared	 by	 General	











2-(Pyrrolidin-1-ylmethyl)pyridine	 (3.1b).	 The	 product	 was	 prepared	 by	 General	







sodium	 iodide	 (300	mg,	2.0	mmol),	K2CO3	 (13.8	g,	100.0	mmol)	and	pyrrolidine	 	 (4.1	mL,	50.0	








1-Methyl-4-(pyridin-2-ylmethyl)piperazine	 (3.1c).	 The	 product	 was	 prepared	 by	
General	 Procedure	 A	 using	 2-(chloromethyl)pyridine	 hydrochloride	 (3.28	 g,	 20.0	
mmol),	 sodium	 iodide	 (600	 mg,	 4.0	 mmol),	 potassium	 carbonate	 (13.8	 g,	 100.0	




2.20	 (m,	 8H),	 2.29	 (s,	 3H)	 ppm;	 13C{1H}	 NMR	 (125	MHz,	 CDCl3)	 δ	 158.6,	 149.3,	 136.3,	 123.2,	
122.0,	64.6,	55.1,	53.3,	46.1	ppm;	IR	(thin	film):	2944,	2810,	1656,	1595,	1571,	1459,	1437,	1353,	



















N-Ethyl-N-(pyridin-2-ylmethyl)ethanamine	 (3.1e).	 The	 product	 was	 prepared	 by	
General	 Procedure	 A	 using	 2-(chloromethyl)pyridine	 hydrochloride	 (3.28	 g,	 20.0	
mmol),	 sodium	 iodide	 (599.6	mg,	 4.0	mmol),	 potassium	 carbonate	 (13.8	 g,	 100.0	mmol)	 and	




7.2	Hz,	4H),	1.05	 (t,	 J	=	7.2	Hz,	6H)	ppm;	 13C{1H}	NMR	(125	MHz,	CDCl3)	δ	160.9,	149.1,	136.3,	
122.0,	 121.7,	 59.8,	 47.5,	 12.0	 ppm;	 The	 NMR	 spectral	 data	 match	 the	 previously	 published	
data.24	
	
N-Benzyl-N-methyl-1-(pyridin-2-yl)methanamine	 	 (3.1f).	 The	 product	 was	














139.3,	 136.6,	 129.1,	 128.4,	 127.2,	 123.1,	 122.1,	 63.7,	 62.3,	 42.7;	 IR	 (neat)	 3061,	 3028,	 2978,	




	4-(Pyridin-4-ylmethyl)morpholine	 (3.1g).	 	 The	 product	 was	 prepared	 by	 General	
Procedure	 A	 using	 4-(chloromethyl)pyridine	 hydrochloride	 (3.28	 g,	 20.0	 mmol),	
sodium	iodide	(599.6	mg,	4.0	mmol),	potassium	carbonate	(13.8	g,	100.0	mmol)	and	







1-Methyl-4-(pyridin-4-ylmethyl)piperazine	 (3.1h).	 The	 product	 was	 prepared	 by	


















General	 Procedure	 A	 using	 4-(chloromethyl)pyridine	 hydrochloride	 (3.28	 g,	 20.0	







N,N-Dimethyl-1-(quinolin-2-yl)methanamines	 (3.1j).	 The	 product	 was	
prepared	 by	 General	 Procedure	 A	 using	 2-(chloromethyl)quinoline	
hydrochloride	 (0.64	 g,	 3.0	 mmol),	 sodium	 iodide	 (89.9	 mg,	 0.6	 mmol),	 potassium	 carbonate	
(2.10	 g,	 15.0	mmol)	 and	 dimethylamine	 solution	 5.6	M	 in	 ethanol	 	 (1.34	mL,	 7.5	mmol).	 The	








2974,	 2943,	 2858,	 2820,	 2772,	 1615,	 1601,	 1561,	 1504,	 1455,	 1425,	 1376,	 1362,	 1311,	 1259,	
1225	cm-1;	HRMS	m/z	187.1236	[(M+H)+;	calcd		for	C12H15N2:	187.1235.	
	
	4-(Pyridin-3-ylmethyl)morpholine	 (3.1k).	 	 The	 product	 was	 prepared	 by	 General	
Procedure	 A	 using	 3-(chloromethyl)pyridine	 hydrochloride	 (3.28	 g,	 20.0	 mmol),	
sodium	iodide	(599.6	mg,	4.0	mmol),	potassium	carbonate	(13.8	g,	100.0	mmol)	and	
morpholine	 	 (4.3	 mL,	 50.0	 mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 column	










box	 under	 a	 nitrogen	 atmosphere.	 1	 mL	 of	 Pd(OAc)2/NIXANTPHOS	 stock	 solution	 (5	 mol	 %	







and	aryl	halide	(0.24	mmol)	were	added	to	the	solution.	 	Note	that	aryl	bromide	 in	solid	 form	
was	added	to	the	reaction	vial	prior	to	LiN(SiMe3)2.		The	reaction	mixture	was	heated	to	65	°C	in	








product	 was	 prepared	 by	 General	 Procedure	 B	 using	 4-(pyridin-2-
ylmethyl)morpholine	 3.1a	 (35.6	 mg,	 0.2	 mmol)	 and	 1-bromo-4-tert-
butylbenzene	(51.2	mg,	41.6	µL,	0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.		The	





122.1,	 78.1,	 67.2,	 52.7,	 34.5,	 31.4	 ppm;	 IR	 (neat)	 3052,	 3006,	 2960,	 2905,	 2854,	 2811,	 2762,	









		4-(Phenyl(pyridin-2-yl)methyl)morpholine	 (3.3b).	 The	 product	 was	 prepared	
by	General	Procedure	B	using	4-(pyridin-2-ylmethyl)morpholine	 3.1a	 (35.6	mg,	
0.2	 mmol)	 and	 bromobenzene	 (37.7	 mg,	 25.4	 µL,	 0.24	 mmol)	 with	 5	 mol%	











4-(Naphthalen-1-yl(pyridin-2-yl)methyl)morpholine	 (3.3c).	 The	 product	was	
prepared	 by	 General	 Procedure	 B	 using	 4-(pyridin-2-ylmethyl)morpholine	













4H),	 	 2.70	–	2.50	 (m,	2H),	 2.50	–	2.30	 (m,	2H)	ppm;	 13C	NMR	 (75	MHz,	CDCl3)	δ	 161.4,	 149.2,	
136.8,	 136.7,	 134.2,	 132.1,	 128.9,	 128.1,	 126.2,	 125.8,	 125.7,	 125.6,	 124.2,	 123.2	 122.2,	 73.9,	
67.4,	 53.1	ppm;	 IR	 (neat)	3050,	2958,	2853,	2811,	1588,	1570,	1511,	1452,	1432,	1396,	1310,	
1275,	1117	cm-1;	HRMS	m/z	305.1648	[(M+H)+;	calcd	for	C20H21N2O:	305.1654].		
	
	2-(Phenyl	 (pyrrolidin-1-yl)methyl)pyridine	 (3.3d).	 The	 product	 was	 prepared	
by	 General	 Procedure	 using	 2-(pyrrolidin-1-ylmethyl)pyridine	 3.1b	 (32.5	 mg,	
0.20	 mmol)	 and	 bromobenzene	 (37.7	 mg,	 25.3	 µL,	 0.24	 mmol)	 with	 5	 mol%	











product	 was	 prepared	 by	 General	 Procedure	 B	 using	 4-(pyridin-2-
ylmethyl)morpholine	 3.1a	 (35.6	mg,	0.2	mmol)	and	4-bromoanisole	(44.9	
mg,	30.1	µL,	0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	

















The	 product	 was	 prepared	 by	 General	 Procedure	 B	 using	 1-methyl-4-


































product	 was	 prepared	 by	 General	 Procedure	 B	 using	 4-(pyridin-2-
















2-((4-Fluorophenyl)(pyrrolidin-1-yl)methyl)pyridine	 (3.3i).	 The	 product	was	
prepared	 by	 General	 Procedure	 B	 using	 2-(pyrrolidin-1-ylmethyl)pyridine	
3.1b	(32.5	mg,	0.20	mmol)	and	1-bromo-4-fluorobenzene	(42.0	mg,	26.4	µL,	
0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	purified	by	
flash	 column	 chromatography	 on	 silica	 gel	 (hexanes:EtOAc	 =	 50:50)	 to	 give	 the	 product	 as	 a	
yellow	oil	(44.6	mg,	87%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.50	(d,	J	=	4.8	Hz,	1H),	7.61	(tt,	J	=	
7.6,	1.6	Hz,	1H),	7.54	–	7.49	(m,	3H),	7.10	–	7.07	(m,	1H),	6.96	(t,	J	=	8.5	Hz,	2H),	4.36	(s,	1H),	2.44	








product	was	 prepared	 by	General	 Procedure	B	 using	 1-methyl-4-(pyridin-2-
ylmethyl)piperazine	 3.1c	 (38.3	 mg,	 0.20	 mmol)	 and	 1-bromo-4-














2.15	 (m,	 8H),	 2.33	 (s,	 3H);	 13C	NMR	 (125	MHz,	 CDCl3)	δ	 162.2	 (d,	 J	 =	 244.8	Hz),	 161.7,	 149.6,	
136.9,	136.8	(d,	J	=	3.2	Hz),	129.9	(d,	J	=	8.1	Hz),	122.4,	122.3,	115.5	(d,	J	=	21.0	Hz),	77.0,	55.1,	
51.5,	 45.7	ppm;	 IR	 (neat)	3067,	2961,	2941,	2807,	1603,	1591,	1571,	1507,	1471,	1459,	1434,	





ylmethyl)morpholine	 3.1a	 (35.6	 mg,	 0.2	 mmol)	 and	 3-
bromobenzotrifluoride	 (54.0	 mg,	 33.5	 μL,	 0.24	 mmol)	 with	 5	 mol%	 Pd(OAc)2/	 7.5	 mol%	






3.8	Hz),	 124.5	 (q,	 J	 =	 3.8	Hz),	 124.2	 (q,	 J	 =	 270.7	Hz),	 122.6,	 122.5,	 78.0,	 67.1,	 52.7;	 IR	 (neat)	
3054,	 2959,	 2854,	 2813,	 2769,	 1588,	 1571,	 1470,	 1449,	 1433,	 1327,	 1277,	 1166,	 1118,	 1073,	
1014	cm-1;	HRMS	m/z	323.1358	[(M+H)+;	calcd	for	C17H18N2OF3:	323.1371].	
	












5	 mol%	 Pd(OAc)2/	 7.5	 mol%	 NIXANTPHOS.	 The	 crude	 product	 was	 purified	 by	 flash	 column	






1571,	 1472,	 1453,	 1433,	 1396,	 1305,	 1286,	 1273,	 1251,	 1211,	 1117,	 1070,	 1029,	 1012	 cm-1;	
HRMS	m/z	256.1456	[(M+H)+;	calcd	for	C15H18N3O:	256.1450].	
	
4-((4-Fluorophenyl)(pyridin-2-yl)methyl)morpholine	 (3.3m).	 The	 product	
was	prepared	by	General	Procedure	using	4-(pyridin-2-ylmethyl)morpholine	
















(3.4a).	 	 The	 product	 was	 prepared	 by	 General	 Procedure	 B	 using	 N,	 N-
dimethyl-1-(pyridin-2-yl)methanamine	 3.1d	 (27.2	 mg,	 0.20	 mmol)	 and	 1-bromo-4-tert-
butylbenzene	(51.2	mg,	41.6	µL,	0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	









N,	 N-Dimethyl-1-(pyridin-2-yl)-1-(m-tolyl)methanamine	 (3.4b).	 The	
product	 was	 prepared	 by	 General	 Procedure	 B	 using	 N,	 N-dimethyl-1-
(pyridin-2-yl)methanamine	3.1d	 (27.2	mg,	0.20	mmol)	 and	3-bromotoluene	 (41.1	mg,	29.1	µL,	
0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	purified	by	


















(pyridin-2-yl)methanamine	3.1d	 (27.2	mg,	 0.20	mmol)	 and	 3-bromoanisole	 (44.9	mg,	 30.4	µL,	
0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	purified	by	
flash	 column	 chromatography	 on	 silica	 gel	 (hexanes:EtOAc	 =	 50:50)	 to	 give	 the	 product	 as	 a	
yellow	oil	(41.2	mg,	85%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.53	–	8.51	(m,	1H),	7.60	(dt,	J	=	7.7,	
1.7	Hz,	1H),	7.52	(d,	J	=	8.0	Hz,	1H),	7.19	(t,	J	=	7.7	Hz,	1H),	7.10	–	7.08	(m,	3H),	6.75	–	6.73	(m,	
1H),	 4.22	 (s,	 1H),	 3.78	 (s,	 3H),	 2.22	 (s,	 6H);	 13C	 NMR	 (125	MHz,	 CDCl3)	δ	 162.7,	 159.9,	 149.3,	
143.7,	 136.8,	 129.6,	 122.3,	 122.1,	 120.7,	 113.6,	 113.2,	 79.7,	 55.4,	 44.8;	 IR	 (neat)	 3053,	 2987,	





(pyridin-2-yl)methanamine	3.1d	 (27.2	mg,	 0.20	mmol)	 and	 4-bromoanisole	 (44.9	mg,	 30.1	µL,	
0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	purified	by	
flash	 column	 chromatography	 on	 silica	 gel	 (hexanes:EtOAc	 =	 50:50)	 to	 give	 the	 product	 as	 a	
yellow	oil	(45.1	mg,	93%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.51	(d,	J	=	4.8	Hz,	1H),	7.60	(t,	J	=	7.7	
Hz,	1H),	7.52	(d,	J	=	7.4	Hz,	1H),	7.41	(d,	J	=	8.5	Hz,	2H),	7.08	–	7.06	(m,	1H),	6.82	(d,	J	=	8.5	Hz,	



























26.4	 µL,	 0.24	mmol)	 with	 5	 mol%	 Pd(OAc)2/	 7.5	 mol%	 NIXANTPHOS.	 The	 crude	 product	 was	












(neat)	 3052,	 2982,	 2952,	 2867,	 2821,	 2776,	 1602,	 1589,	 1570,	 1507,	 1471,	 1433,	 1325,	 1293,	




product	 was	 prepared	 by	 General	 Procedure	 B	 using	 N,	 N-dimethyl-1-
(pyridin-2-yl)methanamine	3.1d	(27.2	mg,	0.20	mmol)	and	1-bromo-4-chlorobenzene	(46.0	mg,	
0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	mol%	NIXANTPHOS.	The	crude	product	was	purified	by	









(trifluoromethyl)phenyl)methanamine	 (3.4h).	 The	 product	 was	
prepared	by	General	 Procedure	B	using	N,	N-dimethyl-1-(pyridin-2-yl)methanamine	3.1d	 (27.2	
mg,	 0.20	 mmol)	 and	 3-bromobenzotrifluoride	 (54.0	 mg,	 33.5	 µL,	 0.24	 mmol)	 with	 5	 mol%	



















by	General	 Procedure	B	 using	N,	N-dimethyl-1-(pyridin-2-yl)methanamine	3.1d	 (27.2	mg,	 0.20	
mmol)	and	4-bromobenzotrifluoride	(54.0	mg,	33.6	µL,	0.24	mmol)	with	5	mol%	Pd(OAc)2/	7.5	
mol%	NIXANTPHOS.	The	crude	product	was	purified	by	 flash	column	chromatography	on	silica	













product	 was	 prepared	 by	 General	 Procedure	 B	 using	 N,	 N-dimethyl-1-





1H),	 4.35	 (s,	 1H),	 2.24	 (s,	 6H);	 13C	NMR	 (125	MHz,	 CDCl3)	δ	 163.2,	 154.5,	 149.4,	 145.4,	 136.8,	

























B	 using	 N,	 N-dimethyl-1-(pyridin-2-yl)methanamine	 3.1d	 (27.2	 mg,	 0.20	 mmol)	 and	 2-(3-
bromophenyl)-1,3-dioxolane	 (55.0	mg,	 36.3	µL,	 0.24	mmol)	 with	 5	mol%	 Pd(OAc)2/	 7.5	mol%	










N-Ethyl-N-(phenyl(pyridin-2-yl)methyl)ethanamine	 (3.4m).	 The	 product	 was	
prepared	 by	 General	 Procedure	 B	 using	 N-ethyl-N-(pyridin-2-


















(s,	1H),	3.75	 (s,	3H),	2.65	–	2.54	 (m,	4H),	0.97	 (t,	 J	 =	7.1	Hz,	6H);	 13C	NMR	 (125	MHz,	CDCl3)	δ	
163.7,	 158.7,	 149.1,	 136.6,	 134.3,	 129.6,	 122.3,	 121.8,	 113.9,	 73.0,	 55.3,	 42.9,	 10.8.	 IR	 (neat)	
3051,	 2969,	 2932,	 2871,	 2835,	 1610,	 1588,	 1569,	 1509,	 1467,	 1432,	 1373,	 1302,	 1247,	 1173,	
1108,	1036	cm-1;	HRMS	m/z	271.1801	[(M+H)+;	calcd	for	C17H23N2O:	271.1810].	
	
N-Ethyl-N-((4-fluorophenyl)(pyridin-2-yl)methyl)ethanamine	 	 	 (3.4o).	 The	
product	was	prepared	by	General	Procedure	B	using	N-ethyl-N-(pyridin-2-
ylmethyl)ethanamine	 3.1e	 (32.8	 mg,	 0.20	 mmol)	 and	 1-bromo-4-

















4-(Pyridin-4-yl(p-tolyl)methyl)morpholine	 (3.5a).	 The	 product	 was	
prepared	 by	 General	 Procedure	 B	 using	 4-(pyridin-4-ylmethyl)morpholine	







1412,	 1305,	 1274,	 1118,	 1070,	 1011	 cm-1;	 HRMS	 m/z	 268.1582	 [(M)+;	 calcd	 for	 C17H20N2O:	
268.1576].	
	
4-(Phenyl(pyridin-4-yl)methyl)morpholine	 (3.5b).	 The	 product	 was	 prepared	
by	General	Procedure	B	using	4-(pyridin-4-ylmethyl)morpholine	3.1f	 (35.6	mg,	
0.20	mmol)	 and	 bromobenzene	 (37.7	 mg,	 25.4	 µL,	 0.24	mmol)	 with	 1	 mol%	
Pd(OAc)2/	 1.5	 mol%	 NIXANTPHOS.	 The	 crude	 product	 was	 purified	 by	 flash	 column	
chromatography	on	 silica	 gel	 (hexanes:EtOAc	 =	 50:50	 to	 only	 EtOAc)	 to	 give	 the	 product	 as	 a	
yellow	oil	(46.8	mg,	92%	yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.49	(dd,	J	=	5.0,	1.5	Hz,	2H),	7.40	–	
7.35	(m,	4H),	7.29	(app	t,	J	=	7.0	Hz,	2H),	7.22	(app.	t,	J	=	7.0	Hz,	1H),	4.20	(s,	1H),	3.72	(t,	J	=	5.0	
















product	 was	 prepared	 by	 General	 Procedure	 B	 using	 4-(pyridin-4-
ylmethyl)morpholine	 3.1f	 (35.6	 mg,	 0.20	 mmol)	 and	 1-bromo-4-(tert-










The	 product	 was	 prepared	 by	 General	 Procedure	 B	 using	 1-methyl-4-
(pyridin-4-ylmethyl)piperazine	3.1g	 (38.3	mg,	0.20	mmol)	and	1-bromo-4-
(tert-butyl)benzene	 (51.2	 mg,	 41.6	 µL,	 0.24	 mmol)	 with	 1	 mol%	 Pd(OAc)2/	 1.5	 mol%	














The	 product	 was	 prepared	 by	 General	 Procedure	 B	 using	 1-methyl-4-







































gel	 (hexanes:EtOAc	 =	 50:50	 to	 only	 EtOAc)	 to	 give	 the	 product	 as	 a	 yellow	 oil	 (26.7	mg,	 63%	
yield).	1H	NMR	(500	MHz,	CDCl3)	δ	8.49	(dd,	J	=	4.5,	15	Hz,	2H),	7.39	–	7.35	(m,	4H),	7.29	(t,	J	=	
7.8	Hz,	2H),	7.24	–	7.18	 (m,	1H),	4.07	 (s,	1H),	2.19	 (s,	6H);	 13C	NMR	(125	MHz,	CDCl3)	δ	152.5,	
150.2,	 141.7,	 128.9,	 128.1,	 127.7,	 123.0,	 77.1,	 44.6;	 IR	 (neat)	 3062,	 3026,	 2987,	 2952,	 2864,	











dimethyl-1-(pyridin-4-yl)	 3.1h	 (27.2	 mg,	 0.20	 mmol)	 and	 1-bromo-4-(tert-butyl)benzene	 (51.2	
mg,	41.6	µL,	0.24	mmol)	with	1	mol%	Pd(OAc)2/	1.5	mol%	NIXANTPHOS.	The	crude	product	was	
purified	by	flash	column	chromatography	on	silica	gel	(hexanes:EtOAc	=	50:50	to	only	EtOAc)	to	
give	 the	 product	 as	 a	white	 solid	 (36.5	mg,	 68%	 yield),	m.p.=	 70	 –	 72	 ºC.	 1H	NMR	 (500	MHz,	
CDCl3)	δ	8.49	(app.	d,	J	=	6.0	Hz,	2H),	7.37	(app.	d,	J	=	6.0	Hz,	2H),	7.32	–	7.26	(m,	4H),		4.04	(s,	






(3.5i).	 The	 product	 was	 prepared	 by	 General	 Procedure	 B	 using	 1-
(isoquinolin-3-yl)-N,	 N-dimethylmethanamine	 3.1i	 (37.3	 mg,	 0.20	
mmol)	 and	 4-bromoanisole	 (44.9	 mg,	 30.0	 µL,	 0.24	 mmol)	 with	 5	 mol%	 Pd(OAc)2/	 7.5	 mol%	




3H),	2.26	 (s,	6H);	 13C	NMR	 (125	MHz,	CDCl3)	δ	163.5,	159.0,	147.8,	136.9,	134.0,	129.5,	129.4,	
127.6,	127.6,	126.3,	120.2,	114.1,	79.7,	55.4,	44.9.	IR	(neat)	3060,	2950,	2932,	2863,	2821,	2775,	







4-(Pyridin-3-yl(p-tolyl)methyl)morpholine	 (3.5j).	 The	 product	 was	
prepared	 by	 General	 Procedure	 B	 (Pd(OAc)2/NIXANTPHOS	 stock	 solution	







MHz,	 CDCl3)	 δ	 149.7,	 148.7,	 138.3,	 138.3,	 137.4,	 135.5,	 129.7,	 128.0,	 123.8,	 74.1,	 67.3,	 52.7,	
21.2.	IR	(neat)	3028,	2958,	2920,	2854,	2808,	1661,	1606,	1586,	1576,	1511,	1453,	1426,	1307,	
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	 The	synthesis	of	diverse	chemical	structures	 is	an	 important	endeavor	 in	the	discovery	
of	 new	medications.	 	 Forging	 structural	 diversity	 from	 a	 common	 set	 of	 organic	 substrates	 is	
extremely	desirable	in	this	venture,	but	is	quite	difficult	to	achieve	with	high	selectivity.1		This	is	











































	 Upon	 examination	 of	 the	 reactions	 in	 Figure	 4.2,	 several	 challenges	 are	 evident.		
Reversible	 deprotonation	 of	 ether	 4.1	 generates	 the	 intermediate	 carbanion	 4.2.3	 	 a-Alkoxy	
carbanions	 are	 known	 to	 undergo	 [1,2]-Wittig	 rearrangements	 to	 generate	 alcohols	 4.3.4	 	 If	
anion	4.2	could	be	intercepted	by	a	palladium	catalyst	via	rapid	transmetallation,5	arylation	may	
































for	obtaining	high	selectivity	and	for	the	realization	of	this	strategy.	 	 If	 the	selectivity	could	be	
controlled	 in	 the	 DCCP/[1,2]-Wittig	 rearrangement	 in	 Figure	 2,	 the	 core	 structures	 of	 the	
antihistamines	Doxylamine,6	Carbinoxamine,7	Bepotastine,8	Triprolidine9	(Figure	4.1)	and	related	
pyridines10	could	be	accessed	followed	by	further	organic	transformations.			





	 Given	 the	 importance	of	pyridines	 in	medicinal	 chemistry	and	materials	 science,11	 it	 is	
not	 surprising	 that	 palladium	 catalyzed	 C–H	 functionalization	 reactions	 involving	 benzylic	
arylation	of	 pyridines	 and	derivatives	 have	 attracted	 significant	 attention.12	 	Difficulties	 in	 the	
direct	 benzylic	 arylation	 of	 2-substituted	 pyridines,	 however,	 have	 been	 encountered	 and	 are	
attributed	 to	 the	 ability	 of	 pyridyl	 nitrogens	 to	 act	 as	 ligands.12j,13	 	 Successful	 strategies	 to	
circumvent	 this	potential	problem	 include	addition	of	 Lewis	acids	 to	bind	 the	pyridyl	nitrogen	
and	increase	the	reactivity	of	the	benzylic	C–H’s.12j		Notably,	acceleration	of	palladium	catalyzed	




as	 2-(2-pyridyl)acetic	 acids,12h	 2-(2-pyridyl)ethanols,12b	 pyridine	 N-oxides,12d,12f	 and	 N-
iminopyridines.12e	 	 We	 previously	 used	 2-benzylpyridine	 (pKa	 =	 28.3–28.7	 in	 THF),	 where	 the	
benzylic	hydrogens	are	estimated	to	about	6	orders	of	magnitude	more	acidic	than	those	in	2-
picoline	 (pKa	 =	34	 in	THF).17	 	 2-Benzylpyridines	are	also	expected	 to	be	at	 least	 four	orders	of	
magnitude	more	acidic	than	the	pyridylmethyl	ether	substrates	that	are	the	focus	of	the	current	
investigation.18	 	Over	 the	 last	decade,	direct	C–H	 functionalization	of	benzylic	ethers	has	been	




	 	In	 the	course	of	our	studies20	 in	 the	DCCP	of	a	variety	of	weakly	acidic	substrates,	we	
discovered	that	palladium	complexes	of	van	Leeuwen’s	NIXANTPHOS	ligand21	(Table	4.1)	enable	
a	 wide	 variety	 of	 transformations,	 whereas	 other	 ligands	 are	 much	 less	 effective.	 	 Thus,	 we	
employed	 a	 Pd(OAc)2	(5	mol	%)/NIXANTPHOS	 (7.5	mol	%)	 based	 catalyst	 to	 initiate	 the	 direct	
arylation	of	2-pyridylmethyl	ethyl	ether	4.1a	with	bromobenzene	 in	combination	with	6	bases	
[LiO-tBu,	NaO-tBu,	KO-tBu,	LiN(SiMe3)2,	NaN(SiMe3)2,	and	KN(SiMe3)2].	 	Both	LiO-tBu	and	NaO-
tBu	 resulted	 in	 no	 product,	 while	 KO-tBu	 afforded	 a	 low	 yield	 of	 the	 arylation/[1,2]-Wittig	
rearrangement	 product.	 	 Interestingly,	 LiN(SiMe3)2	 generated	 the	 arylation/[1,2]-Wittig	
rearrangement	product	4.5aa	exclusively	in	48%	assay	yield	(AY,	entry	1).		Although	NaN(SiMe3)2	
gave	a	mixture	of	arylation	4.4aa	and	arylation/[1,2]-Wittig	rearrangement	4.5aa	in	25	and	38%	





Table	 4.1.	 Optimization	 of	 the	 reactions	 of	 2-pyridylmethyl	 ethyl	 ether	 4.1a	 with	
bromobenzene.[a]	
	
entry	 M	 solvent[b]	 time	(h)	 temp	(°C)	 4.4aa	(%)[c]	 4.5aa	(%)[c]	
1	 Li	 THF	 12	 45	 0	 48	
2	 Na	 THF	 12	 45	 25	 38	
3	 K	 THF	 12	 45	 trace	 33	
4	 Na	 dioxane	 12	 45	 31	 17	
5	 Na	 CPME	 12	 45	 33	 65	
6	 Na	 DME	 12	 45	 64	 30	
7	 Na	 DME	 12	 23	 95[d]	 0	
8	 Li	 dioxane	 12	 45	 16	 15	
9	 Li	 DME	 12	 45	 68	 25	
10	 Li	 CPME	 12	 45	 38	 56	
11	 Li	 CPME	 24	 45	 0	 85[d]	
12[e]	 Li	 CPME	 24	 45	 0	 83[d]	
	
[a]	 Reaction	 conditions:	 4.1a	 (0.1	 mmol),	 Ph–Br	 (0.12	 mmol),	 base	 (0.3	 mmol),	
Pd(OAc)2/NIXANTPHOS	 (5	mol	%/7.5	mol	%),	 solvent	 (1.0	mL).	 [b]	 tetrahydrofuran	 (THF),	 1,4-
dioxane	 (dioxane),	 cyclopentyl	 methyl	 ether	 (CPME),	 1,2-dimethoxyethane	 (DME).	 [c]	 Yield	






Pd(OAc)2 (5 mol %)























	 Given	 the	 higher	 yield	 afforded	 by	 NaN(SiMe3)2,	 we	 set	 out	 to	 examine	 different	
solvents	with	this	base.		Employing	NaN(SiMe3)2	at	45	°C	in	dioxane,	CPME	and	DME	(entries	4–
6)	 resulted	 in	 assay	 yields	 of	 up	 to	 64%	 arylation	 (4.4aa)	 and	 30%	 arylation/[1,2]-Wittig	
rearrangement	(4.5aa)	 in	DME.	 	To	our	surprise,	 lowering	the	temperature	to	23	°C	 in	DME	to	
minimize	the	 [1,2]-Wittig	 rearrangement	actually	prevented	 it,	providing	 the	arylation	product	
in	95%	 isolated	yield	 (entry	7).	 	With	a	highly	 selective	protocol	 for	 the	arylation	 in	place,	we	
desired	to	perform	the	tandem	arylation/[1,2]-Wittig	rearrangement.			
	 The	 [1,2]-Wittig	 rearrangement	of	a-alkoxy	carbanions	has	attracted	much	attention.22		
Despite	significant	 interest,	 relatively	harsh	reaction	conditions	are	still	 the	norm.23	 	There	are	
only	 a	 few	examples	 of	 the	 [1,2]-Wittig	 rearrangement	 in	 tandem	 reactions.	 	 Recently,	Wolfe	
and	 co-workers	 introduced	 highly	 stereoselective	 tandem	 [1,2]-Wittig	 rearrangement/aldol	 or	
Mannich	 reactions.24	 	 Dudley	 and	 co-workers	 reported	 pyridine-directed	 organolithium	
additions	to	enol	ethers.	 	The	resulting	intermediates	then	undergo	anionic	rearrangements	to	
afford	tertiary	pyridyl	carbinols.25		These	examples	indicate	that	the	use	of	a-alkoxy	carbanions	
in	 tandem	 reactions	 can	 be	 an	 effective	 strategy	 to	 generate	 multiple	 C–C	 bonds	 and	 forge	
complex	molecular	structures.	
	 To	 develop	 the	 tandem	 arylation/[1,2]-Wittig	 rearrangement	 process,	 we	 focused	 on	
LiN(SiMe3)2	base	in	dioxane,	DME	and	CPME	(entries	8–10).	 	Of	these	solvents,	CPME	gave	the	
best	results	(4.4aa	:	4.5aa,	38:56),	but	exhibited	incomplete	[1,2]-Wittig	rearrangement	after	12	
h	 (entry	 10).	 	 With	 a	 24	 h	 reaction	 time,	 the	 tandem	 arylation/[1,2]-Wittig	 rearrangement	

















Pd(OAc)2  (5 mol %)





NaN(SiMe3)2 (3.0 equiv) 



























4.4aa 95% 4.4ab 90%
(5 mmol, 83%)
4.4ac 88% 4.4ad 99%
4.4ae 82% 4.4af 75% 4.4ag 82% 4.4ah 83%
 [a] Reaction conditions: 4.1a (0.2 mmol), Ar–Br (0.24 mmol), NaN(SiMe3)2 (0.6 mmol), 




bromotoluene	 coupled	 in	 75%	 yield.	 	 Heterocyclic	 N-methyl	 5-bromo	 indole	 and	 5-bromo	
benzofuran	underwent	coupling	to	provide	the	products	in	82–83%	yield.		It	is	noteworthy	that	


















































4.4bd 83% 4.4dd 88% 4.4ed 82% 4.4be 85%
4.4ce 88% 4.4de 80% 4.4fe 82% 4.4ge 80%
R
Br
R = NMe2, 4.6d
R = F, 4.6e
[a] Reaction conditions: 4.1 (0.2 mmol), Ar–Br (0.24 mmol), NaN(SiMe3)2 (0.6 mmol), 
Pd(OAc)2/NIXANTPHOS (5 mol %/7.5 mol %), DME (2.0 mL); Isolated yield.
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	 The	 substrate	 scope	 of	 2-pyridylmethyl	 ethers	 was	 next	 explored	 (Table	 4.3)	 with	
electron-donating	 4-bromo-N,N-dimethylaniline	 (entries	 1–4)	 and	 with	 1-bromo-4-




bromo-N,N-dimethylaniline	 and	 1-bromo-4-fluorobenzene	 to	 furnish	 arylated	 ether	 products	
4.4bd–4.4dd	 (83−92%)	 and	 4.4be–4.4de	 (80−88%).	 	 In	 addition,	 2-pyridylmethyl	 aryl	 ethers,	





arylation/[1,2]-Wittig	 rearrangement.	 	 Employing	 the	 optimized	 conditions	 in	 Table	 4.1	 (entry	
12)	with	LiN(SiMe3)2	in	CPME	at	45	°C,	reaction	of	2-pyridylmethyl	ethyl	ether	with	aryl	bromides	
was	investigated	(Table	4.4).		Electron	neutral	1-bromo-4-tert-butylbenzene	and	bromobenzene	
furnished	 the	 desired	 products	 4.5aa	 and	 4.5ab	 in	 85	 and	 78%	 yields,	 respectively.	 	 Aryl	
bromides	bearing	electron-donating	4-OMe	and	4-NMe2	groups	 led	to	the	coupled/rearranged	
products	4.5ac	 and	4.5ad	 in	 75	and	78%	yield,	 respectively.	 	Heterocyclic	 5-bromobenzofuran	














	 The	 scope	 in	 the	 migrating	 O–R	 group	 in	 the	 tandem	 arylation/[1,2]-Wittig	
rearrangement	 was	 investigated	 with	 various	 aryl	 groups.	 	 The	 2-pyridylmethyl	 ethers	 with	
primary	migrating	 groups	 (Table	 4.4),	methyl,	 secondary,	 and	 tertiary	 alkyl	 ethers	 (Table	 4.5,	
N
Pd(OAc)2  (2.5 mol %)
NIXANTPHOS (3.75 mol %)
+
LiN(SiMe3)2 (3.0 equiv)




4.5aa 85% 4.5ab 78% 4.5ac 75% 4.5ad 72%
































[a] Reaction conditions: 4.1a (0.2 mmol), Ar–Br (0.24 mmol), LiN(SiMe3)2 (0.6 mmol), 
Pd(OAc)2/NIXANTPHOS (2.5 mol %/3.75 mol %), CPME (2.0 mL); Isolated yields.
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entries	 1–6)	 gave	 arylation/[1,2]-Wittig	 rearranged	 products	 in	 60−85%	 yield.	 	 To	 examine	
selectivity	 in	 the	 oxidative	 addition	 step	 (aryl	 bromide	 vs.	 chloride)	 2-pyridylmethyl	 tert-butyl	
ether	 was	 coupled	 with	 1-bromo-4-chlorobenzene	 (entry	 6).	 	 The	 arylation/[1,2]-Wittig	
rearrangement	product	4.5di	was	obtained	 in	60%	 isolated	yield,	despite	 the	known	ability	of	







R = Meb 72% (4.5bd)
R = Cy 82% (4.5cd)
R = tBu 65% (4.5dd)
60% (4.5di)R = Meb 75% (4.5be)
R = Cy 85% (5ce)
N
Pd(OAc)2  (2.5 mol %)
NiXantphos (3.75 mo l%)
+
LiN(SiMe3)2 (3.0 equiv)















4.5ia; NR12 = NMe2, R2 = H, 74% yield
4.5ii; NR12 = NMe2, R2 = Cl, 74% yield
4.5ja; NR12 = N(CH2)4, R2 =H, 64% yield





[a] Reaction conditions: 4.1 (0.2 mmol), Ar–Br (0.24 mmol), LiN(SiMe3)2 (0.6 mmol), 
Pd(OAc)2/NIXANTPHOS (2.5 mol %/3.75 mol %), CPME (2.0 mL); Isolated yields; no arylated 




	 Our	 focus	 on	 the	 arylation	 and	 tandem	 arylation/[1,2]-Wittig	 rearrangement	 of	 2-
pyridylmethyl	ethers	stems	from	their	utility	in	the	preparation	of	biologically	active	compounds	
(Figure	 4.1).	 	 At	 this	 juncture,	 we	 were	 curious	 if	 the	 2-pyridyl	 group	 was	 required	 for	 the	
deprotonation	 and	 arylation	 outlined	 above.	 	 To	 probe	 this	 question,	 as	well	 as	 broaden	 the	
scope	of	our	coupling	chemistry,	we	examined	reactions	of	4-pyridylmethyl	alkyl	ethers	(4.1j	and	
4.1k,	Table	4.6)	with	various	aryl	bromides.		
		Under	 our	 standard	 arylation	 conditions	 [NaN(SiMe3)2	 in	 DME	 at	 23	 °C],	 arylation	 of	 4-
pyridylmethyl	 alkyl	 ethers	 (4.1j	 and	 4.1k)	 with	 aryl	 bromides	 provided	 the	 arylated	 products	
4.4jd,	 4.4kb	 and	 4.4kc	 in	 85–88%	 yield	 (Table	 4.6),	 demonstrating	 that	 chelation	 is	 not	 a	
prerequisite	to	deprotonation	or	arylation.		The	increased	reactivity	of	the	4-pyridyl	derivatives	
over	 the	2-pyridyl	 analogues	enabled	us	 to	 reduce	 the	palladium	 loading	 to	1	mol	%	 in	 these	
cases.		
	 To	 our	 surprise,	 conducting	 the	 reaction	 under	 the	 tandem	 arylation/[1,2]-Wittig	




of	 tandem	 arylation/[1,2]-Wittig	 rearrangement	 product	 and	 72%	 of	 arylation	 product	 4.4je.		
Higher	reaction	temperatures	resulted	in	decomposition.		These	results	suggest	that	[1,2]-Wittig	
rearrangement	of	4-pyridylmethyl	ethers	are	possible,	but	require	higher	activation	energy.	This	
difference	 in	 reactivity	 between	 2-	 and	 4-pyridylmethyl	 ethers	 most	 likely	 stems	 from	 the	
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increased	 stability	 of	 the	 deprotonated	 4-pyridylmethyl	 ethers.	 	 We	 are	 aware	 of	 a	 few	
examples	 of	 [1,2]-Wittig	 rearrangements	 of	 4-pyridyl	 methyl	 ethers	 in	 the	 literature.26	 	 The	
mechanism	 of	 [1,2]-Wittig	 rearrangement	 proceeds	 via	 radical	 intermediates.	 	 The	 radical	


















(23 oC, 86% y)[a]
(60 oC, 84% y)[b]
4.4jd
(23 oC, 85% y)[a]
4.4kc

















(60 oC, 88% y)[b]
4.4je
(60 oC, 87% y)[b]
4.4ke
(60 oC, 80% y)[b]
4.4jf













Pd(OAc)2  (1 mol %)
NIXANTPHOS (1.5 mol %)
[a] Conditions A: 4.1 (0.2 mmol), Ar–Br (0.24 mmol), NaN(SiMe3)2 (0.6 mmol), 
Pd(OAc)2/NIXANTPHOS (1 mol %/1.5 mol %), DME (2.0 mL) at 23 °C. [b] Conditions B: 4.1 
(0.2 mmol), Ar–Br (0.24 mmol), LiN(SiMe3)2 (0.6 mmol), Pd(OAc)2/NIXANTPHOS (1 mol 






benzyl	 (Scheme	 4.1A).	 	 These	 substrates	 underwent	 [1,2]-Wittig	 rearrangement	 faster	 than	
arylation,	highlighting	the	fine	line	in	chemoselectivity	between	the	[1,2]-Wittig	rearrangement	
of	 the	 carbanion	 4.2	 relative	 to	 transmetallation	 to	 palladium	 (Figure	 4.2).	 	 Additionally,	 2-
pyridylmethyl	aryl	ethers	did	not	undergo	the	[1,2]-Wittig	rearrangement.	 	These	observations	
are	in	accord	with	the	mechanism	of	[1,2]-Wittig	rearrangement,	which	proceeds	via	free	radical	
intermediates.22a	 	 The	 general	 order	 of	 reactivity	 of	 migrating	 groups	 in	 the	 Wittig	
rearrangement	 is	dictated	by	the	stability	of	the	corresponding	radicals:	allyl	~	benzyl	>	alkyl	>	
aryl.28		
	 To	 probe	 the	 order	 of	 the	 reactions	 leading	 to	 the	 tertiary	 alcohols	 4.5,	 (pyridin-2-
yl)propan-1-ol	4.3a	was	prepared	by	[1,2]-Wittig	rearrangement	of	4.1a	with	n-BuLi	in	THF	at	–
40	°C.4d		When	alcohol	4.3a	was	subjected	to	our	arylation	conditions,	no	arylation	product	was	
observed	 (Scheme	 4.1B),	 and	 starting	 material	 was	 recovered.	 	 In	 contrast,	 ether	 4.4ad	
underwent	 [1,2]-Wittig	 rearrangement	 upon	 exposure	 to	 LiN(SiMe3)2	 in	 the	 absence	 of	 the	






Scheme	 4.1.	 Probing	 the	 order	 of	 the	 tandem	arylation/[1,2]-Wittig	 rearrangement.	 	 A.	 [1,2]-
Wittig	rearrangement	of	allyl	and	benzyl	ethers	 is	 faster	 than	Pd-catalyzed	arylation	reactions.		




	 [1,2]-Wittig	 rearrangements	 are	 known	 to	 be	 influenced	 by	 combinations	 of	 alkali	
metals	and	solvents.23d,29		Although	a	full	mechanistic	study	of	the	[1,2]-Wittig	rearrangement	is	






Pd(OAc)2  (5 mol %)
NIXANTPHOS (7.5 mol %)
NaN(SiMe3)2 (3 equiv) 




















Pd(OAc)2  (5 mo l%)





NaN(SiMe3)2 (3.0 equiv) 
DME, RT, 12 h
Ph–Br
4.1l: R = CH2CH=CH2 
4.1m: R = CH2Ph
4.3l 80%: R = CH2CH=CH2 







crown-4	 and	 15-crown-5]	were	 examined.	 	 Reactions	were	 conducted	 at	 45	 °C	 to	 give	 higher	
amounts	of	[1,2]-Wittig	rearrangement	product	than	reactions	conducted	at	room	temperature	
(as	 in	 Tables	 4.1–4.3).	 	 Reactions	 were	 intentionally	 quenched	 before	 completion	 to	 assess	
reaction	 progress.	 The	 quantities	 of	 starting	 materials	 and	 products	 were	 determined	 by	 1H	
NMR	integration	of	reaction	mixtures	against	an	internal	standard.		
	 The	 results	of	 this	 study	are	 illustrated	 in	 Table	4.7.	 	 Reactions	 in	CPME	promoted	by	
LiN(SiMe3)2	 and	 NaN(SiMe3)2	 undergo	 relatively	 fast	 [1,2]-Wittig	 rearrangements	 at	 45	 °C	
(entries	 1	 and	 2).	 	 In	 DME	 both	 bases	 are	 less	 capable	 of	 promoting	 the	 rearrangement,	 but	







7	 and	 13%	 product	 formation	 (entries	 6–7,	 respectively)	 compared	 to	 75%	 in	 CPME	 in	 the	
absence	 of	 crown	 ether	 (entry	 2).	 	 Thus,	 we	 conclude	 that	 coordinating	 solvent	 (DME)	 and	
coordinating	additives	 (12-crown-4	and	15-crown-5)	both	 inhibit	 the	 reaction	with	 the	sodium	





Table	 4.7.	 Effect	 of	 Alkali	 Metals,	 Solvents,	 and	 Additives	 in	 [1,2]-Wittig	 Rearrangement	 of	
4.4ab.	
	
entry	 solvent	 M	 additive	 4ab	(%)[b]	 5ab	(%)[b]	
1	 CPME	 Li	 –	 37	 64	
2	 CPME	 Na	 –	 24	 75	
3	 DME	 Li	 –	 72	 27	
4	 DME	 Na	 –	 85	 9	
5	 CPME	 Li	 12-Crown-4	 53	 47	
6	 CPME	 Na	 12-Crown-4	 90	 7	
7	 CPME	 Na	 15-Crown-5	 86	 13	






In	 summary,	 we	 have	 developed	 a	 unified	 approach	 for	 the	 synthesis	 of	 structurally	 diverse	
pyridines,	 which	 are	 among	 the	most	 important	 heterocycles	 and	 are	 found	 in	many	 natural	
products	 and	 pharmaceutically	 relevant	molecules	 (Figure	 4.1).	 	 The	 key	 to	 achieving	 skeletal	
diversity	 from	 a	 single	 starting	 material	 is	 to	 effect	 either	 the	 arylation	 or	 tandem	
arylation/[1,2]-Wittig	rearrangement	with	high	selectivity.		Despite	the	remarkable	similarity	of	
the	 reaction	 parameters	 for	 these	 processes,	 both	 being	 promoted	 by	 silylamide	 bases	 and	 a	
















either	 reaction.	 The	 exceptional	 selectivity	 between	 secondary	 pyridyl	 ethers	 and	 their	





General	Methods.	 	All	 reactions	were	 conducted	 under	 an	 inert	 atmosphere	 of	 dry	 nitrogen.	
Anhydrous	 dioxane	 and	 cyclopentyl	methyl	 ether	 (CPME)	were	 purchased	 from	 Sigma-Aldrich	
and	used	without	further	purification.	Dimethoxyethane	(DME)	and	tetrahydrofuran	(THF)	were	
dried	through	activated	alumina	columns	under	nitrogen.		Solvents	were	commercially	available	
and	 used	 as	 received	 without	 further	 purification.	 	 Chemicals	 were	 purchased	 from	 Sigma-
Aldrich,	 Acros,	 Fisher	 Scientific	 or	 Matrix	 Scientific,	 and	 solvents	 were	 obtained	 from	 Fisher	
Scientific.		Thin-layer	chromatography	was	performed	on	Whatman	precoated	silica	gel	60	F-254	
plates	and	visualized	by	ultraviolet	 light.	 	Flash	chromatography	was	performed	with	 silica	gel	




of	 an	 AB	 quartet;	 if	 additional	 splittings	 were	 evident,	 they	 are	 noted	 following	 the	 ABq	
designation	 (e.g.,	 ABqq).	 	 The	 infrared	 spectra	were	 obtained	with	 KBr	 plates	 using	 a	 Perkin-


































mmol),	 sodium	 hydroxide	 (1.2	 g,	 30	 mmol),	 phenol	 (12	 mmol)	 and	 toluene	 (5	 mL)	 at	 room	
temperature.	The	flask	was	capped	with	a	reflux	condenser	and	a	septum.	The	resulting	biphasic	
mixture	was	stirred	and	heated	to	reflux	for	4–8	h	until	TLC	showed	complete	consumption	of	2-




Procedure	 A	 with	 2-(chloromethyl)pyridine	 hydrochloride	 (2.0	 g,	 12	 mmol),	





2-(Methoxymethyl)pyridine	 (4.1b).	 The	 reaction	 was	 performed	 following	
General	 Procedure	 A	 with	 2-(chloromethyl)pyridine	 hydrochloride	 (2.0	 g,	 12	









	2-((Cyclohexyloxy)methyl)pyridine	 (4.1c).	 The	 reaction	 was	 performed	
following	 General	 Procedure	 B	 with	 2-(chloromethyl)pyridine	 hydrochloride	
(2.0	 g,	 12	 mmol),	 sodium	 hydride	 (0.73	 g,	 30	 mmol)	 and	 cyclohexanol	 (5	 mL).	 The	 reaction	
mixture	 was	 stirred	 and	 refluxed	 for	 8	 h.	 The	 crude	 product	 was	 purified	 by	 flash	
chromatography	on	 silica	gel	 (eluted	with	EtOAc:hexanes	=	1:6)	 to	afford	 the	product	 (2.00	g,	
88%	yield)	as	a	yellow	oil.	1H	NMR	(500	MHz,	CDCl3):	δ	8.47	(d,	J	=	4.0	Hz,	1H),	7.62	(t,	J	=	8.0	Hz,	
1H),	 7.44	 (d,	 J	 =	 8.0	 Hz,	 1H),	 7.10	(t,	 J	 =	 6.5	 Hz,	1H),	4.61	(s,	 2H),	3.37	 –	 3.34	(m,	 1H),	1.95	 –	
1.90	(m,	 2H),	1.69	 –	 1.72	(m,	 2H),	1.49	 –	 1.21	(m,	 6H)	 ppm;	 13C{1H}	 NMR	 (125	 MHz,	 CDCl3):	
δ	159.5,	 148.7,	 136.3,	 121.9,	 121.1,	 77.6,	 70.7,	 32.1,	 25.7,	 23.9	 ppm;	 HRMS	 m/z	 192.1383	
[(M+H)+;	calcd	for	C12H18NO:	192.1388].	
	
	2-(tert-Butoxymethyl)pyridine	 (4.1d).	 The	 reaction	 was	 performed	 following	
General	 Procedure	 A	 with	 2-(chloromethyl)pyridine	 hydrochloride	 (2.0	 g,	 12	
mmol),	 sodium	 tert-butoxide	 (2.88	g,	 30	mmol)	 and	 tert-butanol	 (5	mL).	 The	 reaction	mixture	






148.6,	 136.3,	 121.7,	 121.0,	 73.6,	 65.2,	 27.5	 ppm;	 HRMS	 m/z	 166.1226	 [(M+H)+;	 calcd	 for	
C10H16NO:	166.1232].	
	
	2-(Phenoxymethyl)pyridine	 (4.1e).	 The	 reaction	 was	 performed	 following	
General	 Procedure	C	with	 2-(chloromethyl)pyridine	hydrochloride	 (2.0	 g,	 12	
mmol),	phenol	 (1.13	g,	12	mmol),	sodium	hydroxide	(1.2	g,	30	mmol)	and	toluene	(5	mL).	The	





following	 General	 Procedure	 C	 with	 2-(chloromethyl)pyridine	
hydrochloride	(2.0	g,	12	mmol),	4-fluorophenol	(1.34	g,	12	mmol),	sodium	hydroxide	(1.2	g,	30	
mmol)	 and	 toluene	 (5	mL).	 The	 reaction	mixture	was	 stirred	 and	 refluxed	 for	 6	 h.	 The	 crude	
product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	1:6)	to	
afford	 the	product	 (2.09	g,	86%	yield)	 as	a	white	 solid.	m.p.	=	52	–	55	 °C;	 1H	NMR	 (500	MHz,	
CDCl3):	δ	8.57	(d,	J	=	5.0	Hz,	1H),	7.69	(t,	J	=	8.0	Hz,	1H),	7.48	(d,	J	=	8.0	Hz,	1H),	7.21	–	7.19	(m,	
1H),		6.96	–	6.88	(m,	4H),	5.14	 (s,	 2H)	ppm;	 13C{1H}	NMR	 (125	MHz,	CDCl3):	δ	157.4	 (d,	 J	 =	250	







	2-((4-(tert-Butyl)phenoxy)methyl)pyridine	 (4.1g).	 The	 reaction	 was	
performed	following	General	Procedure	C	with	2-(chloromethyl)pyridine	
hydrochloride	(2.0	g,	12	mmol),	4-tert-butylphenol	(1.8	g,	12	mmol),	sodium	hydroxide	(1.2	g,	30	





136.7,	 126.2,	 122.4,	 121.2,	 114.1,	 70.5,	 34.5,	 31.4	 ppm.	 The	 1H	NMR	data	 for	 this	 compound	
match	the	literature	data.6		
	
	N,N-Dimethyl-2-(pyridin-2-ylmethoxy)ethan-1-amine	 (4.1h).	 To	 an	 oven-
dried	 round-bottomed	 flask	 equipped	 with	 a	 stir	 bar	 was	 added	 sodium	
tert-butoxide	(3.36	g.	30	mmol)	and	THF	(20	mL)	in	a	dry	box	under	N2	at	room	temperature	and	
the	flask	was	then	capped	with	a	septum.	The	flask	was	brought	out	of	 the	glove	box	and	the	




°C	 for	 10	min,	 the	 ice	 bath	 was	 removed	 and	 the	 reaction	mixture	 stirred	 for	 12	 h	 at	 room	
temperature.	 The	 reaction	 mixture	 was	 diluted	 with	 EtOAc	 (20	 mL)	 and	 quenched	 with	















	2-((2-(Pyrrolidin-1-yl)ethoxy)methyl)pyridine	 (4.1i).	 The	 reaction	 was	
performed	 following	 the	 procedure	 for	 4.1h	 with	 sodium	 tert-butoxide	
(3.36	g.	30	mmol),	N-(2-hydroxyethyl)pyrrolidine	(2.10	mL,	18	mmol),	2-(chloromethyl)pyridine	













Procedure	 A	 with	 4-(chloromethyl)pyridine	 hydrochloride	 (2.0	 g,	 12	 mmol),	
sodium	ethoxide	 (2.04	 g,	 30	mmol)	 and	ethanol	 (5	mL).	 The	 reaction	mixture	was	 stirred	 and	
refluxed	 for	4	h.	The	crude	product	was	purified	by	 flash	chromatography	on	silica	gel	 (eluted	




	4-(tert-Butoxymethyl)pyridine	 (4.1k).	 The	 reaction	 was	 performed	 following	




NMR	(500	MHz,	CDCl3):	δ	8.50	 (dd,	 J	=	4.5,	1.5	Hz,	2H),	7.24	 (m,	2H),	4.43	 (s,	2H),	1.25	 (s,	9H)	
ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ	149.5,	149.2,	121.6,	73.8,	62.5,	27.5	ppm.	IR	(neat)	3029,	
2975,	 2934,	 2874,	 1722,	 1605,	 1562,	 1472,	 1415,	 1391,	 1364,	 1322,	 1298,	 1235,	 1195,	 1099,	
1075,	1066,	1027,	993	cm-1	
	
2-(Allyloxymethyl)pyridine	 (4.1l).	 The	 reaction	 was	 performed	 following	











chromatography	on	 silica	gel	 (eluted	with	EtOAc:hexanes	=	1:5)	 to	afford	 the	product	 (1.16	g,	
65%	yield)	as	a	yellow	oil.	1H	NMR	(500	MHz,	CDCl3):	δ	8.54	(ddd,	J	=	5.0,	1.5,	1.0	Hz,	1H),	7.70	–	
7.67	(m,	1H),	7.46	(d,	J	=	8.0	Hz,	1H),	7.18	(dt,	J	=	8.0,	5.0	Hz,	1H),	6.01	–	5.94	(m,	1H),	5.34	(dd,	J	




2-(Benzyloxymethyl)pyridine	 (4.1m).	 The	 reaction	 was	 performed	
following	General	Procedure	C	with	2-(chloromethyl)pyridine	hydrochloride	
(2.0	 g,	 12	 mmol),	 benzyl	 alcohol	 (1.3	 g,	 12	 mmol),	 sodium	 hydroxide	 (1.2	 g,	 30	 mmol)	 and	
toluene	 (5	mL).	The	 reaction	mixture	was	 stirred	and	 refluxed	 for	4	h.	The	crude	product	was	












(4.1,	 0.2	mmol,	 1.0	 equiv),	 aryl	 bromide	 (4.6,	 0.24	mmol,	 1.2	 equiv)	 and	dry	DME	 (1	mL)	 in	 a	
glove	box	under	a	nitrogen	atmosphere	at	room	temperature.	NaN(SiMe3)2	(110	mg,	0.6	mmol,	




consumption	 of	 pyridylmethyl	 ether.	 The	 reaction	 mixture	 was	 quenched	 with	 four	 drops	 of	
H2O,	diluted	with	3	mL	of	ethyl	acetate,	and	filtered	over	a	pad	of	MgSO4	and	silica.	The	pad	was	










2-((4-(tert-Butyl)phenyl)(ethoxy)methyl)pyridine	 (4.4ab).	 The	 reaction	 was	
















with	 2-(ethoxymethyl)pyridine	 (4.1a,	 686	 mg,	 5.0	 mmol),	 1-bromo-4-tert-butylbenzene	
(1.04	mL,	 6.0	mmol)	 and	 DME	 (25	mL)	 in	 a	 glove	 box	 under	 a	 nitrogen	 atmosphere	 at	 room	
temperature.	 To	 the	 mixture	 was	 added	 NaN(SiMe3)2	 (2.75	 g,	 15	 mmol),	 and	 the	 flask	 was	
stirred	for	10	min.	In	a	separate	50	mL	round	bottomed	flask	equipped	with	a	stir	bar	was	added	
Pd(OAc)2	 (41.5	mg,	0.185	mmol)	 and	NIXANTPHOS	 (154	mg,	0.28	mmol)	 in	DME	 (20	mL).	 The	
Pd/NIXANTPHOS	solution	was	stirred	for	10	min	and	was	transferred	to	the	reaction	flask	by	a	
syringe,	 and	 the	 flask	 was	 rinsed	 with	 additional	 DME	 (5	 mL).	 The	 flask	 was	 capped	 with	 a	
rubber	septum,	removed	from	the	glove	box,	and	stirred	for	12	h	at	room	temperature	(23	°C)	
until	TLC	showed	complete	consumption	of	4.1a.	The	reaction	mixture	was	quenched	with	H2O	
(300	mL),	 diluted	with	 30	mL	of	 ethyl	 acetate,	 and	 filtered	over	 a	 pad	of	 Celite.	 The	pad	was	






2-(Ethoxy(4-methoxyphenyl)methyl)pyridine	 (4.4ac).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 D	 with	 2-(ethoxymethyl)pyridine	 (4.1a,	










4-(Ethoxy(pyridin-2-yl)methyl)-N,N-dimethylaniline	 (4.4ad).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 D	 with	 2-(ethoxymethyl)pyridine	 (4.1a,	
27.4	 mg,	 28	 uL,	 0.2	 mmol)	 and	 4-bromo-N,N-dimethylaniline	 (48.0	 mg,	 0.24	






1H),	6.69	 (app.	 d,	 J	 =	 8.5	 Hz,	 2H),	 5.41	(s,	 1H),	3.55	 (ABqq,	 ΔνAB	 =	 26.2	 Hz,	 J	 =	 9.5,	 7.0	 Hz,	
2H),	2.90	(s,	 6H),	1.27	 (t,	 J	 =	 7.0	 Hz,	 3H)	 ppm;	 13C{1H}	 NMR	 (125	MHz,	 CDCl3):	 δ	162.6,	 150.1,	
148.9,	136.6,	129.1,	127.9,	121.9,	120.4,	112.4,	84.5,	64.4,	40.5,	15.4	ppm;	IR	(thin	film):	1613,	
1588,	 1433,	 1346,	 1162,	 1098,	 806	 cm-1;	 HRMS	 calculated	 for	 C16H21N2O,	 257.1654,	 found	
257.1655	[M+H]+.	
	
2-(Ethoxy(4-fluorophenyl)methyl)pyridine	 (4.4ae).	 The	 reaction	 was	 performed	
following	General	Procedure	D	with	2-(ethoxymethyl)pyridine	 (4.1a,	27.4	mg,	28	





1.25	 (t,	 J	 =	 7.0	Hz,	 3H)	 ppm;	 13C{1H}	NMR	 (125	MHz,	 CDCl3):	δ	162.1	 	(d,	 J	 =	 250.0	Hz),	 161.8,	
148.9,	 137.1	 (d,	 J	 =	 3.2	 Hz),	136.7,	 128.5		(d,	 J	 =	 12.5	 Hz),	122.2,	 120.3,	 115.1	 	(d,	 J	 =	 25.0	
Hz),	83.8,	64.7,	15.2	ppm;	 IR	 (thin	 film):	2974,	1609,	1588,	1433,	1337,	1104,	699	cm-1;	HRMS	
calculated	for	C14H15FNO,	232.1138,	found	232.1141	[M+H]+.	
	
2-(Ethoxy(o-tolyl)methyl)pyridine	 (4.4af).	 The	 reaction	 was	 performed	
following	General	Procedure	D	with	2-(ethoxymethyl)pyridine	(4.1a,	27.4	mg,	28	












5-(Ethoxy(pyridin-2-yl)methyl)-1-methyl-1H-indole	 (4.4ag).	 The	 reaction	 was	
performed	following	General	Procedure	D	with	2-(ethoxymethyl)pyridine	(4.1a,	28	
uL,	0.2	mmol)	and	5-bromo-1-methyl-1H-indole	(50.4	mg,	0.24	mmol).	The	crude	
































128.4,	127.9,	121.9,	120.3,	112.3,	86.2,	56.8,	40.4	ppm;	 IR	 (thin	 film):	2928,	2819,	1613,	1521,	
206	
	
















4-(tert-Butoxy(pyridin-2-yl)methyl)-N,N-dimethylaniline	 (4.4dd).	 The	 reaction	
was	 performed	 following	 General	 Procedure	 D	 with	 2-(tert-












N,N-Dimethyl-4-(phenoxy(pyridin-2-yl)methyl)aniline	 (4.4ed).	 The	 reaction	
was	 performed	 following	 General	 Procedure	 D	 with	 2-





4.5	Hz,	 1H),	 6.98	 (d,	 J	 =	 8.5	Hz,	 2H),	 6.88	 (t,	 J	 =	 8.5	Hz,	 1H),	 6.68	 (d,	 J	 =	 8.5	Hz,	 2H),	 6.27	(s,	
1H),		2.90	(s,	6H)	ppm;	13C{1H}	NMR	(125	MHz,	CDCl3):	δ	161.3,	157.9,	150.1,	149.1,	136.8,	129.2,	
127.9,	127.7,	122.2,	120.7,	120.5,	115.9,	112.4,	82.4,	40.4	ppm;	IR	(thin	film):	3402,	2974,	2886,	
1613,	 1599,	 1521,	 1445,	 1410,	 1351,	 1163,	 1095,	 796	 cm-1;	 HRMS	 calculated	 for	 C20H21N2O,	
305.1654	found	305.1658	[M+H]+.	
	



















performed	 following	 General	 Procedure	 D	 with	 2-
((cyclohexyloxy)methyl)pyridine	 (4.1c,	 38.2	 mg,	 0.2	 mmol)	 and	 1-bromo-4-
fluorobenzene	 (31.2	uL,	 42	 mg,	 0.24	 mmol).	 The	 crude	 product	 was	 purified	 by	 flash	
chromatography	on	 silica	gel	 (eluted	with	EtOAc:hexanes	=	15:85)	 to	afford	 the	product	 (50.1	
mg,	88%	yield)	as	a	yellow	solid.	m.p.	=	82	–	84	°C;	1H	NMR	(500	MHz,	CDCl3):	δ	8.50	(ddd,	J	=	
5.0,	 1.5,	 1.0	 Hz,	 1H),	 7.66	 (td,	 J	 =	 8.0,	 7.5,	 1.5	 Hz,	 1H),	 7.56	 (ddd,	 J	 =	 7.5,	 1.5,	 1.0	 Hz,	 1H),	
7.38	(app.	d,	J	=	8.5,	5.0	Hz,	2H),	7.14	–	7.11	(m,	1H),	6.97	(app.	t,	J	=	8.5	Hz,	2H),	5.62	(s,	1H),	
3.38	 (m,	1H),	1.94	–	1.87	(m,	2H),	1.74	–	1.72	(m,	2H),	1.49	–	1.41	(m,	3H),	1.24	–	1.21	 (m,	3H)	







2-(tert-Butoxy(4-fluorophenyl)methyl)pyridine	 (4.4de).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 D	 with	 2-(tert-butoxymethyl)pyridine		
(4.7d,	33.0	mg,	0.2	mmol)	and	1-bromo-4-fluorobenzene	(31.2	uL,	0.24	mmol).	




2H),	5.69	(s,	1H),	1.22	 (s,	9H)	ppm;	 13C{1H}	NMR	 (125	MHz,	CDCl3):	δ	164.4,	161.9	(d,	 J	 =	250.0	
Hz),	 148.5,	 139.6	 (d,	 J	 =	 2.5	Hz),	136.6,	 128.2	 (d,	 J	 =	 12.5	Hz),	121.9,	120.9,	115.3	 	(d,	 J	 =	 25.0	
Hz),	76.4,	75.4,	28.5	ppm;	IR	(thin	film):	3054,	2975,	1932,	1604,	1589,	1507,	1469,	1434,	1390,	
1367,	 1220,	 1155,	 1102,	 1072,	 819,	 804,	 750,	 650	 cm-1;	 HRMS	 calculated	 for	 C16H19FNO,	
260.1451,	found	260.1451	[M-H]+.	
	
2-((4-Fluorophenoxy)(4-fluorophenyl)methyl)pyridine	 (4fe).	 The	 reaction	
was	 performed	 following	 General	 Procedure	 D	 with	 2-((4-
fluorophenoxy)methyl)pyridine	 (4.1f,	 40.6	mg,	0.2	mmol)	 and	1-bromo-4-
fluorobenzene	 (31.2	uL,	 42	 mg,	 0.24	 mmol).	 The	 crude	 product	 was	 purified	 by	 flash	















4-fluorobenzene	 (31.2	uL,	 42	 mg,	 0.24	 mmol).	 The	 crude	 product	 was	 purified	 by	 flash	















General	 Procedure	 E	 for	 the	 Pd-catalyzed	 chemoselective	 tandem	 arylation/[1,2]-Wittig	
rearrangement	reaction	of	2-pyridylmethyl	ethers:	
An	oven-dried	 10	mL	 reaction	 vial	 equipped	with	 a	 stir	 bar	was	 charged	with	 pyridinylmethyl	
ether	(4.1,	0.20	mmol,	1.0	equiv)	and	aryl	bromide	(0.24	mmol,	1.2	equiv)	and	CPME	(1	mL)	in	a	
glove	box	under	a	nitrogen	atmosphere	at	room	temperature.	LiN(SiMe3)2	 (100	mg,	0.6	mmol,	
3.0	 equiv)	was	 added	 to	 the	 reaction	mixture.	 A	 solution	 (from	 a	 stock	 solution)	 of	 Pd(OAc)2	
(1.12	mg,	0.05	mmol,	2.5	mol	%)	and	NIXANTPHOS	(4.14	mg,	0.075	mmol,	3.75	mol	%)	in	1.0	mL	
of	 dry	 CPME	 was	 taken	 up	 by	 syringe,	 and	 added	 to	 the	 reaction	 vial.	 The	 vial	 was	 capped,	
removed	 from	 the	 glove	 box,	 and	 stirred	 for	 24	 h	 at	 45	 °C	 until	 TLC	 showed	 complete	
consumption	of	pyridylmethyl	ether	starting	material	and	arylation	 intermediate.	The	reaction	
mixture	was	quenched	with	four	drops	of	H2O,	diluted	with	3	mL	of	ethyl	acetate,	and	filtered	




1-Phenyl-1-(pyridin-2-yl)propan-1-ol	 (4.5aa).	 The	 reaction	 was	 performed	








	1-(4-(tert-Butyl)phenyl)-1-(pyridin-2-yl)propan-1-ol	 (4.5ab).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 E	 with	 2-(ethoxymethyl)pyridine	 (4.1a,	
27.4	mg,	28	uL,	0.2	mmol)	and	1-bromo-4-tert-butylbenzene	(42.0	uL,	0.24	mmol).	










1-(4-Methoxyphenyl)-1-(pyridin-2-yl)propan-1-ol	 (4.5ac).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 E	 with	 2-(ethoxymethyl)pyridine	 (4.1a,	
27.4	mg,	 28	uL,	 0.2	mmol)	 and	4-bromoanisole	 (30.0	uL,	 0.24	mmol).	 The	 crude	
product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	20:80)	








1248,	 1030,	 985,	 841,	 591	 cm-1;	 HRMS	 calculated	 for	 C15H18NO2,	 244.1338,	 found	 244.1330	
[M+H]	+.	
	
	1-(4-(Dimethylamino)phenyl)-1-(pyridin-2-yl)propan-1-ol	 (4.5ad).	 The	 reaction	
was	 performed	 following	 General	 Procedure	 E	 with	 2-(ethoxymethyl)pyridine	
(4.1a,	27.4	mg,	28	uL,	0.2	mmol)	and	4-bromo-N,N-dimethylaniline	(48.0	mg,	0.24	





14.3,	 7.3	Hz,	 2H),	0.84	 (t,	 J	 =	 7.3	Hz,	 3H)	 ppm;	 13C{1H}	NMR	 (125	MHz,	 CDCl3):	δ	164.2,	 149.3,	
146.9,	136.6,	134.3,	126.7,	121.5,	120.4,	112.1,	76.7,	40.4,	33.7,	7.9	ppm;	 IR	 (thin	 film):	2924,	
1611,	 1519,	 1432,	 1351,	 1162,	 816	 cm-1;	 HRMS	 calculated	 for	 C16H19N2,	 239.1548,	 found	
239.1545	[M-OH]	+.	
	
1-(4-Fluorophenyl)-1-(pyridin-2-yl)propan-1-ol	 (4.5ae).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 E	 with	 2-(ethoxymethyl)pyridine	 (4.1a,	
214	
	




(ddd,	 J	=	8.0,	1.7,	1.0	Hz,	1H),	7.15	(ddd,	 J	=	7.5,	4.7,	1.0	Hz,	1H),	6.96	(app.	t,	 J	=	8.5	Hz,	2H),		
5.88	(s,	1H),	2.28	 (ABqq,	2H,	ΔνAB	=	38.9	Hz,	 J	=	13.5,	7.5	Hz,	2H),	0.83	 (t,	 J	=	7.5	Hz,	3H)	ppm;	
13C{1H}	NMR	(125	MHz,	CDCl3):	δ	163.3,	162.6	(d,	J	=	250.0	Hz),	147.1,	142.1,	136.9,	127.7		(d,	J	=	
12.5	 Hz),	121.9,	120.2,	114.8	(d,	 J	 =	 25.0	 Hz),	76.9,	33.8,	7.8	 ppm;	 IR	 (thin	 film):	 3364,	 2935,	




with	 Pd(OAc)2	 (28.1	mg,	 0.125	mmol)	 and	NIXANTPHOS	 (103.7	mg,	 0.188	mmol)	 in	 CPME	 (50	
mL).	The	Pd/NIXANTPHOS	solution	was	stirred	for	5	min	and	LiN(SiMe3)2	(2.51	g,	15	mmol)	was	
added.	After	stirring	for	5	min	at	24	°C,	2-(ethoxymethyl)pyridine	(4.1a,	686	mg,	5.0	mmol)	and	





washed	with	 saturated	aqueous	NaHCO3	 (30	mL)	and	brine	 (30	mL).	 The	organic	 solution	was	






	1-(4-Chlorophenyl)-1-(pyridin-2-yl)propan-1-ol	 (4.5ai).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 E	 with	 2-(ethoxymethyl)pyridine	 (4.1a,	
27.4	mg,	28	uL,	0.2	mmol)	and	1-bromo-4-chlorobenzene	 (45.8	mg,	0.24	mmol).	






122.0,	 120.0,	 77.0,	 33.7,	 7.8	 ppm;	 The	 1H	 NMR	 data	 for	 this	 compound	match	 the	 literature	
data.10	
	
1-(Pyridin-2-yl)-1-(3-(trifluoromethyl)phenyl)propan-1-ol	 (4.5aj).	 The	 reaction	
was	 performed	 following	 General	 Procedure	 E	 with	 2-(ethoxymethyl)pyridine	
(4.1a,	 27.4	 mg,	 28	 uL,	 0.2	 mmol)	 and	 1-bromo-2-(trifluoromethyl)benzene	






Hz,	 1H),	 7.30	 (ddd,	 J	 =	 8.0,	 1.7,	 1.0	 Hz,	 1H),	 7.18	 (ddd,	 J	 =	 7.4,	 4.9,	 1.0	 Hz,	 1H),	 5.98	(s,	






1-(1-Methyl-1H-indol-5-yl)-1-(pyridin-2-yl)propan-1-ol	 (4.5ag).	 The	 reaction	 was	








7.2	 Hz,	 3H)	 ppm;	 13C{1H}	 NMR	 (125	 MHz,	 CDCl3):	 δ	164.5,	 146.9,	 137.3,	 136.6,	 135.6,	 128.9,	






1-(Benzofuran-5-yl)-1-(pyridin-2-yl)propan-1-ol	 (4.5ah).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 E	 with	 2-(ethoxymethyl)pyridine	 (4.1a,	











1-(4-(Dimethylamino)phenyl)-1-(pyridin-2-yl)ethanol	 (4.5bd).	 The	 reaction	 was	
performed	 following	General	 Procedure	 E	with	 2-(methoxymethyl)pyridine	 (4.1b,	
24.6	mg,	0.2	mmol)	and	4-bromo-N,N-dimethylaniline	 (48.0	mg,	0.24	mmol).	 The	
crude	product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	

















1H),	1.90	 (s,	 3H)	ppm;	 13C{1H}	NMR	 (125	MHz,	 CDCl3):	δ	164.5,	 161.8	 	(d,	 J	 =	 250.0	Hz),	 147.4,	
142.9	(d,	J	=	2.5	Hz),		137.0,	127.6		(d,	J	=	12.5	Hz),	122.1,	120.1,	115.3		(d,	J	=	25.0	Hz),	74.7,	29.3	




reaction	 was	 performed	 following	 General	 Procedure	 E	 with	 2-







1.0	Hz,	1H),	6.69	 (app.	d,	 J	 =	8.5	Hz,	2H),	6.02	(s,	1H),		2.90	(s,	6H),	2.37	–	2.32	 (m,	1H),	1.78	–	
1.72	 (m,	1H),	1.71	–	1.60	 (m,	3H),	1.35	–	1.10	 (m,	5H),	1.06	–	0.98	 (m,	1H)	ppm;	 13C{1H}	NMR	
(125	MHz,	 CDCl3):	 δ	164.0,	 149.1,	 146.6,	 136.8,	 133.7,	 126.7,	 121.4,	 120.3,	 112.3,	 79.0,	 46.2,	
40.5,	26.9,	26.8,	26.6,	26.4	ppm;	IR	(thin	film):	3352,	2930,	2850,	1733,	1611,	1592,	1392,	1349,	
1161,	 1090,	 998,	 947,	 823,	 750,	 647	 cm-1;	 HRMS	 calculated	 for	 C20H25N2,	 293.2018	 found	
293.2016	[M+H]+.	
	
Cyclohexyl(4-fluorophenyl)(pyridin-2-yl)methanol	 (4.5ce).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 E	 with	 2-
((cyclohexyloxy)methyl)pyridine	 (4.1c,	 38.2	 mg,	 0.2	 mmol)	 and	 1-bromo-4-
fluorobenzene	 (31.2	uL,	0.24	mmol).	 The	crude	product	was	purified	by	 flash	 chromatography	




1.54	(m,	 4H),	1.31	 –	 0.98	(m,	 6H)	 ppm;	 13C{1H}	 NMR	 (125	MHz,	 CDCl3):	 δ	163.1,	 162.6	 (d,	 J	 =	
250.0	Hz),	146.9,	141.6	 (d,	 J	=	2.5	Hz),	137.1,	127.6	 (d,	 J	=	12.5	Hz),	121.8,	120.3,	114.9	 (d,	 J	=	
25.0	 Hz),	 79.1,	 46.3,	 26.8,	 26.7,	 26.6,	 26.5,	 26.3	 ppm;	 IR	 (thin	 film):	 3339,	 2932,	 2852,	 1593,	






The	 reaction	 was	 performed	 following	 General	 Procedure	 E	 with	 2-(tert-










reaction	 was	 performed	 following	 General	 Procedure	 E	 with	 2-(tert-
butoxymethyl)pyridine	(4.1d,	33.0	mg,	0.2	mmol)	and	1-bromo-4-chlorobenzene	
(45.8	mg,	 0.24	mmol).	 The	 crude	 product	 was	 purified	 by	 flash	 chromatography	 on	 silica	 gel	
(eluted	with	EtOAc:hexanes	=	20:80)	to	afford	the	product	(33.0	mg,	60%	yield)	as	a	yellow	oil.	
1H	NMR	(500	MHz,	CDCl3):	δ	8.51	(ddd,	J	=	4.5,	1.5,	1.0	Hz,	1H),	7.77	(d,	J	=	8.5	Hz,	1H),	7.76	–	
7.69	(m,	1H),	7.70	(d,	J	=	9.0	Hz,	 2H)	7.26	–	7.20	(m,	3H),	6.40	(s,	 1H),	1.05	 (s,	 9H)	ppm;	 13C{1H}	
NMR	 (125	MHz,	 CDCl3):	 δ	161.9,	 146.8,	 142.7,	 136.2,	 132.4,	 129.6,	 127.2,	 122.6,	 122.2,	 81.0,	











and	 bromobenzene	 (25.2	uL,	 0.24	 mmol).	 The	 crude	 product	 was	 purified	 by	 flash	




MHz,	 CDCl3):	 δ	165.4,	 147.9,	 146.6,	 136.9,	 128.2,	 126.8,	 125.7,	 121.8,	 121.1,	 79.1,	 56.1,	 44.8,	
35.9	 ppm;	 IR	 (thin	 film):	 3309,	 3054,	 2976,	 2950,	 2860,	 2825,	 2780,	 1586,	 1568,	 1463,	 1447,	




The	 reaction	was	performed	 following	General	Procedure	E	at	60	 °C	 for	24	h	
with	 N,N-dimethyl-2-(pyridin-2-ylmethoxy)ethan-1-amine	 (4.1h,	 36.1	 mg,	 0.2	
mmol)	and	1-bromo-4-chlorobenzene	(45.8	mg,	0.24	mmol).	The	crude	product	was	purified	by	













(thin	 film):	 3307,	 3056,	 3011,	 2953,	 2826,	 2679,	 2468,	 1588,	 1569,	 1489,	 1467,	 1400,	 1292,	





reaction	 was	 performed	 following	 General	 Procedure	 E	 at	 60	 °C	 for	 24	 h	
with	2-((2-(pyrrolidin-1-yl)ethoxy)methyl)pyridine	(4.1i,	41.3	mg,	0.2	mmol)	and	bromobenzene	










	1-(Pyridin-2-yl)-3-(pyrrolidin-1-yl)-1-(p-tolyl)propan-1	 (4.5ik).	 The	 reaction	
was	performed	following	General	Procedure	E	at	60	°C	for	24	h	with	2-((2-













1.84	 –	 1.74	 (m,	 4H)	 ppm;	 13C{1H}	NMR	 (125	MHz,	 CDCl3):	δ	166.1,	 147.9,	 144.1,	 136.8,	 136.1,	
128.8,	 125.6,	 121.6,	 121.0,	 79.4,	 53.9,	 52.7,	 37.0,	 23.6,	 21.1	 ppm;	 IR	 (thin	 film):	 3154,	 3055,	






4-(Ethoxy(pyridin-4-yl)methyl)-N,N-dimethylaniline	 (4.4jd).	 The	 reaction	 was	
performed	 following	 General	 Procedure	 D	 with	 4-(ethoxymethyl)pyridine	 (4.1j,	
27.4	mg,	0.2	mmol)	and	4-bromo-N,N-dimethylaniline	(48.0	mg,	0.24	mmol)	with	
Pd(OAc)2	 (1	mol	%)	and	NIXANTPHOS	 (1.5	mol	%)	 in	1	mL	of	dry	DME	 for	12	h	at	23	 °C.	 	 The	
crude	product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	
10:90)	 to	 afford	 the	 product	 (43.6	mg,	 85%	 yield)	 as	 a	 yellow	 oil.	 1H	NMR	 (500	MHz,	 CDCl3):	
δ	8.49	(dd,	J	=	5.5,	1.5	Hz,	2H),	7.26	(m,	2H),	7.13	(d,	J	=	9.0	Hz,	2H),	6.66	(d,	J	=	9.0	Hz,	2H),	5.21	
(s,	1H),		3.47	(ABqq,	2H,	ΔνAB	=	26.3	Hz,	J	=	9.2,	7.0	Hz,	2H),		2.90	(s,	6H),	1.23	(t,	J	=	7.0	Hz,	3H)	




1032,	 992,	 946,	 885,	 804,	 751,	 690	 cm-1;	 HRMS	 calculated	 for	 C16H21N2O,	 257.1654,	 found	
257.1650	[M+H]+.	
	
	4-(tert-Butoxy(4-(tert-butyl)phenyl)methyl)	 (4.4kb).	 The	 reaction	 was	
performed	following	General	Procedure	D	with	4-(butoxymethyl)pyridine	(4.1k,	
33.0	mg,	0.2	mmol)	and	1-bromo-4-tert-butylbenzene	(42.0	uL,	0.24	mmol)	with	





Hz,	 2H),	 5.50	 (s,	 1H),	 1.27	 (s,	 9H),	 1.20	 (s,	 9H)	 ppm;	 13C{1H}	 NMR	 (125	MHz,	 CDCl3):	 δ	 154.3,	
150.4,	149.8,	140.6,	126.7,	125.5,	122.0,	75.5,	74.7,	34.6,	31.5,	28.8	ppm;	 IR	 (thin	 film):	3026,	
2967,	 2094,	 2869,	 1596,	 1562,	 1511,	 1463,	 1413,	 1391,	 1366,	 1269,	 1109,	 1065,	 1018	 cm-1;	
HRMS	calculated	for	C20H27NO,	298.2171,	found	298.2176	[M+H]+.	
	
















1.20	 (s,	 9H)	 ppm;	 13C{1H}	 NMR	 (125	MHz,	 CDCl3):	 δ	159.0,	 154.3,	 149.8,	 136.0,	 128.3,	 121.8,	
114.0,	75.5,	74.4,	5.4,	28.8	ppm;	IR	(thin	film):	3074,	3027,	2974,	2934,	2906,	2836,	1610,	1597,	












15.4	 ppm;	 IR	 (thin	 film):	 3030,	 2976,	 2872,	 1600,	 1561,	 1508,	 1443,	 1411,	 1305,	 1223,	 1187,	
1157,	 1104,	 1091,	 1015,	 993	 cm-1;	HRMS	calculated	 for	C14H15NOF,	 232.1138,	 found	232.1134	
[M+H]+.	
	
	4-(Ethoxy(4-methoxyphenyl)methyl)pyridine	 (4.4jc).	 The	 reaction	 was	





















	4-(tert-Butoxy(4-fluorophenyl)methyl)	 pyridine	 (4.4ke).	 The	 reaction	 was	
performed	following	General	Procedure	E	with	4-(ethoxymethyl)pyridine	(4.1k,	
33.0	mg,	 0.2	mmol)	 and	 1-bromo-4-fluorobenzene	 (31.2	uL,	 0.24	mmol)	 with	
Pd(OAc)2	 (1	mol	%)	and	NIXANTPHOS	 (1.5	mol	%)	 in	1	mL	of	dry	CPME	 for	12	h	at	60	 °C.	The	
crude	product	was	purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	
20:80)	 to	 afford	 the	product	 (41.5	mg,	 80%	yield)	 as	 a	 yellow	oil.	 	 1H	NMR	 (500	MHz,	 CDCl3):	
δ	8.49	 (dd,	 J	 =	 4.5,	 2.0	 Hz,	 2H),	 7.29	 –	 7.21	(m,	 4H),		 6.96	 (t,	 J	 =	 8.7	 Hz,	 2H),	 5.49	(s,	
1H),	1.19	(s,	9H)	 ppm;	 13C{1H}	 NMR	 (125	MHz,	 CDCl3):	 δ	162.2	 (d,	 J	 =	 244.2	 Hz),	 153.8,	 149.9,	
139.7	(d,	J	=	2.9	Hz),	128.7	(d,	J	=	8.0	Hz),	121.8,	115.5	(d,	J	=	21.1	Hz),	75.8,	74.2,	28.8	ppm;	IR	










	4-(Ethoxy(o-tolyl)methyl)pyridine	 (4.4jf).	 The	 reaction	 was	 performed	
following	General	Procedure	D	with	4-(ethoxymethyl)pyridine	(4.1j,	27.4	mg,	0.2	
mmol),	1-bromo-2-methylbenzene	(28.8	uL,	0.24	mmol)	with	Pd(OAc)2	(1	mol	%)	




ppm;	 13C{1H}	NMR	 (125	MHz,	 CDCl3):	δ	150.8,	 150.0,	 138.7,	 136.4,	 131.0,	 128.2,	 127.9,	 126.4,	
122.2,	80.0,	65.0,	19.6,	15.5	ppm;	IR	(thin	film):	3025,	2975,	2871,	1597,	1560,	1491,	1460,	1411,	













The	 reaction	 was	 performed	 following	 General	 Procedure	 D	 with	 2-((allyloxy)methyl)pyridine	









Pd(OAc)2  (5 mol %)
NIXANTPHOS (7.5 mol %)
NaN(SiMe3)2 (3 equiv) 




















Pd(OAc)2  (5 mol %)





NaN(SiMe3)2 (3.0 equiv) 
DME, RT, 12 h
Ph–Br
4.1l: R = CH2CH=CH2 
4.1m: R = CH2Ph
4.3l 80%: R = CH2CH=CH2 






In	 a	 10	 mL	 dry	 one-necked	 flask	 under	 a	 nitrogen	 atmosphere	 was	 added	 2-
(ethoxymethyl)pyridine	 (4.1a,	 109.6	 mg,	 112	 uL,	 0.8	 mmol)	 and	 THF	 (5	 mL)	 at	 room	
temperature.	The	reaction	vessel	was	cooled	to	–	40	°C	in	a	dry	ice	bath	and	stirred	for	5	min.	
nBuLi	 (0.5	 mL,	 2.5	 M	 in	 hexanes,	 1.5	 equiv)	 was	 added	 dropwise.	 The	 reaction	 mixture	 was	













mg,	 0.4	 mmol,	 2	 equiv)	 and	 by	 2	 mL	 of	 dry	 CPME	 under	 a	 nitrogen	 atmosphere	 at	 room	








ethyl	 acetate	 (3	 mL),	 and	 the	 solution	 was	 concentrated	 in	 vacuo.	 	 The	 crude	 product	 was	
purified	by	flash	chromatography	on	silica	gel	(eluted	with	EtOAc:hexanes	=	10:90)	to	afford	1-
(4-(dimethylamino)phenyl)-1-(pyridin-2-yl)propan-1-ol	 (4.5ad,	 40.9	mg,	 80%	 yield)	 as	 a	 yellow	
oil.	
	
Effect	 of	 Alkali	 Metals,	 Solvents	 and	 Additives	 in	 [1,2]-Wittig	 Rearrangement	 of	 Arylation	
product	4.4ab.	
Experiments	were	set	up	inside	a	glove	box	under	a	nitrogen	atmosphere.		






In	 a	 4	mL	 reaction	 vial	 equipped	with	 a	 stir	 bar	was	 added	0.6	M	LiN(SiMe3)2	 in	CPME	 (0.075	
mmol,	125	μL)	and	12-Crown-4	(0.075	mmol,	12.1	μL).		After	the	vial	was	stirred	for	3	min,	0.4	M	
4.4ab	 in	 CPME	 (0.05	 mmol,	 125	 μL)	 was	 added	 to	 the	 reaction	 vial.	 	 The	 vial	 was	 capped,	
removed	from	the	glove	box,	and	stirred	for	1	h	at	45	°C,	then	cooled	to	room	temperature.		The	








entry	 solvent	 M	 additive	 4.4ab	(%)[b]	 4.5ab	(%)[b]	
1	 CPME	 Li	 –	 37	 64	
2	 CPME	 Na	 –	 24	 75	
3	 DME	 Li	 –	 72	 27	
4	 DME	 Na	 –	 85	 9	
5	 CPME	 Li	 12-Crown-4	 53	 47	
6	 CPME	 Na	 12-Crown-4	 90	 7	








































	(11)	 (a)	 Joule,	 J.	 A.;	Mills,	 K.	Heterocyclic	 Chemistry;	 5th	 ed.;	 John	Wiley	&	 Sons:	 Chichester,	U.K.,	
2010.	(b)	Alexander	F.	Pozharskii,	A.	S.,	Alan	R.	Katritzky	Heterocycles	in	Life	and	Society:	An	Introduction	
to	Heterocyclic	 Chemistry,	 Biochemistry	 and	Applications;	 2nd	ed.;	 John	Wiley	&	 Sons:	 Chichester,	U.K.,	
2011.	
	(12)	 (a)	 Niwa,	 T.;	 Yorimitsu,	 H.;	 Oshima,	 K.	Org.	 Lett.	 2007,	 9,	 2373.	 (b)	 Niwa,	 T.;	 Yorimitsu,	 H.;	
Oshima,	 K.	Angew.	 Chem.	 Int.	 Ed.	 2007,	 46,	 2643.	 (c)	 Hlavinka,	M.	 L.;	 Hagadorn,	 J.	 R.	Organometallics	
233	
	
2007,	 26,	 4105.	 (d)	 Campeau,	 L.-C.;	 Schipper,	 D.	 J.;	 Fagnou,	 K.	 J.	 Am.	 Chem.	 Soc.	 2008,	 130,	 3266.	 (e)	


























	(20)	 (a)	McGrew,	G.	 I.;	 Temaismithi,	 J.;	 Carroll,	 P.	 J.;	Walsh,	 P.	 J.	Angew.	 Chem.	 Int.	 Ed.	2010,	49,	
5541.	(b)	McGrew,	G.	I.;	Stanciu,	C.;	Zhang,	J.;	Carroll,	P.	J.;	Dreher,	S.	D.;	Walsh,	P.	J.	Angew.	Chem.	Int.	Ed.	








1446.	 (n)	Yücel,	B.;	Walsh,	P.	 J.	Adv.	Synth.	Cat.	2014,	356,	3659.	 (o)	Zheng,	B.;	 Jia,	T.;	Walsh,	P.	 J.	Adv.	
Synth.	Cat.	2014,	356,	165.	(p)	Zhang,	J.;	Bellomo,	A.;	Trongsiriwat,	N.;	Jia,	T.;	Carroll,	P.	J.;	Dreher,	S.	D.;	
Tudge,	M.	T.;	Yin,	H.;	Robinson,	 J.	R.;	 Schelter,	E.	 J.;	Walsh,	P.	 J.	 J.	Am.	Chem.	Soc.	2014,	136,	6276.	 (q)	
Mao,	 J.;	 Eberle,	 K.;	 Zhang,	 J.;	 Rodríguez-Escrich,	 C.;	 Xi,	 Z.;	 Pericàs,	M.	A.;	Walsh,	 P.	 J.	Tetrahedron	 Lett.	
2015,	56,	3604.	(r)	Sha,	S.-C.;	Zhang,	J.;	Walsh,	P.	J.	Org.	Lett.	2015,	17,	410.	
	(21)	 (a)	 van	der	Veen,	 L.	A.;	 Keeven,	 P.	H.;	 Schoemaker,	G.	 C.;	 Reek,	 J.	N.	H.;	 Kamer,	 P.	 C.	 J.;	 van	
Leeuwen,	 P.	 W.	 N.	 M.;	 Lutz,	 M.;	 Spek,	 A.	 L.	 Organometallics	 2000,	 19,	 872.	 (b)	 Kamer,	 P.	 C.	 J.;	 van	
Leeuwen,	P.	W.	N.	M.;	Reek,	J.	N.	H.	Acc.	Chem.	Res.	2001,	34,	895.	
	(22)	(a)	Nakai,	T.;	Mikami,	K.	Chem.	Rev.	1986,	86,	885.	(b)	Marshall,	J.	A.	In	Comprehensive	Organic	
Synthesis;	 Trost,	 B.	 M.,	 Fleming,	 I.,	 Eds.;	 Pergamon:	 Oxford,	 1991;	 Vol.	 3,	 p	 975.	 (c)	 Tomooka,	 K.;	






493.	 (i)	Miyashita,	A.;	Matsuoka,	Y.;	 Suzuki,	 Y.;	 Iwamoto,	K.;	Higashino,	T.	Chem.	Pharm.	Bull.	1997,	45,	
1235.	 (j)	 Paquette,	 L.	 A.;	 Zeng,	 Q.	 Tetrahedron	 Lett.	1999,	40,	 3823.	 (k)	 Garbi,	 A.;	 Allain,	 L.;	 Chorki,	 F.;	
Ourévitch,	M.;	Crousse,	B.;	Bonnet-Delpon,	D.;	Nakai,	T.;	Bégué,	J.-P.	Org.	Lett.	2001,	3,	2529.	(l)	Kitagawa,	
O.;	Momose,	S.-i.;	Yamada,	Y.;	Shiro,	M.;	Taguchi,	T.	Tetrahedron	Lett.	2001,	42,	4865.	 (m)	Vilotijevic,	 I.;	
Yang,	 J.;	Hilmey,	D.;	Paquette,	L.	A.	Synthesis	2003,	1872.	 (n)	Hameury,	T.;	Guillemont,	 J.;	Van	Hijfte,	L.;	
Bellosta,	V.;	Cossy,	J.	Synlett	2008,	2345.	(o)	Yang,	J.;	Dudley,	G.	B.	J.	Org.	Chem.	2009,	74,	7998.	(p)	Yang,	
J.;	Wangweerawong,	 A.;	 Dudley,	 G.	 B.	Heterocycles	2012,	85,	 1603.	 (q)	Nakano,	 T.;	 Soeta,	 T.;	 Endo,	 K.;	
Inomata,	K.;	Ukaji,	Y.	J.	Org.	Chem.	2013,	78,	12654.	
	(23)	(a)	Schreiber,	S.	L.;	Goulet,	M.	T.;	Schulte,	G.	J.	Am.	Chem.	Soc.	1987,	109,	4718.	(b)	Schreiber,	S.	
L.;	 Goulet,	M.	 T.	Tetrahedron	 Lett.	1987,	28,	 1043.	 (c)	 Tomooka,	 K.;	 Kikuchi,	M.;	 Igawa,	 K.;	 Suzuki,	M.;	
Keong,	P.	H.;	Nakai,	T.	Angew.	Chem.	Int.	Ed.	2000,	39,	4502.	(d)	Tomooka,	K.;	Yamamoto,	H.;	Nakai,	T.	J.	
Am.	Chem.	Soc.	1996,	118,	3317.	(e)	Maleczka,	R.	E.;	Geng,	F.	Org.	Lett.	1999,	1,	1115.	



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
 
Figure	A-	21.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.5d	in	CDCl3.	
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Figure	A-	22.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.5e	in	CDCl3.	
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Figure	A-	23.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.5f	in	CDCl3.	
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Figure	A-	24.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.5g		in	CDCl3.	
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Figure	A-	25.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.5h	in	CDCl3.		
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Figure	A-	26.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.6a	in	CDCl3.	
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Figure	A-	27.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.6b		in	CDCl3.	
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Figure	A-	28.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.6c	in	CDCl3.	
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Figure	A-	29.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.6d	in	CDCl3.	
n-Bui-Pr
OAc
2.6d
298	
	
 
 
	
Figure	A-	30.	300	MHz	1H	and	75	MHz	13C{1H}	NMR	of	2.	6e	in	CDCl3.	
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Figure	A-	31.	300	MHz	1H	and	75	MHz	13C{1H}	NMR	of	2.6f		in	CDCl3.	
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Figure	A-	32.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.6g	in	CDCl3.	
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Figure	A-	33.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.	6h	in	CDCl3.	
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Figure	A-	34. 300	MHz	1H	and	75	MHz	13C{1H}	NMR	of	2.6i	in	CDCl3.		
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Figure	A-	35.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.6j		in	CDCl3.	
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Figure	A-	36.	300	MHz	1H	and	75	MHz	13C{1H}	NMR	of	2.6k	in	CDCl3.	
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Figure	A-	37. 500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.6l	in	CDCl3.		
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Figure	A-	38. 500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.6m	in	CDCl3.	
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Figure	A-	39.500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.7a	in	CDCl3.	
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Figure	A-	40.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.7b	in	CDCl3.	
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Figure	A-	41.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.7c-ol	in	CDCl3.	
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Figure	A-	42.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.7c		in	CDCl3.	
B(pin)
n-Bu
OBz
2.7c
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Figure	A-	43.500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.8a	in	CDCl3.		
B(pin)
n-Bun-Bu
OCO2t-Bu
2.8a
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Figure	A-	44.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.8b	in	CDCl3.		
B(pin)
n-Bun-Bu
OCO2Et
2.8b
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Figure	A-	45. 500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.8c	in	CDCl3.		
Ph
OCO2t-Bu
n-Bu
B(pin)
2.8c
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Figure	A-	46.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	82.8d	in	CDCl3.		
B(pin)
n-Bu
OCO2t-Bu
2.8d
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Figure	A-	47.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.9a	in	CDCl3.	
n-Bun-Bu
OBz
2.9a
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Figure	A-	48. 500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.9b	in	CDCl3.		
n-Bun-Bu
OBz
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Figure	A-	49.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.9c	in	CDCl3.		
n-Bun-Bu
OCO2t-Bu
2.9c
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Figure	A-	50.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.9d	in	CDCl3.		
n-Bun-Bu
OCO2t-Bu
2.9d
NO2
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Figure	A-	51.	300	MHz	1H	and	75	MHz	13C{1H}	NMR	of	2.9e	in	CDCl3.	
n-Bun-Bu
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Figure	A-	52.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.9f	in	CDCl3.	
n-Bun-Bu
OCO2Et
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Figure	A-	53.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.10a	in	CDCl3.	
2.10a
n-Bu•
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Figure	A-	54. 500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.10b	in	CDCl3.	
n-Bu•
Cl
2.10b
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Figure	A-	55.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.10c	in	CDCl3.	
n-Bu•
F3C
2.10c
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Figure	A-	56.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.10d	in	CDCl3.		
n-Bu•
Me
2.10d
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Figure	A-	57.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.10e	in	CDCl3.		
2.10e
n-Bu•
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Figure	A-	58.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.10f	in	CDCl3.		
2.10f
n-Bu•
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Figure	A-	59.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	2.10g	in	CDCl3.	
2.10g
n-Bu•
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Racemic	10a	
	
	
Enantioenriched	10a,	(Table	10,	entry	2,	after	10	min)	
	
	
Racemized	10a,	(Table	10,	entry	6,	after	60	min)	
 
 
Figure	A-	60.	HPLC	spectra	of	racemic	10a	and	representative	(S)-10a	in	10	min	and	racemized	
10a	in	60	min.	
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Figure	A-	61. 500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1a	in	CDCl3.		
3.1a
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Figure	A-	62. 500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1b	in	CDCl3.		
 
3.1b
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Figure	A-	63.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1c	in	CDCl3.			
3.1c
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Figure	A-	64.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1d	in	CDCl3.	
3.1d
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Figure	A-	65.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1e	in	CDCl3.	
3.1e
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Figure	A-	66.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1f	in	CDCl3.	
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Figure	A-	67.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1g	in	CDCl3.	
3.1g
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Figure	A-	68.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1h	in	CDCl3.	
3.1h
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Figure	A-	69.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1i	in	CDCl3.		
3.1i
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Figure	A-	70.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1j	in	CDCl3.	
3.1j
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Figure	A-	71.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.1k	in	CDCl3.	
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Figure	A-	72.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3a	in	CDCl3.	 
3.3a
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Figure	A-	73.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3b	in	CDCl3.	
3.3b
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Figure	A-	74.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3c	in	CDCl3.	
3.3c
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Figure	A-	75.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3d	in	CDCl3.	
3.3d
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Figure	A-	76.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3e	in	CDCl3.	
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Figure	A-	77.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3f	in	CDCl3.	
3.3f
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Figure	A-	78.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3g	in	CDCl3.	
3.3g
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Figure	A-	79.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3h	in	CDCl3.	
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Figure	A-	80.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3i	in	CDCl3.	
3.3i
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igure	A-	81.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3j	in	CDCl3.	
3.3j
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Figure	A-	82.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3k	in	CDCl3.	
3.3k
N
N
CF3
O
352	
	
 
	
Figure	A-	83.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3l	in	CDCl3.	 
3.3l
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Figure	A-	84.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.3m	in	CDCl3.  
3.3m
354	
	
 
	
Figure	A-	85.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4a	in	CDCl3.	
3.4a
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Figure	A-	86.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4b	in	CDCl3.	
3.4b
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Figure	A-	87.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4c	in	CDCl3.	
3.4c
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Figure	A-	88.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4d	in	CDCl3.	
3.4d
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Figure	A-	89.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4e	in	CDCl3.	 
3.4e
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Figure	A-	90.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4f	in	CDCl3.	
3.4f
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Figure	A-	91.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4g	in	CDCl3.	 
3.4g
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Figure	A-	92.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4h	in	CDCl3.	
3.4h
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Figure	A-	93.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4i	in	CDCl3.	 
3.4i
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Figure	A-	94.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4j	in	CDCl3.	
3.4j
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Figure	A-	95.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4k	in	CDCl3.	
3.4k
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Figure	A-	96.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4l	in	CDCl3.	
3.4l
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Figure	A-	97.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4m	in	CDCl3.	
3.4m
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Figure	A-	98.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4n	in	CDCl3.	
3.4n
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Figure	A-	99.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.4o	in	CDCl3.	
3.4o
369	
	
 
	
Figure	A-	100.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5a	in	CDCl3.	
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Figure	A-	101.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5b	in	CDCl3.	
3.5b
N
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Figure	A-	102.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5c	in	CDCl3.	
3.5c
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Figure	A-	103.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5d	in	CDCl3.	
3.5d
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Figure	A-	104.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5e	in	CDCl3.	
3.5e
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Figure	A-	105.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5f	in	CDCl3.	
3.5f
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Figure	A-	106.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5g	in	CDCl3.		
3.5g
N
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Figure	A-	107.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5h	in	CDCl3.	
3.5h
N
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Figure	A-	108.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	of	3.5i	in	CDCl3.	
 
3.5i
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Figure	A-	109.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.1c	in	CDCl3.	
4.1c
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Figure	A-	110.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.1d	in	CDCl3.	
4.1d
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Figure	A-	111.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.1f	in	CDCl3.	
4.1f
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Figure	A-	112.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.1h	in	CDCl3.	
4.1h
N O N
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Figure	A-	113.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.1i	in	CDCl3.	
N O N
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Figure	A-	114.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.1j	in	CDCl3.	
4.1j
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Figure	A-	115.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.1k	in	CDCl3.	
4.1k
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Figure	A-	116.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4aa	in	CDCl3.	
4.4aa
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Figure	A-	117.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ab	in	CDCl3.	
4.4ab
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Figure	A-	118.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ac	in	CDCl3.	
4.4ac
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Figure	A-	119.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ad	in	CDCl3.	
4.4ad
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Figure	A-	120.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ae	in	CDCl3.	
4.4ae
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Figure	A-	121.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4af	in	CDCl3.	
4.4af
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Figure	A-	122.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ag	in	CDCl3.	
4.4ag
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Figure	A-	123.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ah	in	CDCl3.	
4.4ah
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Figure	A-	124.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4bd	in	CDCl3.	
4.4bd
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Figure	A-	125.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4cd	in	CDCl3.	
4.4af
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Figure	A-	126.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4dd	in	CDCl3.	
4.4dd
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Figure	A-	127.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ed	in	CDCl3.	
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Figure	A-	128.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4be	in	CDCl3.	
4.4be
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Figure	S21.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4ce	in	CDCl3.	
4.4ce
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Figure	A-	129.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4de	in	CDCl3.	
4.4de
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Figure	A-	130.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4fe	in	CDCl3.	
4.4fe
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Figure	A-	131.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ge	in	CDCl3.	
4.4ge
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Figure	A-	132.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5aa	in	CDCl3.	
4.5aa
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Figure	A-	133.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ab	in	CDCl3.	
4.5ab
405	
	
	
Figure	A-	134.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ac	in	CDCl3.	
4.5ac
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Figure	A-	135.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ad	in	CDCl3.	
4.5ad
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Figure	A-	136.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ae	in	CDCl3.	
4.5ae
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Figure	A-	137.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ai	in	CDCl3.	
4.5ai
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Figure	A-	138.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5aj	in	CDCl3.	
4.5aj
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Figure	A-	139.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ag	in	CDCl3.	
4.5ag
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Figure	A-	140.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ah	in	CDCl3.	
4.5ah
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Figure	A-	141.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5bd	in	CDCl3.	
4.5bd
413	
	
	
	
Figure	A-	142.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5be	in	CDCl3.	
4.5be
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Figure	A-	143.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5cd	in	CDCl3.		
4.5cd
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Figure	A-	144.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ce	in	CDCl3.	
4.5ce
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Figure	A-	145.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5dd	in	CDCl3.	
4.5dd
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Figure	A-	146.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5di	in	CDCl3.	
4.5di
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Figure	A-	147.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ha	in	CDCl3.	
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Figure	A-	148.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5hi	in	CDCl3.	
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Figure	A-	149.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ia	in	CDCl3.	
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Figure	A-	150.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.5ik	in	CDCl3.	
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Figure	A-	151.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4jd	in	CDCl3.	
4.4jd
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Figure	A-	152.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4kb	in	CDCl3.	
4.4kb
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Figure	A-	153.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4kc	in	CDCl3.	
N
O
tBu
OMe
4.4kc
425	
	
	
	
Figure	A-	154.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4je	in	CDCl3.	
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Figure	A-	155.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4jc	in	CDCl3.	
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Figure	A-	156.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4ke	in	CDCl3.	
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Figure	A-	157.	500	MHz	1H	and	125	MHz	13C{1H}	NMR	spectra	of	4.4jf	in	CDCl3.	 
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